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Abstract
The purpose of this work was to develop a novel prokaryotic two-hybrid (P2H) system for the 
detection of protein-protein interactions in vivo. The system is based on the transcriptional 
activation and DNA binding domains of the Sinorhizobium meliloti 2011 enhancer binding 
protein NifA. This protein is responsible for the transcriptional activation of several n if  and fix  
genes, including the nifHDK operon, in response to cellular oxygen and/or nitrogen status.
NifA is modular in nature and has three independently folded domains. The central domain of 
about 220 amino acids is responsible for the activation of transcription. The function of the N- 
terminal domain is unknown while the C-terminal domain contains a helix-turn-helix motif 
that is required for binding to a specific upstream activator sequence. PCR was used to 
amplify the individual domains of the NifA protein and also to amplify the nifH  promoter. 
The PCR products obtained were used to construct suitable plasmids and reporter gene 
constructs for the P2H system.
Three pKK223-3 based Prey plasmids were constructed using the N-terminal-central (NC) 
transcriptional activation domain of NifA. Cloning of a known gene or a library of DNA 
fragments into the multiple cloning site (MCS) of any of these plasmids generates hybrid 
proteins bearing the N terminal-central (NC) activation domain of NifA. The three Prey 
plasmids differed from each other only in the reading frame of the MCS relative to the 
upstream NifA activation domain sequence. The purpose of constructing these three plasmids 
was to facilitate library construction. Another pKK223-3 based Control plasmid expressing 
the whole NifA protein was also constructed.
Two pACYC184 based Bait plasmids were also constructed encoding the sequence for the C- 
terminal DNA binding domain o f NifA. Cloning into the MCS of the Bait construct on either 
of the plasmids results in the expression of a hybrid protein bearing the DNA binding domain 
of NifA. In addition to the Bait construct these plasmids also maintained the reporter gene 
constructs. One of the Bait plasmids contained a nifH. lacZa reporter gene construct while the 
other contained a nifH:genf (gentamycin resistance) reporter gene construct. These Bait 
plasmids were compatible with the Prey plasmids and the Control plasmid.
In addition to the construction o f the above mentioned plasmids suitable host strains of E. coli 
were developed in which the plasmids could be used. These strains had deletions of the glnG 
gene since the product of this gene, NtrC, had been observed to weakly activate the nifH  
promoter and could therefore contribute to false positives. Two glnG mutant strains of E. coli 
called ET6016 and YMC11 were obtained. These lacked the correct lacZa complementation 
background required for the nifH .lacZareporter system to function and so the correct genetic 
background was introduced into the two strains on an F ’ factor by conjugation to form strains 
ET6016r//F' and YMC1 \rifF'.
Having constructed the appropriate plasmids, developed suitable strains and optimised growth 
conditions under which the novel NifA based P2H system would be used, the system was 
evaluated with the model protein-protein interaction between the appropriate domains of the 
intimin protein and the Tir receptor of enteropathagenic E. coli which had been demonstrated 
in a yeast two-hybrid system by another laboratory. The sequence for the Int280oc protein was 
cloned into the pPC229-A Prey plasmid to form plasmid pPC233 which expressed a hybrid 
protein consisting of the Int280a protein fused to the NifA transcription activating NC 
domain. The sequence for the Tir protein was cloned into the pPC187-A Bait plasmid to form 
plasmid pPC190 which expressed a hybrid protein consisting of the Tir protein fused to the C- 
terminal DNA binding domain of NifA. The plasmids pPC233 and pPC190 were co­
transformed into the E. coli strain ET6016r/yF’ which was then plated on appropriate selective 
media to test for activation of the nifH:lacZa reporter gene. No interaction between Tir and 
Int280oc hybrid proteins was detected and the possible reasons for the failure to detect an 
interaction are discussed.
Chapter 1
Introduction.
1.1; Protein-Protein Interactions And Their Biological Significance.
Protein-protein interactions are intrinsic to virtually every cellular process. DNA 
replication, transcription, translation, splicing, secretion, cell cycle control, signal 
transduction and intermediary metabolism are all processes in which protein complexes 
and protein-protein interactions have been implicated as essential components (Phizicky 
and Fields, 1995). In consequence, the analysis o f protein-protein interactions is no longer 
exclusively the domain o f the biochemist. Geneticists, cell biologists, molecular biologists 
and developmental biologists, to name just a few, have all by necessity become involved in 
the analysis o f protein-protein interactions. The identification and characterisation of 
protein-protein interactions has led to significant insights into many different biological 
processes and their underlying mechanisms.
Protein-protein interactions are self-evident in multi-subunit proteins. Such proteins are 
found in many classes o f proteins and include classical proteins such as haemoglobin, 
tryptophan synthetase and core RNA polymerase. Other well known examples of multi­
subunit proteins include much more complicated assemblies o f polypeptides. These include 
metabolic enzymes such as pyruvate dehydrogenase and a-ketoglutarate dehydrogenase 
complexes, the DNA replication complex of Escherichia coli and other organisms, the 
bacterial flagellar apparatus, ribosomes, the nuclear pore complex and the tail assembly of 
bacteriophage T4. Although some of the subunits o f these proteins are not tightly bound, 
activity is associated with a large structure that in many cases is called a protein machine 
(Alberts and Miake-Lye, 1992).
There are also a large number of transient protein-protein interactions, which in turn 
control a large number of cellular processes. All modifications of proteins necessarily 
involve such transient protein-protein interactions. These include the interactions of protein 
kinases, protein phosphatases, glycosyl transferases, acyl transferases, proteases etc., with 
their substrate proteins. Such protein modifying enzymes encompass a large number of 
protein-protein interactions in the cell and regulate all manner of fundamental processes 
such as cell growth, cell cycle, metabolic pathways, and signal transduction. Transient 
protein-protein interactions are also involved in the recruitment and assembly of the 
transcription complex to specific promoters, the transport of proteins across membranes,
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the folding of native proteins (catalysed by chaparones), individual steps in the translation 
cycle, and the breakdown and reformation of sub-cellular structures during the cell cycle. 
Such transient complexes are by their very nature difficult to study, especially by 
biochemical methodologies, because the proteins or conditions responsible for the transient 
reaction have to be identified first.
Because of their biological significance a vast array of biochemical and genetic 
methodologies have been developed to facilitate the identification and analysis of protein- 
protein interactions, and in recent years there has been an explosion in the development of 
novel innovative technologies for this purpose. The development of such technologies is 
becoming ever more important with the onset o f genomics.
1.2: G en om ic  Sequencing  A nd F unction al G enom ics.
Genomic analysis is currently enjoying exponential growth and for many biologists the new 
millennium marks the beginning of the era of genomics. During the past few years the 
sequencing of several eukaryotic and dozens of prokaryotic genomes have been completed 
and many more sequencing projects are under way. A list of completed microbial 
sequencing projects is given in Table 1.2.1 below while Table 1.2.2 lists microbial 
sequencing projects that are in progress. A list of current microbial genome sequencing 
projects can be found at the web site o f the institute of genomic research (www.tigr.org/). 
This genomic sequence information has the potential to revolutionise biological research 
by providing scientists with a very powerful tool for studying the biology of organisms.
The availability of extensive genomic information makes it possible to carry out 
comparative genomic analysis, particularly in the context of determining evolutionary 
relationships between organisms. The comparison of multiple genome sequences can 
reveal important functional information; characteristics conserved in an evolutionary 
lineage indicate important functions within that lineage while sudden shifts indicate 
functional change. We can also begin to compare the genomes of closely related organisms 
such as the laboratory strain of E. coli K12 and the strain 9157 (which was responsible for
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several recent outbreaks o f food poisoning) with a view to understanding the genetic basis 
for differences in pathogenicity between the strains. Similar analysis could be performed 
for other pathogenic species like Mycobacterium tuberculosis.
Two major challenges now face us with respect to extensive genomic sequence 
information. The first o f these is concerned with storing, accessing and analysing the vast 
amount o f genetic information. These problems can be addressed with the development of 
new improved, easily accessible and searchable computer databases. The second challenge 
is concerned with interpreting the information in biological terms.
Table 1.2.1: Published Microbial Genomes And Chromosomes.
Genome Genome
Aeropyium pernix A Leishmania major Chrl E
Aquifex aeolicus B Listeria monocytogenes B
Archaeoglobus fulgidus A Methanobacterium thermoautotrophicum A
Bacillus halodurans B Methanococcus jannaschii A
Bacillus subtilis B Mycobacterium tuberculosis B
Borrelia burgdorferi B Mycoplasma genitalium B
Campylobacter jejuni B Mycoplasma pneumoniae B
Chlamydia pneumoniae B Plasmodium falciparum Chr2 E
Chlamydia pneumoniae B Plasmodium falciparum Chr3 E
Chlamydia trachomatis B Pyrococcus abyssi A
Chlamydia trachomatis B Pyrococcus horikoshii A
Deinococcus radiodurans B Rickettsia prowazekii B
Escherichia coli B Saccharomyces cerevisiae E
Haemophilus influenzae Rd B Synechocystis sp. B
Helicobacter pylori B Thermotoga maritima B
Helicobacter pylori B Treponema pallidum B
Lactococcus lactis B
Key: A= Archaebateria B= Eubacteria E= Eukaryotes
The sequencing o f whole genomes results in the identification o f a large number o f novel 
genes encoding proteins whose functions and interactions with other proteins have to be 
determined. When the first complete bacterial genome sequence (Haemophilus influenza) 
was published in 1995, 40% o f the predicted genes had no known function and half of 
these were 'new', i.e. they did not match anything in the databases at the time (Fleischmann 
etal, 1995).
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Tablel.2.2: Microbial Genomes And Chromosomes Currently Being
Scquenced.
Genome Genome
Actinobacillus actinomycetemcomitans B Neisseria meningitidis (Serogroup C strain FAM18) B
Aspergillus nidulans E Neurospora crassa E
Bacillus anthracis B Nitrosomonas europaea B
Bacillus stearothermophilus B Pasteurella haemolytica B
Bordetella bronchiseptica B Photorhabdus luminescens B
Bordetella parapertussis B Plasmodium falciparum Chrl ,4,5,6,7,8,9, / 3 E
Bordetella pertussis B Plasmodium falciparum Chrl 0,11 E
Candida albicans (1161) E Plasmodium falciparum Chrl4 E
Candida albicans (SC5314) E Pneumocystis carinii (f. sp. carinii) E
Caulobacler crescentus B Pneumocystis carinii (f. sp. hominis) E
Chlamydia pneumoniae B Porphyromonas gingivalis B
Chlamydia trachomatis B Prochlorococcus marinus B
Chlorobium lepidum B Pseudomonas aeruginosa B
Clostridium acetobutylicum B Pseudomonas putida B
Clostridium difficile B Pyrobaculum aerophilum ACoiynebacterium diphtheriae B Pyrococcus furiosus A
Corynebacterium glutamicum B Ralstonia solanacearum B
Dehalococcoides ethenogenes B Rhodobacter capsulatus B
Dictyostelium discoideum Chr 2 E Rickettsia conorii B
Encephalitozoon cuniculi E Salmonella typhi B
Enterococcus faecalis B Salmonella typhimurium (SGSCI412) B
Francisella tularensis B Salmonella typhimurium (TR7095) B
Geobacter sulfurreducens B Schizosaccharomyces pombe E
Giardia lamblia E Shewanella putrefaciens B
Haemophilus ducreyi B Shigella flexneri 2a B
Halobacterium salinarium A Sinorhizobium meliloti B
Halobacterium sp. A Staphylococcus aureus (COL) B
Klebsiella pneumoniae B Staphylococcus aureus (8325) B
Lactobacillus acidophilus B Staphylococcus aureus (MRSA) B
Legionella pneumophila B Staphylococcus aureus (MSSA) B
Leishmania major Chr3(Friedlin) E Streptococcus agalactiae B
Leishmania major Chr4(Friedlin) E Streptococcus mutans B
Leishmania majorChr5,13,14,19,21,23(Friedlin) E Streptococcus pneumoniae B
Leishmania major Chr27(Friedlin) E Streptococcus pyogenes B
Leishmania major Chr35 (Friedlin) E Streptococcus pyogenes (Manfredo ) B
Leptospira interrogans serovar icterohaemorrhagiae B Streptomyces coelico/or B
Listeria innocua B Sulfolobus solfataricus A
Methanococcus maripaludis A Thermoplasma acidophilum A
Methanosarcina mazei A Thermoplasma volcanium A
Methylobacterium extorquens B Thermits thermophilus B
Methylococcus capsulatus B Thiobacillus ferrooxidans B
Mycobacterium avium B Treponema denticola B
Mycobacterium bovis B Trypanosoma brucei Chrl E
Mycobacterium leprae B Trypanosoma brucei E
Mycobacterium tuberculosis B Ureaplasma urealyticum B
Mycoplasma mycoides subsp. mycoides SC B Ustilago maydis E
Mycoplasma pulmonis B Vibrio cholerae B
Neisseria gonorrhoeae B Xanthomonas citri B
Neisseria meningitidis (MC58) B Xylella fastidiosa B
Neisseria meningitidis (serogroup A strain Z2491) B Yersinia pestis B
Key: A= Archaebateria B= Eubacteria E= Eukaryotes
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Similarly, 60% of the yeast Saccharomyces cerevisiae genes had no assigned function and 
half o f these encoded putative proteins that had no homology with known proteins (Dujon,
1996). The determination of protein functions from genome sequences has emerged as the 
next major challenge in molecular biology and for this reason much attention is now being 
focused on functional genomics.
The field of functional genomics seeks to devise and apply novel technologies that take 
advantage of the growing body of sequence information to analyse the full complement of 
genes and proteins encoded by an organism (Fields et cil, 1999). One of the first steps in 
determining possible functions of novel proteins is identifying their interactions with other 
proteins. As already mentioned, there has been an explosion of novel technologies that 
facilitate the analysis o f protein-protein interactions and other molecular interactions of 
biological significance. The ultimate goal is to apply these technologies for the elucidation 
of protein-protein interaction networks and the generation o f proteomic interaction/protein 
linkage maps for entire organisms (Bartel et al, 1996). The integration of protein 
interaction maps with genomic sequence information will greatly advance our 
understanding of complex biological processes and will help to establish an image that 
accurately reflects how individual genes and their protein products interact to create the 
complex world of biological specialisation. In addition to this it will have a dramatic effect 
on medicine through the identification o f genes and mutations involved in disease and by 
greatly accelerating the discovery of novel therapeutic targets.
1.3: Identification And Analysis Of Protein-Protein Interactions.
Traditionally protein-protein interactions were studied using physical biochemical methods 
such as affinity chromatography, affinity blotting and co-immunoprecipitation (methods 
reviewed in Phizicky and Fields, 1995). More recent strategies have taken advantage of 
genetic methods to isolate genes encoding polypeptides that interact with a protein of 
interest. Such strategies include the screening of protein expression libraries with labelled 
protein probes and the use of phage display (Smith, 1985), E. coli display (Wilson and 
Beveridge, 1993; Lu et al, 1995) and Yeast display (Boder and Wiltrup, 1997) techniques.
6
The phage display technique was expanded upon with the development of Selective 
Infective Phage (SIP) technology (Spada and Plunkthun, 1997). All of these methodologies 
essentially detect protein-protein interactions in vitro.
The advent of the yeast two-hybrid system (Y2H) has accelerated the pace of in vivo 
interaction analysis and few would dispute that o f all of the methods currently available, 
the Y2H system is a powerful and efficient method for the identification and analysis of 
protein-protein interactions. Since its original description by Fields and Song in 1989 the 
Y2H system has been used extensively to identify and study protein-protein interactions 
from a wide range of organisms and a very large number of reviews describing the system 
have been published (Fields and Sternglanz, 1994; Allen et al, 1995; Luban and Goff, 
1995; Bartel and Fields, 1995; Bai and Elledge, 1996; Brent and Finley, 1997; Warbrick,
1997). The system is easy to use and results in the immediate availability of the cloned 
genes for any proteins identified as interacting with a protein of interest (Chien et al, 1991). 
These features, along with the fact that interactions are detected in vivo, which abrogates 
the need for purification of proteins, guarantee the continued popularity of the Y2H system 
as we enter the age o f functional genomics.
1.4: The Yeast Two-Hybrid System.
The conceptual basis for the Y2H system was established from the accumulated 
understanding o f the factors involved in the regulation o f eukaryotic gene expression.
1.4.1: Gene Expression.
The entire complement of genes in a single cell represents a staggering amount of 
biological information. Some of this information is needed by the cell all of the time; for 
example, most cells continuously synthesis ribosomes and thus there is a continuous 
requirement for transcription of rRNA and ribosomal protein genes. Similarly, genes 
coding for enzymes such as DNA polymerase or those involved in basal metabolic 
pathways are active all o f the time. These genes are sometimes referred to as housekeeping
genes reflecting the nature o f the biological information that they encode. On the other 
hand, many genes have a more specialised role and expression of their biological 
information depends on the cell growth rate or environmental conditions.
Control o f gene expression is in essence control of the amount of gene product in the cell. 
This amount is a balance between two factors:
a .) The rate of product synthesis b .) The rate of product degradation
The result of this balance is a steady state concentration for each gene product in the cell. If 
either the rate of synthesis or degradation of a particular gene product changes then the 
steady state concentration o f that gene product will change. In practice critical variations in 
the steady state concentration of a gene product arise due to changes in the rate of product 
synthesis while the rate of product degradation seems to be relatively constant.
Synthesis o f a particular gene product can be regulated by exerting control over any one or 
a combination of the various steps involved in the gene expression pathway;
•  Transcription.
•  mRNA Processing.
•  mRNA Turnover.
•  Translation.
Control o f gene expression is highly complex involving each of the above strategies. 
However, the best understood mechanisms in both prokaryotes and eukaryotes depend 
solely on transcriptional regulation. This is not surprising, it makes sense that a cell should 
not waste energy by making more mRNA than it needs.
1.4.2: Transcriptional Regulation And DNA Binding Proteins.
As well as being the essential step in the conversion of the genetic information in the DNA 
into protein, the process o f transcription is also the major point at which gene expression is 
regulated. In most cases gene regulation is achieved by activating or repressing the 
transcription of a particular gene in specific cell types or in response to a specific signal.
Once this has occurred, all o f the other stages of gene expression follow and the 
appropriate protein is produced in a cell type specific or inducible manner.
Processes such as attenuation can influence the rate at which a particular gene is 
transcribed but specific DNA binding proteins called transcription factors primarily 
regulate transcription. These proteins bind to specific short DNA sequences that may lie 
within the promoter or further upstream from the promoter of the gene they are responsible 
for regulating (Collado-Vides et al, 1991; Gralla and Collado-Vides). Transcriptional 
activator proteins usually bind to specific sequences that lie upstream of the promoters for 
genes they regulate. These binding sites are referred to as Upstream Activating Sequences 
(UAS).
The study of transcription factors is a critical aspect of gene regulation studies. A large 
number of transcriptional activator proteins have been studied and the majority of these 
have been found to have distinct functional domains;
•  A DNA binding domain (DBD) responsible for binding o f the transcription 
factor to its cognate DNA sequence.
•  A transcriptional activation domain (AD) responsible for activation of 
transcription via interactions with core RNA polymerase.
The important feature of some of these transcription factors such as Gal4 (Keegan et al, 
1986) and GCN4 (Hope and Struhl, 1986) is that these functional domains can be 
physically separated from each other and still retain their functionality i.e. the domains can 
function independently o f each other. The truly modular nature of transcription factors was 
demonstrated by an experiment in which a hybrid LexA-Gal4 fusion protein was found to 
activate transcription in yeast containing a reporter gene under the control of LexA operator 
sequences (Brent and Ptashne, 1985). In the case of this fusion protein the DNA binding 
activity was provided by the LexA component and the activation function by the Gal4 
component. Not only can heterologous DNA binding and activation domains function as a 
single fusion protein, but these two domains can also function when non-covalently joined 
via protein-protein interactions. This was first demonstrated for the naturally occurring 
protein Oct-1, which possesses a DNA binding domain that locates it to certain promoters. 
However, it only activates these promoters when it is further complexed with a
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transcription activation domain provided by the Herpes Virus protein, VP 16 (McKnight et 
al, 1987). This phenomenon is now called recruitment. At about the same time, Ma and 
Ptashne (1988) demonstrated that a DNA-bound Gal4 derivative, which could not activate 
transcription, did activate transcription when it recruited a chimeric protein that contained a 
Gal4-interacting protein (Gal80) and a wild type Gal4 transcriptional activation domain. 
These observations formed the basis for the Y2H System.
1.4.3: Principle Of The Two-Hybrid System.
It was independent work by Fields and Song (1989) that resulted in the first Y2H system 
which takes advantage of the modular domain structure of eukaryotic transcription factors. 
The system utilises hybrid genes to detect protein-protein interactions by means of 
activation of reporter gene expression. Two putative protein partners, X  and Y, are 
genetically fused to a DNA binding domain (DBD) and a transcriptional activation domain 
(AD), respectively. These hybrid genes are then co-expressed in a suitable yeast strain that 
contains a reporter gene (usually lacZ or a nutritional marker) that is under the 
transcriptional control o f a specially constructed promoter bearing cognate DBD binding 
sequences. Productive interactions between the two proteins of interest brings the 
transcriptional AD into proximity with the DNA bound DBD and triggers the transcription 
o f the adjacent reporter gene resulting in a screenable phenotype (see Figure 1.4.1).
1.4.4: Components Of The Y2H System.
The initial Y2H system devised by Fields and Song was based on the Gal4 transcriptional 
activator from the yeast Saccharomyces cerevisiae. This protein consists of 881 amino 
acids (Laughon and Gesteland, 1984) and is required for the expression of the genes 
involved in galactose utilisation (Johnston, 1987)', gall, gal2, gal7 and gallO. The Gal4 
protein consists of two separable and functionally essential domains (Keegan et al, 1986; 
Ma and Ptashne, 1987a);
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•  An N-terminal DNA binding domain (amino acids 1-147) which binds to 
a specific DNA sequence found upstream o f promoters for genes involved 
in galactose utilisation such as the gall gene.
•  A C-terminal domain (amino acids 768-881) which is necessary for 
activation o f transcription.
Fields and Song demonstrated the system using two yeast proteins known to interact with 
each other, SNF1 and SNF4. Using the sequences for the Gal4 domains and the sequences 
for SNF1 and SNF4 they constructed two plasmids, pEE5 and pNI12.
Figure 1.4.1: Schem atic D iagram  D ep ictin g  T h e A ctivation O f T ranscrip tion  In A 
T y p ica l E u k aryotic  System  A n d  In T h e T w o H yb rid  System .
A.)
B.)
(A ) A ctivation  o f  transcription by a  typical eukaryotic transcriptional activator with separable D N A  
binding dom ain  (D B D ) and activation  dom ain  (A D ). (B) A ctivation  o f  transcription by chim eric 
proteins in a  two hybrid system . X  represents a  given  protein fu sed  to a  sp ec ific  D B D . In library screens 
this protein is term ed the 'bait'. Y  represents a  given  protein, or a  pool o f  proteins encoded by a  D N A  
library fu sed  to a  transcriptional activation  dom ain. Th is fusion  protein is often term ed the ’prey1. I f  X  
and Y  bind to each other, the A D  is brought to the vicinity  o f  the D N A  bound D B D  and transcription is 
activated  from  the ad jacen t prom oter.
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Plasmid pEE5 expressed a hybrid protein containing the Gal4 DBD (aa's 1-147) fused N- 
terminally to SNF1. Hybrid proteins, such as this one, bearing DBD's are now commonly 
referred to as Bait proteins and the plasmids expressing these proteins are referred to as 
Bait vectors. The Gal4 DBD contained its own nuclear localisation signal (Silver et al, 
1984) which meant that the hybrid protein would be localised to the nucleus and the 
plasmid also had a HIS 3 nutritional marker gene to allow independent selection for the 
plasmid.
Plasmid pNI12 expressed a hybrid protein containing the SNF4 protein fused N-terminally 
to the Gal4 AD (aa's 768-881). Hybrid proteins, such as this one, bearing AD's are now 
often referred to as Prey proteins and the plasmids expressing them are called Prey vectors. 
This vector contained a LEU2 nutritional marker gene to allow independent selection for 
the plasmid.
The two plasmids were co-transformed and expressed in the yeast strain GGY1::171 (Gill 
and Ptashne, 1987) which was deleted for both the Gal4 and Gal80 (a negative inhibitor of 
Gal4). The strain also had a fusion between a gall promoter and a lacZ gene integrated into 
the chromosome and mutations in the HIS3 and LEU2 genes to allow positive independent 
selection for each of the plasmids. Interaction of the Gal4(DBD)-SNFl and SNF4- 
Gal4(AD) was determined on the basis of (3-galactosidase activity using X-gal.
The Prey vector used in the initial experiment was later improved upon by Chien et al 
(1991). In the original paper by Fields and Song (1989), the Gal4 AD was fused C- 
terminally to SNF4. Although the C-terminal location for the Gal4 activation domain 
corresponded to its normal position within the Gal4 protein, this location was inconvenient 
for the construction of libraries of Prey (Activation Domain) hybrid proteins. It was 
therefore investigated whether the Gal4 AD could function at the N-terminus of hybrid 
proteins. This required the Gal4 termination sequence to be eliminated by mutagenesis and 
because the C-terminal DNA sequence for the Gal4 AD lacked its own endogenous 
initiation codon and nuclear localisation signal sequence, these had to be provided. A 
heterologous signal sequence consisting of the sequence for the first five codons of the 
SV40 large T-antigen was used. Three new Prey vectors called pGADl, pGAD2 and
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pGAD3, which differed from each other only in the reading frame o f the unique BamHl 
site, were constructed (see Figure 1.4.2).
•  Figure 1.4.2: pGAD Prey Vector Constructed By Chien et al 1991.
Pro = Pronto ter
n il = Nuclear Localisation sequence
Vector Readm e Frame O f BamHl Site
pGADl GGATCC
pGAD2 XGGATC CXX
pOAD3 XXG GAT CCX
LEU2
nls G a I4 (A D )
Pro
pBR322 
ori
Using the pGAD3 vector Chien et al constructed a hybrid between the Gal4 AD and the 
yeast SNF4 protein. The hybrid Gal4(AD) protein was tested for its ability to interact with 
originally constructed Gal4(DBD)-SNFl hybrid which was expressed from the pEE5 Bait 
vector. It was found that the Gal4 activation domain could function at the N-terminus of 
hybrids since significant gall-lacZ  activity, comparable to that obtained with the original 
SNF4 hybrid, was obtained. This demonstrated that the pGAD vectors were suitable for 
testing defined protein-protein interactions.
Placement o f  the Gal4 AD at the N-terminus meant that the same vector encoded yeast 
promoter, initiation codon and nuclear localisation signal sequence could be used for all 
gene fusions. This facilitated easier construction o f libraries o f AD hybrid proteins by 
allowing a single fusion joint between the Gal4 AD and heterologous proteins to be used. 
In performing library screens a library o f AD hybrids would be constructed by cloning a 
cDNA library into the unique BamHl site o f one o f the pGAD vectors. However, only a
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small proportion of a cloned cDNA population would be in frame with the upstream Gal4 
AD sequence. It was for this reason that Chien et al (1991) constructed three versions of 
the pGAD vector which differed only in the reading frame of the unique BamHl site with 
respect to the upstream Gal4 AD sequence, one vector for each possible reading frame. The 
same cDNA population would therefore be cloned into each o f the three pGAD vectors to 
ensure that an in frame fusion between every cDNA in a population and the Gal4 AD 
would be obtained. Chien et al (1991) demonstrated the usefulness o f the system for 
performing library screens using the Sacchromyces cerevisiae protein Sir4 that plays a role 
in determining yeast mating type. They transformed a yeast strain that expressed a bait 
protein, Sir4 fused to the Gal4 DBD, with pGAD based libraries expressing yeast proteins 
fused to the Gal4 AD and identified transformants that turned blue on the indicator X-gal 
plates. While some of the identified library plasmids in the blue colonies encoded Gal4, 
which bound to the Gal4 sites on the reporter, others encoded proteins that interacted with 
Sir4. These included Sir4 itself (as expected from previous experiments) and a new Sir4- 
interacting protein, Sfil.
The work done by Chien et al (1991) defined the basic structure for Y2H system vectors 
and although many improvements have been made to the Y2H system vectors since then, 
primarily through the expansion of multiple cloning sites (MCS's), the basic structure of 
Y2H system vectors has remained the same. Several laboratories have constructed Y2H 
system vectors (see Table 1.4.1) (Bartel and Fields, 1995). Durfee et al (1993) constructed 
vectors using the Gal4 DBD and the Gal4 AD, Vojtek et al (1993) constructed a system 
employing the LexA DBD and the Herpes virus VP 16 AD and Gyuris et al (1993) 
constructed a system employing the bacterial LexA DBD and the E. coli B42 AD. The 
system developed by Gyuris et al (1993) and further developed by Golemis et al (1997) is 
often referred to as the interaction trap assay and is commercially available from Invitrogen 
Corporation. Because it employs the LexA DBD, and thus reporter genes controled by 
LexA binding sites, it has several advantages over the standard two-hybrid systems that 
employ Gal4 DBD's. First, it is not necessary to use gal4 deleted strains which are often 
unhealthy. Second, in the case of library screens using yeast proteins, it is not necessary to 
remove false positives caused by re-cloning of Gal4.
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As with the initial pGAD vectors, many of the newly constructed commercially available 
vectors have been constructed with the MCS's in all three reading frames. In some 
instances, such as the pGAD424 Prey and pGBT9 Bait vectors (Roder et al, 1996) which 
are available from Clontech, the versatility of the vectors has been further increased by also 
making both vectors with inverted MCS's in all three reading frames.
Table 1.4.1:Vectors For The Yeast Two Hybrid System (Bartel and Fields, 1995)
Plasmid Domain Restriction Sites Marker
pMA424Gal4 bd
DNA-Binding Domain Vectors
ÊcoRI, S  mal, BamHl, Sali, Pstl HIS3
pGBT9 Gal4 bd £coRl, Smal, BamHl, Sa li, Pstl TRP1
pASl Gal4 bd Ndel, Ncol, Sf'tl, Smal, BamHl TRP1
pAS2 Gal4 bd NdeI, Ncol, Sfîl, Smal, BamHl TRP1, C YH2
pCP62 Gal4 bd Sali, Pstl, Smal, Spel, Xbal, Notl, SacII LEU2
pBTMl 16 LexA £coRI, Smal, BamHl, Sali, Pstl TRP1
lex(l-202)PL LexA ZscoRI, Smal, BamHl, Sali, Pstl HIS3
pGAD.F Gal4 ad
Activation Domain Vectors
BamHl LEU2
pGAD424 Gal4 ad EcoRI, Smal, BamHl, Sali, Pstl, Bglll LEU2
pGAD.GH Gal4 ad EcoRI, Smal, BamHl, Sali, Spel,Xhol LEU2
pACT Gal4 ad EcoRI, BamHl, Xhol, Bgll LEU2
pGADNOT Gal4 ad BamHl, Notl, Sali LEU2
pPC86 Gal4 ad Sali, Smal, EcoRI, Bglll, Spel, Notl TRP1
pJG4-5 B42 £coRl, Xhol TRP1
pVP16 VP 16 BamHl, Notl LEU2
pSD.10 VP 16 EcoRI, Bstl, Xhol URA3
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The most significant improvements to the Y2H system since its initial description have 
been concerned with the development of new reporter gene systems. Reporters derived 
from the yeast LEU2 (Gyuris et al, 1993) and HIS3 (Vojtek et al, 1993; Durfee et al, 1993) 
genes were developed and allow direct selection for yeast cells expressing interacting 
hybrid proteins. This has greatly facilitated library screens by allowing higher plating 
densities which increases the probability of detecting low abundance interacting partners in 
large complex libraries.
Reporter genes can either be integrated into the chromosome or maintained on 
independently replicating plasmid vectors. For example, the plasmid vectors pSH18-34, 
pRB1840 and p.TKl 03 (Golemis et al, 1997), which are available from Invitrogen 
Corporation, have lacZ reporter constructs on them. These can be transformed into yeast 
strains bearing integrated auxotrophic reporters, such as strain EGY48 and EGY191 
(Golemis et al, 1997) available from Invitrogen (see Table 1.4.2 below), to allow dual 
reporter selection. The location of the reporter gene has a significant affect on the 
sensitivity of a system. Phenotypes derived from integrated reporters tend to be weaker 
than those derived from plasmid borne reporters and thus systems employing integrated 
reporter genes tend to be less sensitive to weak interactions. However, most systems utilise 
specific yeast reporter strains with integrated reporter constructs (see Table 1.4.2). The 
sensitivity of the assay is manipulated by varying the number of UAS's present in the 
reporter constructs (strains EGY191 and EGY48 in Table 1.4.2; EGY191 has a LEU2 
reporter with two LexA operator sites while EGY48 has a reporter with six LexA operator 
sites). The greater the number of UAS sites the more sensitive the system but it is 
important to note that increasing the sensitivity of the assay also has the effect of increasing 
the number of false positives that are obtained when performing library screens. The 
reasons for false positives and methods employed to eliminate them are the discussed later.
Many systems now employ dual reporter selection (see strains L40, Y190 and Hflc in Table
1.4.2). This simply means that they use two distinct reporter genes, usually lacZ and HIS3 
(Vojtek et al, 1993; Durfee et al, 1993) or LEU2 (Gyuris et al, 1993; Golemis et al, 1997), 
simultaneously. In some yeast reporter strains the two reporter genes, employed are driven 
by unrelated promoters that have had UAS's for a Gal4 or a LexA DBD incorporated 
upstream of their transcriptional start sites (see strain Hf7c in Table 1.4.2: strain utilizes a
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g a ll  promoter:HIS3 reporter and an unrelated CYC1 promoter:/acZ reporter). Huang and 
Schreiber (1997) produced two such strains by introducing a second URA3 reporter gene 
under the transcriptional control o f a SP013 promoter with four upstream LexA operator 
sites into strains EGY48 and EGY191. The use o f dual reporter strains like these where 
individual reporter genes are driven by unrelated promoters can help to significantly reduce 
the number o f false positives detected while performing library screens. This is discussed 
in greater detail later in this literature review.
T a b le  1 .4 .2 : R e p o r te r  s t r a in s  F o r  T w o -H v h rid  S y ste m s (B artel a n d  F ields. 1995)
I i [ i fyiXi YTtvitZi f 7?1 u f rm1 *
GGY1..171 gall-lacZ his3, leu2
PCY2 gall-lacZ his3, leu2, trpl
Y526 gall-lacZ his3, leu2, trpl
Y527 CYCl-lacZ his3, leu2, trpl
Y190 gall-lacZ
g a ll-m S 3
leu2, trpl
Hf7c CYCl-lacZ
gaU-HIS2>
leu2, trpl
, L40 41exAop-HIS3
SlexAop-lacZ
his3, leu2, trpl
EGY48 6/ex.4op-LEU2 his3, leu2, trpl
EGY191 2feo4op-LEU2 leu2, trpl, ura3
The availability o f a wide range o f systems employing a wide range o f different reporters 
and exhibiting varying levels o f sensitivity is o f great benefit to an experimenter, allowing 
the selection o f a system exhibiting the characteristics and the degree o f sensitivity best 
suited to a specific application. The ease o f performing library screens has also been 
significantly increased by the commercial availability o f pre-constructed Prey hybrid 
protein libraries for specific cell types, tissues and organisms from companies such as 
Invitrogen Corporation.
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The two-hybrid system is an extremely sensitive method for the detection of protein- 
protein interactions. It is capable of detecting in vivo binding that is often beyond the limits 
o f in vitro detection methods. For example, the interaction of the mammalian Ras protein 
with the protein kinase R af was observed in the Y2H system but had not been detected by 
co-immunoprecipitation (Aelst et al, 1993). Protein affinity chromatography is the most 
sensitive of the physical biochemical methods for detecting protein-protein interactions. 
With appropriate use (high concentrations of immobilised test protein), it can detect 
interactions with a binding constant as weak as 10‘5M (Formosa et al, 1991). On the basis 
o f binding of different proteins to the retinoblastoma protein, Durfee et al (1993) estimated 
that the minimal binding constant required to detect an interaction in their version of the 
Y2H system was on the order of l|oM (10'6 M). The sensitivity of the Y2H system depends
•  the number of UAS's in the reporter gene construct
•  the level o f expression of hybrid proteins.
• the amount of reporter protein required for a detectable phenotype.
As mentioned earlier, the greater the number o f UAS's placed upstream of the reporter gene 
construct the more sensitive the system. Most commercially available systems allow 
selection of the number of UAS's in reporter constructs and thus the selection of a system 
exhibiting the degree o f sensitivity best suited to a specific application. Hybrid proteins are 
usually over-expressed from strong promoters on high copy number vectors as this favours 
complex formation and increases the possibility of detecting weak protein-protein 
interactions. In addition to this, each reporter mRNA transcript induced by productive 
protein-protein interactions can be translated many times to generate several stable enzyme 
molecules. This type of amplification leads to a detectable signal even when the initiating 
interaction is weak.
Physical methods used for the detection of protein-protein interactions, such a co- 
immunoprecipitation, generally rely on a low rate of dissociation since complexes must 
survive several washes. This diminishes the signal but is necessary to prove specificity.
1.4.5: Why Is The Two-Hybrid System So Sensitive?
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This is not the case with Y2H system. In addition to this, the stability of the hybrid protein 
complex is “probably enhanced by the interaction of the activation domain with proteins 
from the transcription initiation complex that also associates with promoter DNA. This 
ternary complex formation increases the overall stability of the complex on the DNA and 
further increases the probability of detection.
Sensitivity of a given system also depends on the strength of the activation domain being 
used. The Prey vector used by Gyuris et al (1993) uses the relatively weak activation 
domain of E. coli B42. While this activation domain is weak, it may increase the spectrum 
of protein-protein interactions that can be detected by eliminating the toxic effects (called 
squelching) that strong activators can have in yeast (Gill and Ptashne, 1988). The system 
developed by Durfee et al (1993) uses the stronger Gal4 AD while the system employed by 
Vojtek et al (1993) uses the even stronger VP 16 AD.
The combination of the above factors generates the remarkable sensitivity of Y2H systems. 
In fact, the very sensitivity of these systems may present a problem when applying 
secondary biochemical assays such as co-immunoprecipitation or affinity chromatograph to 
examine the authenticity of the in vivo signal.
1.4.6: A dvan tages A n d  A pp lica tion s O f  The Yeast T w o-H ybrid  System .
The Y2H system has many advantages over biochemical and classical genetic methods for 
the detection and analysis o f protein-protein interactions. As already discussed the system 
is highly sensitive, detecting interactions that are not detected by other methods. As the 
assay is carried out in vivo the need for the detailed and laborious manipulation of 
conditions necessary for in vitro biochemical binding assays is abrogated and detected 
interactions are more physiologically relevant. In addition to this there is no need for 
biochemical purification of hybrid proteins.
The system can be used to screen libraries o f activation domain hybrids to identify proteins 
capable o f binding to a protein of interest. The use of well characterised genetic 
backgrounds in yeast hosts allows direct selection for interacting proteins through the use
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of appropriate reporter genes like HIS3 (Vojtek et al, 1993; Durfee et al, 1993) and LEU2 
(Gyuris et al, 1993; Golemis et al, 1997) rather than the laborious screening procedures 
required for biochemical methods. This direct selection allows high plating densities which 
increases the probability of detecting rare interacting partners in large complex libraries. It 
also makes Y2H systems simple to use and allows library screens to be performed very 
rapidly. These screens result in the immediate availability of the cloned gene for any new 
protein identified (Chien et al 1991) and this makes further analysis o f identified protein- 
protein interactions more feasible. Deletion mutants can be made to delineate domains 
important for interaction. This approach was employed by Holt et al (1994) to identify the 
192 residue domain o f the p85 subunit of phosphatidylinositol-3-kinase required for 
interaction with the pi 10 subunit of the enzyme. Once specific interacting domains have 
been identified point mutations may be made to identify specific residues that are important 
for interaction. This approach was employed by Li and Fields (1993) for the identification 
of residues important for the interaction of p53 with the SV40 large T antigen. 
Alternatively, the genes for identified proteins can be cloned into specialised vectors 
systems that simplify purification of the proteins for analysis by in vitro biochemical 
methods. Several such systems have been described and in each case the protein of interest 
is genetically fused to a protein or a domain that can be easily purified on an appropriate 
affinity resin. The most common such fusion contains glutathione S-transferase (GST), 
which can be purified on glutathione-agarose columns (Smith and Johnson, 1988).
Transcriptional activity can be proportional to binding affinity and so the Y2H system 
could be used to evaluate different binding affinities of mutant versions of either the bait or 
prey proteins. For example, with a reporter gene like the HIS3 gene the competitive 
inhibitor o f the HIS3 gene product, 3-aminotriazole, can be used to directly select for 
constructs which yield increased affinity. The presence of increasing concentrations of 3- 
aminotriazole requires higher levels o f HIS3 transcription (Durfee et al, 1993). In a similar 
way, 6 -azauracil can be used with a URA3 reporter as demonstrated in a version of the 
Y2H system using the DNA binding domain of the estrogen receptor (Le Douarin et al,
1995). The sensitivity o f the LEU2 promoter can also be adjusted by adding 6 - 
fluoroleucine to the medium (Brent and Finley, 1997). The Y2H system could also be used 
to establish dissociation values. This would first require the generation of a standard curve
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based on biochemically determined KD values of existing mutants. The system was used in 
this manner*"or the p53-SV40 large T antigen and a good correlation was observed between 
transcription level and affinity (Li and Fields, 1993). It is important to note however that 
the concentration of hybrid proteins, the stability of the hybrid proteins, the extent of 
nuclear transport, accessibility of protein domains to each-other and the accessibility of the 
activation domain to the transcription machinery can all affect the level o f transcriptional 
activity.
The system is widely applicable and has been used for the analysis o f a wide variety of 
proteins including those that normally reside in the nucleus, cytoplasm, mitocondria, in 
addition to membrane associated and extracellular proteins. Proteins can be targeted to the 
nucleus by nuclear localisation signals provided on the vector, such as the nuclear 
localisation signal o f the SV40 large T antigen (Chien et al 1991). However the fact the 
proteins must be targeted to the nucleus may limit the use of the system for certain 
extracellular or membrane bound proteins. This is discussed in more detail later.
1.4.7: A pp lica tion  O f  The Two H yb rid  S ystem  To Genom ics.
As mentioned earlier attempts are being made to apply the two-hybrid system at a genomic 
level for the characterisation of protein-protein interaction networks and the construction of 
proteomic linkage maps. Such protein linkage maps have been successfully completed for 
small genomes like that o f the bacteriphage T7 which encodes 55 proteins (Bartel et al, 
1996), and for subsets o f eukaryotic proteins like the Drosophila cell cycle regulators 
(Finley and Brent, 1994), the proteins of the pheromone response pathway in S. cerevisiae 
(Evangelista et al, 1996) and the yeast RNA polymerase III subunits (Flores et al, 1999). 
The current challenge is the systematic application of two-hybrid screens to every protein 
expressed in eukaryotic cells. Two different strategies are being pursued to apply the two- 
hybrid screen to the entire complement of proteins ('proteome') of the yeast S. cerevisiae 
whose entire genome sequence is available.
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Fromont-Racine et al (1997) have set out on an iterative approach using high frequency 
mating to screen small sets of related proteins against a high quality genomic library. DBD 
fusions and the library o f AD fusions are expressed in haploid yeast strains of the opposite 
mating type, mated on filters and plated on selective media to identify diploids positive for 
two-hybrid interactions. Proteins identified in this way are then used as baits in the next 
round of screens. A recent addition to this strategy is the attempt to simultaneously identify 
all two-hybrid positives from a screen by hybridisation of total plasmid DNA to DNA 
arrays (Cho et al, 1998).
is
Hudson et al (1998) have taken advantage of the availability o f the sequences for the 
approximately 6,000 open reading frames (ORF's) in the yeast genome. Each ORF can be 
expressed as a DBD fusion in haploid yeast of one mating type and then mated to an 
ordered array of approximately 6 , 0 0 0  test strains of the opposite mating type that express 
the complete set o f ORF AD fusions. Advantages of the array approach are that the process 
is easily automated, requires no large-scale sequencing, and has built in controls for 
specificity of interactions. It is unknown, however, how many interactions may be missed, 
so called 'false negatives', by using full length ORF fusions because of misfolding, toxicity 
or steric inhibition.
1.4.8: P roblem s A sso c ia ted  With The Yeast Tw o-H ybrid  System .
While the two-hybrid system is a very useful genetic technique for the identification and 
analysis o f protein-protein interactions, its application does have some limitations. These 
limitations include the failure to detect expected interactions, so called 'false negatives', and 
the detection of large numbers of interactions of no biological significance called 'false 
positives'.
Failure to detect expected interactions ('false negatives') can occur for any one of a number 
of reasons. Hybrid proteins generated in the Y2H system have to be targeted to the nucleus 
where they interact with the promoter of the reporter construct. If the DNA-binding domain 
or the activation domain of the transcription factor lack a nuclear localisation signal, the
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vector usually includes a heterologous nuclear localisation signal sequence such as that of 
the SV40 large T antigen (Chien et al 1991). The fact that hybrid proteins are targeted to 
the nucleus means that interactions that are dependent on post-translational modifications 
that occur within the endoplasmic reticulum (glycosylation and disulfide bond formation) 
may not be detected. Interactions that require other modifications (phosphorylation or 
acétylation) by non-yeast proteins may also fail to be detected. For example, proteins with 
SH2 domains require phosphotyrosine in the proteins to which they bind and this 
phosphorylation may not occur in yeast. The Y2H system may not therefore be suitable for 
certain extracellular and plasma membrane proteins (Fields and Sternglanz, 1994).
False negatives can also occur because some hybrid genes are harmful or lethal when 
expressed in yeast. The introduction of certain genes into yeast may interfere with normal 
cellular events to the point of non-variability. Essential cellular systems that rely on a 
balance o f positive and negative regulators may be particularly susceptible to interference. 
One example of this was lethality owing to over-expression of cell cycle regulators cyclin 
A and cyclin B (Allen et al, 1995).
Proteins must be capable of folding and of stable existence in yeast cells. Western blotting 
of yeast lysates can usually be used to monitor this. If antibodies are not available for the 
protein o f interest, commercially available antibodies for the transcription factor domains 
can be used e.g. anti-Gal4 antibodies. Alternatively some vectors are designed with epitope 
tags such as the V5 epitope tag (Durfee et al 1993), to facilitate monitoring expression of 
hybrid proteins.
Proteins also have to retain their activity as fusion proteins and the use of hybrid proteins 
also means that the site o f interaction may be occluded by the transcription factor domains 
(Fields and Sternglanz, 1994; Beranger et al, 1997). Proteins under investigation are 
usually expressed as C-terminal fusions to AD's or DBD's. This type of construction 
jeopardises interactions that require a 'free' N terminus for a protein to interact with its 
molecular partners because the transcription factor domain blocks accessibility. In such 
cases the orientation of the hybrid could be reversed. This was demonstrated by Beranger 
et al (1997) who, by using N-terminal fusions to the LexA DBD as baits, detected the 
interaction between the negative Ral (N28) mutant and RalGDS which was previously 
undetected when C-terminal fusions to the LexA DBD were used. They also document two
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cases where using N-terminal fusions exhibited enhanced sensitivity compared to the 
standard orientation, i.e. the interaction of the Ras negative mutant (N17) with CDC25 and 
the interaction o f the wild type positive Ras (V I2) with CDC25. In some cases it might be 
possible to overcome the occlusion of a site o f interaction by swapping transcription factor 
domains; the protein (X) fused to the DBD could instead be fused to the activation domain 
o f the transcription factor. In assays of defined protein combinations one orientation of the 
hybrids often activates transcription much more efficiently. This may reflect differences 
between the expression and/or stability o f hybrids containing protein X and those 
containing the interacting protein Y.
Failure to detect an expected interaction when performing library screens may simply be 
because the gene encoding an interacting protein may simply not be represented in the 
library due to a low complexity or a bias in the representation of that clone (Vidal and 
Legrain, 1999). In many screens cDNA's are derived from random or oligo(dT) primed 
RNA's. It must be kept in mind that unlike genomic libraries, the relative representation of 
each cDNA closely reflects the endogenous expression level o f the corresponding gene. 
Thus, interesting proteins might be under-represented if their RNA is expressed at 
relatively low levels. One solution to this problem is the use of normalised AD libraries. 
The process of normalising cDNA libraries consists of reducing the representation of 
highly expressed cDNA's (Soares et al, 1994). In contrast, the complexity of genomic 
libraries is directly correlated to the number of independent clones that compose the library 
and to the size of the genome. For organisms that are encoded by compact genomes, i.e. 
with small intergenic sequences and few introns, screening a genomic library instead of a 
cDNA library for two-hybrid experiments is advantageous. Screening genomic libraries 
allows fragments of proteins to be assayed. This is particularly useful since some full- 
length proteins may be toxic when expressed in yeast.
When performing library screens the bait vector and the AD library are often co­
transformed. A problem that is commonly encountered with library screens is achieving 
optimal transformation efficiency. To overcome this problem some researchers transform 
the yeast with the bait vector first and then subsequently transform with the AD library 
plasmids. Other workers transform the bait vector into yeast o f one mating type and the
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library into yeast of the opposite mating type. The two strains are then mated and the bait 
and library plasmids are brought together in the diploid cells (Bartel et al, 1996).
Proteins that are involved in transcriptional activation activate transcription of the reporter 
gene construct when fused to a DBD. However, some proteins that do not normally activate 
transcription can do so when expressed as DBD hybrid proteins, presumably because these 
proteins have domains resembling activation domains (Ma and Ptashne, 1987b). Libraries 
are thus constructed in the activation domain plasmids to avoid detection of random 
sequences that activate transcription when fused to a DBD (Chien et al, 1991). The target 
DBD hybrid protein should be tested for its ability to auto-activate reporter gene 
transcription. If protein is being tested in a defined combination with a known partner and 
is found to auto-activate reporter gene expression when expressed as a DBD hybrid protein, 
it can instead be expressed as an AD hybrid. Alternatively, it is often possible to delete a 
small region of a protein that activates transcription thus eliminating the activation function 
while retaining other properties of the protein (Iwabuchi et al, 1993). However, if such a 
deleted protein is being used as a bait, it must be remembered that residues not normally 
exposed in the intact protein may mediate interactions and thus that positive interactions 
with other proteins may be artifactual.
In screening libraries it is generally found that in addition to proteins encoded by the library 
that appear to be able to interact with the target protein a number of other classes of 
positives are obtained that are artifactual. There are several reasons for these ‘false 
positives’ and they can be easily eliminated by additional genetic assays (Bartel et al 1993). 
These assays simply involve recovering the library plasmids from transformants that score 
positive in primary library screens and transforming these into E. coli for amplification. 
These plasmids are then re-introduced into the original screening strain in several different 
combinations.
One class o f false positives obtained when performing library screens is capable of 
activating transcription o f the reporter gene system in the absence of any bait hybrid. These 
library plasmids encode Gal4 or other proteins that apparently bind to sequences in other 
proteins bound to the promoter used to drive expression of the reporter gene (Chien et al
1991). These false positives are eliminated by re-transforming isolated library plasmids 
alone and eliminating clones in which the reporter gene is activated. False positives
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resulting from the re-cloning of Gal4 are not encountered in the interaction trap assay, a 
variation o f" the two-hybrid system developed by Gyuris et al (1993) and employing the 
LexA DBD.
Other false positives may arise if a library plasmid encodes a protein that interacts with the 
DBD of Gal4. Re-transforming the library plasmid with the Gal4 DBD vector alone and 
checking for reporter activation eliminates these false positives.
Another class o f false positives initiate transcriptional activity of the reporter gene when 
introduced into a yeast cell with a DBD hybrid consisting of the DBD of Gal4 and the 
target protein used in the initial screen but fail to do so with the Gal4 DBD alone (Bartel et 
al, 1993). The inability of these positives to produce a signal with the DBD alone would 
appear to indicate specificity but when tested with hybrids comprised o f the DBD and a 
totally extrenuous protein they also produce a signal. One explanation for these false 
positives is that these proteins are themselves transcriptional activators that bind to the 
promoter of the reporter gene construct (or to proteins already bound there) but require the 
presence of an inactive hybrid bound to the Gal4 binding sites in order to function. The 
binding of this inactive hybrid might alter nucleosomes or chromatin structure in some 
fashion to allow these weak activators to bind or to trigger transcription. This class of false 
positives can be eliminated by introducing the isolated library plasmid into the original 
yeast test strain with;
•  the Gal4 DBD alone,
•  the DBD hybrid consisting of the DBD domain of Gal4 and the target protein used 
in the initial screen.
•  hybrids comprising the DNA-binding domain and a totally extrenuous protein.
Plasmids that are positive with only the target hybrid protein are then introduced with the 
same set o f DBD hybrids into a strain carrying the lacZ gene under the control of an 
unrelated promoter, such as the CYC1 minimal promoter (Bartel et al, 1993), that has had 
its own upstream activation sequence deleted and replaced with Gal4 binding sites. Using 
this reporter strain, false positives will not produce a signal with either the original target
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protein, the extrenuous protein or with the Gal4 DBD alone. Although the gall promoter 
strain appeaTs to be approximately two fold more sensitive than the CYC I strain in X-gal 
filter assays, this class o f false positives does not show a transcriptional signal in the CYC1 
strain, even when tested with twice the concentration o f X-gal and four fold or longer 
incubation times. A true positive on the other hand will result in (3-galactosidase activity 
with the original protein target. New reporter strains, like Hf7c (see Table 1.4.2), that 
contain two or more reporter genes with unrelated reporters help to eliminate many of these 
false positives in the initial assay. Another possible explanation for proteins capable of 
interacting with both the target hybrid protein and an extrenuous hybrid protein is that these 
library encoded proteins might bind to the Gal4 DBD itself. It might be that this DBD 
alone is not sufficiently stable in yeast to yield a signal and thus the requirement for a DBD 
hybrid to generate transcription of the reporter gene. However, no such proteins have been 
detected to date.
The above assays provide a set of rapid genetic criteria for the elimination o f false positives 
detected in Y2H library screens. Library plasmids that pass all o f the above criteria are 
considered true positives and can then be used for DNA sequence analysis.
Even if a given clone passes through all of the control experiments in yeast it is necessary 
to provide proof of direct interaction between the proteins in a biochemical assay. One 
common approach is to express the candidate cDNA as a fusion protein with glutathione S- 
transferase (GST) in bacteria. One then demonstrates that the bait protein is co-precipitated 
with the GST fusion protein bound to glutathione beads (Durfee et al, 1993). The hybrid 
fusion proteins may subsequently be co-immunoprecipitated in the original yeast reporter 
strain but ideally one should show that the two proteins co-precipitate in their native 
genetic background.
A critical consideration in performing Y2H screens is whether true positives isolated in the 
system are actually representative of in vivo cellular interactions. The system tests every 
binary combination of protein-protein interaction. Two proteins found to interact very 
specifically and strongly with one another may never contact each-other in the cell because 
they are localised in distinct cellular compartments or because they are expressed at 
different developmental stages or in different cell types.
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1.5: Variations Of The Yeast Two Hybrid System.
Since its original conception a large number of variations of the basic Y2H system have 
been developed (reviewed by Brent and Finley, 1997; Fredrickson, 1998; Drees, 1999; 
Vidal and Legrain, 1999). Related systems which allow the in vivo detection of a wide 
range of other biologically significant molecular interactions have been developed. These 
include systems for the detection of DNA-protein interactions (one hybrid system), RNA- 
protein interactions (RNA based three-hybrid system) and small molecule-protein 
interactions (ligand based three-hybrid system). The original concept of the two-hybrid 
system has also been turned upside down with the development of the reverse one-hybrid 
and reverse two-hybrid systems that allow the identification of mutations, peptides or small 
molecules that abrogate macromolecular interactions. The original configuration of the 
system has also been modified to extend the range of possible protein-protein interactions 
that can be analysed. Three component systems have been developed to allow the in vivo 
detection o f trimeric interactions, ligand-receptor interactions and interactions dependent 
on post-translational modifications. A description of these systems is given in sections 
1.5.1 to 1.5.4.
In addition to the above, forward and reverse dual bait systems have also been developed 
and are very useful for functional dissection of proteins capable of interacting with multiple 
binding partners (Serebriiskii et al, 1999). Other interaction screens based on reconstituting 
the activity of proteins other than transcription factors have also been developed which 
facilitate the identification and analysis of protein-protein interactions that are not 
conducive to analysis in the standard Y2H system (Johnson and Varshavsky, 1994; 
Marsolier et al, 1997; Rossi et al, 1997; Aronheim et al, 1997; Broder et ai, 1998)
Mammalian two-hybrid systems (Sadowski et al, 1992) and prokaryotic two-hybrid systems 
have also been developed which provide alternative host genetic backgrounds to yeast. 
These permit the analysis of protein-protein interactions in genetic backgrounds more 
closely related to their native backgrounds. Mammalian systems can be particularly useful 
for the analysis of protein-protein interactions dependent on post-translational 
modifications that do not occur in yeast. A description of prokaryotic systems is given in 
section 1.5.5.
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Systems such as those mentioned above greatly facilitate functional genomics by providing 
scientists with very useful tools for the identification of molecular interactions and for the 
generation of macromolecular interaction maps. A brief description of some of the systems 
mentioned above is given in the following sections. The 21st century will no doubt usher in 
many more novel ways to tap the vast resources of genetic information generated by 
genomic sequencing projects.
1.5.1: O ne-H ybrid  System s.
The yeast one-hybrid (Y1H) system is used for the identification and analysis o f DNA- 
protein interactions that play important roles in several biological processes, most notably 
in the regulation of gene expression as described earlier in this literature review.
The Y1H system is based on principles similar to those of the Y2H system already 
described and consists o f two components. The first of these is a reporter plasmid bearing a 
specially constructed reporter gene construct. This usually consists o f a Gall promoter 
fused to a reporter gene such as lacZ or HIS3. The Gall promoter is deleted for its cognate 
upstream Gal4 DNA binding sequences. These are replaced by unique restriction sites into 
which target DNA binding sequences under investigation are cloned. Cloning target 
sequences into these restriction sites places reporter gene expression under the 
transcriptional control o f the cloned target sequences. Once the target DNA sequences have 
been cloned into the reporter plasmid, the plasmid is usually integrated into the genome of 
a suitable yeast strain. The resulting yeast strain, with the integrated reporter plasmid and 
cloned target DNA sequences, is then transformed with the second component of the Y1H 
system, expression libraries identical to those used when performing Y2H library screens. 
These libraries consist o f random proteins fused to a specific transcriptional activation 
domain like that of the Gal4 protein. Any expressed hybrid proteins capable of binding to 
the cloned target DNA sequences on the integrated reporter plasmid will activate 
transcription of the reporter gene resulting in a screenable phenotype (see Figure 1.5.1a).
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•  Figure 1.5.1: The One Hybrid System.
Reporter Gene
Transcription 
 ►
A.) Principle Of The Yeast One hybrid System.
The Y1H system  u ses similar tools to the Y2H system 
but now the fusion of protein Y with the AD interacts 
directly with a clonedU A S target sequence that it 
recognises and activates transcription o f  the reporter 
gene. Either the UAS or the protein Y can be screened 
for and analysed using the Y1H system.
IRP1
B.) Yeast One Hybrid Reporter Plasmid 
Constructed By Wolf et al
The plasmid has a multiple cloning site (MCS) 
upstream o f a Gall promoter which is in front 
of a HIS3 rep oretr gene. The plasmid has a jreast 
origin of replication(ARS4) and a TRP1 gene for 
selection in yeast. It also has abacterial origin 
of replication (on) and an ampicillin resistance 
gene for selection in bacteria
The earliest description o f the Y1H system was by Wilson et al (1991) who used the 
system to identify the DNA binding site for the nuclear receptor NGF1-B. Later, Wang and 
Reed (1993) used a Y1H system to clone the olfactory neuronal transcription factor Olf-1 
and Li and Herskowitz (1993) used the Y1H system to isolate ORC6 , a component o f the 
yeast origin recognition complex. Luo and Vijaychanders (1996) constructed another Y1H 
system which they tested using the p53 cognate DNA binding sequences and Wolf et al 
(1996) constructed an improved Y1H system reporter plasmid, pRW95-l, which had an 
expanded multiple cloning site (MCS) and that could be used with commercially available 
activation domain libraries (see Figure 1.5.1b).
1.5.2: R everse  O ne a n d  T w o-H ybrid  System s.
Reverse hybrid systems permit the identification o f mutations, peptides or small molecules 
that disrupt protein-protein and protein-DNA interactions. They employ all o f the same 
components as the standard two-hybrid and one-hybrid systems with the exception o f the
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reporter genes employed. Reverse hybrid systems use reporter genes whose expression 
causes toxicity and lethality under specific growth conditions (counterselectable markers). 
Under these growth conditions induced reporter expression resulting from the interaction of 
two proteins expressed in the context o f the Y2H system or the interaction of a DNA 
binding protein and its binding site in the context of the Y1H system is deleterious to 
growth. Dissociation of the interactions therefore provides a selectable growth advantage.
The first reverse one and two-hybrid systems were described by Vidal et al (1996a) and 
utilised URA3 as a reporter gene. In the case of the reverse two-hybrid system the reporter 
was placed under the transcriptional control of Gal4 DNA binding sequences. Productive 
protein-protein interactions between hybrid proteins bearing Gal4 AD's and Gal4 DBD's 
resulted in the expression of the URA3 gene (which is involved in uracil biosynthesis) and 
could be positively selected for by plating yeast cells on media lacking uracil. However, the 
URA3 encoded enzyme can also catalyse the transformation of 5-fluoroorotic acid (5-FOA) 
into a toxic compound and thus cells expressing the URA3 gene (Ura+J are sensitive to 5- 
FOA (Foas). Thus this reporter gene also provided a means of positively selecting for 
dissociation of protein-protein interactions by simply plating yeast on media containing 5- 
FAO since only yeast cells in which the interaction of the hybrid proteins was abrogated
* Rwould grow on such media (Ura‘, Foa ).
Another version of the reverse two-hybrid system was described by Leanna and Hannink 
(1996). Their version of the system employed a CYH2 gene as a reporter gene. This gene is 
responsible for the sensitivity of yeast to cycloheximide. As with the system devised by 
Vidal et al (1996a) described above, this system allowed for direct positive selection for 
disruption of a given protein-protein interaction by simply plating on media containing 
cycloheximide since only yeast cells in which the protein-protein interaction was disrupted 
would grow on such media.
Shih et al (1996) designed another system called the split-hybrid system. Although the 
system they designed took a different approach to the other systems described above it is 
essentially a reverse two-hybrid system. Unlike the other systems the system they designed 
didn't employ a toxic reporter gene. Their system made use of the E. coli Tn/O-encoded tet 
repressor (TetR) operator system. They engineered LexA binding sites upstream of the 
TetR gene and placed TetR binding sites (tet operators) upstream from a nutritional
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reporter gene, HIS3. Interaction of one protein fused to a LexA DBD with a second protein 
fused to a VP 16 AD resulted in expression of the TetR gene. The TetR gene then bound to 
its tet operator sites preventing expression of the HIS3 gene and thus preventing growth on 
media lacking histidine.
Huang and Schreiber (1997) constructed a reverse two-hybrid system which utilised the 
LexA DBD and the B42 AD. Hybrid proteins were expressed from the ga ll promoter and 
thus expression of the proteins could be induced by the addition of galactose. The use of a 
Gal inducible promoter required that the galactose utilisation pathway be intact in the yeast 
strain used for the system. This ruled out the use of yeast strains developed for Gal4 DBD 
based forward or reverse systems in which Gal4 and Gal80 are inactivated. A reporter 
construct consisting of the URA3 gene under the transcriptional control an SP013 
promoter bearing LexA operator sites was integrated into the ura3 locus of strains EGY48 
and EGY191 (Golemis et al 1997) (sqz Table 1.4.2). The resulting strains therefore had two 
integrated reporter constructs, one URA3 reporter construct and the original LEU2 reporter 
which was also under the transcriptional control of LexA operator sites. The presence of 
two distinct reporter genes, having only the LexA operator sequences in common provided 
a means o f reducing false positives obtained when performing two-hybrid screens as 
discussed earlier.
Once a protein-protein interaction has been identified by the standard two-hybrid system a 
great deal of additional work is required to further characterise the functional/biological 
relevance, structure, and regulation of the observed interaction. The most direct approach 
to determine the functional relevance of an identified interaction genetically correlates the 
physical interaction with a biological parameter: the physical interaction is dissociated and 
the consequences are analysed in a functional assay. Logically one would expect that if a 
newly identified interaction was critical for a function o f interest, dissociation of the 
interaction would impair that function.
Conceptually, protein-protein interactions can be dissociated by mutations in either one of 
the interacting partners or by dissociating proteins, peptides or small molecules. Interaction 
defective alleles, mutant proteins specifically altered in their ability to bind a potential 
partner, are very useful for probing the structural components of an interaction and they are 
very useful tools for characterisation of in vivo functions of newly identified protein-
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protein interactions (White, 1996; Vidal and Legrain, 1999). They can be compared with 
their wild-type counterparts for their ability to functionally complement knockout 
mutations in the corresponding gene or for their ability to function in expression assays in 
relevant cells. They are particularly useful for analysing proteins that have multiple 
interacting partners. In vivo expression of variants that interact with only a subset of their 
interacting partners can provide information about which interactions are important to 
mediate specific activities in cells. However, since they usually score as recessive 
mutations, the use of interaction defective mutants is not always feasible. In some cases the 
wild-type protein cannot be removed from an assay. This would be the case if no knockout 
was available for a particular gene of interest or in biochemical assays when the 
corresponding wild-type protein could not be immunodepleted from the test fraction. In 
these cases proteins, peptides or small molecules that specifically affect the ability of a 
particular pair o f proteins to interact can be used for determining functional/biological 
relevance o f a protein-protein interaction.
Until recently genetic strategies such as those mentioned above have not been used widely 
due to the technical difficulties o f identifying informative interaction defective alleles or 
specific dissociating molecules. The main challenge for interaction defective alleles is the 
creation of subtle mutations that disrupt an interaction without grossly affecting the protein, 
i.e. mutations that still allow the expression of a full length, stable and correctly folded 
protein. This problem can be overcome by generating libraries of randomly mutated alleles 
for each o f the interacting partners by error prone PCR. These libraries then have to be 
screened for alleles exhibiting the desired properties. Similarly, one might expect that 
complex libraries would need to be screened to find a few specific dissociating proteins, 
peptides or small molecules. The problems associated with screening such complex 
libraries have been overcome by the reverse two-hybrid system since dissociation of an 
interaction provides a selective growth advantage (Vidal et al, 1996b).
Strategies employing reverse two-hybrid systems have been designed which allow for the 
selection o f informative interaction-defective alleles in the context of stable, full length and 
properly folded proteins, from complex libraries of randomly mutated alleles. In some 
strategies the systems are used to select for conditional mutations that retain some level of 
activity. For example, mutations that affect the interaction only weakly can be selected out
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from nonsense alleles. Vidal et al (1996b), who were studying the interaction of the protein 
E2F1 with another protein, DPI, employed a two-step strategy in which mutants were first 
selected for using their URA3 based reverse two-hybrid system. Identified mutants were 
then subjected to a second round of screening using a standard Gal4 dependent HIS3 
reporter gene. They demonstrated that varying the concentration of 3-aminotriazole (3-AT) 
(a competitive inhibitor o f the HIS3 gene product) in growth media in this second round of 
screening allowed selection of mutations that either weakly or strongly affected the 
interaction of E2F1 with DPI. For proteins that have multiple interacting partners another 
approach can be employed. Mutations affecting the ability of the protein to bind to one of 
its binding partners are selected using a standard reverse two-hybrid screen. Mutants 
obtained are then subjected to a second round of screening in a standard Y2H system to 
identify mutants still capable of interacting with another binding partner (White, 1996). 
Inouye et al (1997) designed a differential interaction trap system that allowed such mutant 
proteins to be identified in one single screening step. They used the system to identify 
single amino acid substitutions that affected the ability of Ste5, a protein involved in the 
yeast S. cerevisiae mating pheromone response pathway, to interact with only one of its 
demonstrated partners, Ste7 or Stel 1. Ste7 was fused to the Gal4 DBD, Stel 1 was fused to 
the LexA DBD and Ste5 was fused to the Gal4 AD. The three hybrid proteins were 
simultaneously expressed in the same yeast strain. To provide transcriptional readouts 
unique to each interaction (the interaction of Ste5/Stel 1 and Ste5/Ste7) the yeast strain had 
two reporter constructs: a URA3 gene under the control o f Gal4 UAS's and a lacZ gene 
under the control o f LexA operator sequences. Ste5 mutants that were defective for binding 
to S te ll but not for Ste7 were selected for by plating on media lacking uracil and 
containing X-gal (Ura+/Lac‘ mutants). Ste5 mutants that were defective for binding to Ste7 
but not for Stel 1 were selected for by plating on media containing 5-FAO and containing 
X-gal (Ura7Lac+mutants).
Many diseases can be attributed to specific protein-protein or protein-DNA interactions and 
thus specific dissociation of such interactions could be viewed as a potential therapeutic 
strategy. Target interactions include interactions between proteins of a parasite and its host, 
unregulated associations between proteins and interactions responsible for the function of 
the downstream event of a regulatory pathway frequently mutated in a particular disease
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(Vidal et al, 1996a). In all cases, peptides or small molecules capable of specifically 
dissociating*abnormal associations could be critical therapeutic reagents. The specificity of 
protein-protein interactions makes them particularly suitable as drug targets. However, 
despite their biological importance in human disease protein-protein interactions have not 
been widely used as drug targets. This has primarily been because of the technical 
constraints o f in vitro screening procedures (Vidal and Endoh, 1999). However, we may 
now have the technological tools and strategies that will make protein-protein interactions 
viable drug targets. Functional genomics projects can rapidly identify large numbers of 
potential protein-protein interactions for a particular pathway using large-scale Y2H 
screens. On the other hand, reverse two-hybrid systems facilitate the rapid screening of 
complex libraries of peptides or small molecules for compounds capable of preventing 
specific interactions. These hybrid technologies, coupled with advances in combinatorial 
chemistry such as split pool synthesis (Huang and Schreiber, 1997) which allows the 
synthesis of libraries o f compounds o f enormous size and complexity, have the potential to 
make screening for molecules capable of dissociating specific protein-protein or protein- 
DNA more feasible and to greatly accelerate the development of novel therapeutic agents.
1.5.3: Three H yb rid  System s.
Other two-hybrid system spin-offs include three-hybrid systems for detecting protein-RNA 
and protein-ligand interactions. A brief description of these systems is given below.
RNA-protein interactions are pivotal in fundamental cellular processes such as 
transcription, mRNA processing, translation, RNA localisation and infection by RNA 
viruses. SenGupta et al (1996) developed a yeast three-hybrid system for the detection and 
analysis o f protein-RNA interactions. The basic principle of the RNA-protein three- hybrid 
system is depicted in Figure 1.5.2. In the system they designed one of the hybrids consists 
of the LexA DBD fused to the well characterised and sequence specific coat protein of 
bacteriophage MS2. The MS2 coat protein of MS2 recognises a 21 nt stem-loop in its 
genome with high affinity. The second hybrid is a hybrid RNA molecule consisting of the 
stem-loop structure recognised by the MS2 coat protein, fused to a ‘bait’ RNA sequence.
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hybrid RNA molecule associates with the LexA-MS2 hybrid molecule bound to sites 
upstream o f a reporter gene. The third hybrid consists o f a ‘prey’ protein fused to the Gal4 
transcriptional activation domain as in the standard yeast two-hybrid system. Interaction of 
the 'prey' protein with the ‘bait’ RNA sequence results in activation o f transcription of a 
reporter gene resulting in a readily screenable phenotype.
• Figure 1.5.2: RNA-Protein Three Hybrid System.
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In the initial system designed by SenGupta et al (1996), each o f the hybrid molecules was 
expressed from a separate plasmid. However, in order to make the system easier to use, the 
gene encoding the LexA-MS2 hybrid protein (which would be constant in all experiments) 
was integrated into a chromosome in strain L40 (see tab le 1.4) to generate a new strain 
called L40-coat. This three-hybrid system is now commercially available from Invitrogen 
with the exception that the commercial system uses the B42 transcriptional activation 
domain. Putz et al (1996) devised a similar system to that described by SenGupta et al 
(1996). They constructed their system with the RevMIO RNA binding protein from HIV-1 
instead o f the MS2 coat protein, and the RNA sequence to which RevMIO binds which is 
called the Rev responsive element (RRE).
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Figure 1.5.3: Protein-Ligand Three Hybrid System.
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Small ligand-receptor interactions underlie many fundamental processes in biology and 
form the basis for pharmacological intervention o f human diseases. Therefore it is often 
important to identify the protein targets o f small molecules. The development o f small 
molecule hybrid systems began with the use o f cell-permeable chemical inducers of
dimerisation (CID's). Spencer et al (1993) expressed the intracellular domain o f the T-
lymphocyte antigen receptor as a fusion with the immunophilin FK505-binding protein 
(FKBP12). They demonstrated that addition o f an FK506-FK506 dimer, FK1012, induced 
aggregation o f the T lymphocyte antigen receptor and resulted in activation of a signalling 
pathway. This demonstrated that small-molecule ligands could be used to activate many 
cellular processes by forcing oligomerization between proteins fused to ligand binding 
proteins. Licitra and Liu (1996) then developed a novel three-hybrid system for the 
detection o f small ligand-protein interactions. The basic principle of the system is depicted 
in Figure 1.5.3 below. In the system they designed the Lex A DBD is expressed as a fusion 
with the glucocorticoid receptor (GR). This hybrid protein is expressed in yeast in the
presence o f a hybrid ligand molecule. The hybrid ligand molecule consists of
dexamethasone, which is a ligand for GR, and a 'bait' ligand molecule. Interaction o f a 
'prey' protein, expressed as a fusion with a transcriptional activation, results in expression 
o f a reporter gene generating a screenable penotype. Systems such as that described above 
can be used either to screen libraries o f 'prey' AD proteins to identify targets for a particular 
small ligand o f interest or for screening libraries o f ligands to identify novel ligands for a 
given 'prey' protein. They could be particularly useful in screening for novel therapeutic
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ligand molecules since any ligand molecules identified in a screen have already been 
screened fo*cell permeability and for their stability in a cellular environment.
1.5.4: Three C om pon en t System s.
Some protein-protein interactions cannot be detected with standard two-hybrid methods 
because they require a third molecule not normally available in yeast. For example, the 
affinity o f two proteins that contact each other directly may be enhanced by the expression 
of a third protein that contacts both (see figure 1,5.4a).
Expression of a third protein can also be used for detection of interactions between proteins 
that make no direct contact but interact solely via a third, bridging protein (see Figure
1.5.4b).
Figure 1.5.4: Different Kinds Of Ternary Protein Complexes.
a.)
Z stabilises the interaction 
between A  and B
Z bridges the interaction 
between A and B
C.)
Z modifies A  which allows 
A to interact with B
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Finally, expression of a third protein can sometimes facilitate a protein-protein interaction 
without forming a lasting part o f a stable complex (see figure 1.5.4c). This situation arises 
for interactions that depend on post-translational modifications that are relatively 
uncommon in yeast. Osborne et al (1995) co-expressed a tyrosine kinase, Lck, capable of 
phosphorylating a DBD-bait hybrid on a target residue to facilitate its interaction with an 
SH-domain containing AD-hybrid. Using intracellular portions of receptors as baits they 
were able to isolate proteins with immunoreceptor based tyrosine activating motifs 
(ITAMs) that interacted with tyrosine phosphorylated forms of receptors.
Zhang and Lauter (1996) demonstrated the use of their three component system for the 
detection o f three component complexes using the epidermal growth factor (EGF) receptor, 
Grb2 and Sos proteins. They then screened a library with Gal4-DBD-EGF receptor and 
Gal4 AD-Sos hybrid proteins and isolated a plasmid encoding Grb2.Tirode et al (1997) 
also developed a three component system and used it to demonstrate that the cdk7-MATl 
interaction was stabilized by the presence of a protein called cyclin H.
1.5.5: P rokaryo tic  T w o-hybrid  System s.
In recent years several prokaryotic two-hybrid systems have been developed. These 
systems have several advantages over the Y2H system. Firstly, they facilitate the analysis 
o f prokaryotic protein-protein interactions in a prokaryotic genetic background. The ability 
to perform such assays in an E. coli background is particularly attractive considering the 
fact that there is a vast resource of E. coli strains with specific mutations which can be 
chosen for specific applications. P2H systems are also useful for the analysis of eukaryotic 
proteins in situations where homologous yeast proteins interfere with the interactions of the 
proteins under investigation. In addition to this manipulation of bacterial DNA is generally 
easier than that o f yeast and much higher transformation efficiencies are attainable in E. 
coli. This facilitates the rapid and simple screening of large complex libraries of protein to 
identify putative binding partners for a given protein of interest. This potential makes
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prokaryotic systems particularly attractive for the purpose for the construction of proteomic 
linkage maps.
It may be argued that prokaryotic based systems would be o f limited use for the analysis of 
eukaryotic proteins on the basis that such proteins may not be stable or be capable of 
folding correctly in a prokaryotic background. Also some eukaryotic proteins require post- 
translational modifications such as phosphorylation or glycosylation in order to fold and 
function correctly and thus would not function in E. coli. However, it is important to note 
that limitations such as these are also encountered in the conventional Y2H system where 
hybrid proteins are targeted to and interact in the nucleus and thus are not subject to post- 
translational modifications such as glycosylation and disulfide bond formation that occur in 
the endoplasmic reticulum. Proteins that require phosphorylation or acétylation by non­
yeast proteins also fail to interact in the conventional Y2H system.
As already mentioned above several P2H systems have been developed. Cairns et al (1997) 
developed a system that permitted the detection and analysis of homodimers. The system 
was based on the cl repressor of X phage. This repressor binds to specific operator sites on 
the X genome as a dimer and prevents transcription from the major leftward (PL) and 
rightward (Pr) promoters. The cl monomer can be divided into two functional domains, an 
amino-terminal DBD (repB) and a C-terminal dimerization domain (repD). In the system 
devised by Cairnes et al (1996) the repD domain is removed and replaced with a 
heterologous protein. If the protein is capable of dimerization the cl repression is recovered 
and detected on the basis of repression of a XPl promoter:lacZ reporter. This system 
facilitated the study of the dimerization properties of proteins in E. coli.
Dimitrova et al (1998) devised a system based on the LexA repressor. This protein 
functions as a dimer and binds to specific operator sequences in E. coli. Like the cl 
repressor the C-terminal dimerization domain of this protein can be removed and replaced 
with a heterologous protein. If the fused protein is capable of dimerization LexA repression 
is recovered. Systems such as this and then one devised by Cairns et al (1997) are of 
limited use for studying the interaction of heterodimers in cases where one of the proteins 
is also capable of forming homodimers (eg. Jun/Fos). Dimitrova et al (1998) overcame this 
problem by using two LexA DBD fusion proteins with different DNA binding specificities.
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In their system one protein (A) is fused to a wild type LexA DBD while the another protein 
(B) is fusecTto a variant LexA DBD with a altered operator sequence requirement. They 
constructed a hybrid promoter with the wild type LexA operator sequence and the operator 
sequence recognized by the variant LexA DBD. This promoter was fused to a lacZ gene 
and thus only interaction between proteins (A) and (B) results in the formation of a 
heterodimer capable of binding to the hybrid promoter and repressing lacZ expression.
Karimova et al (1998) developed a system based on the reconstitution of a signal 
transduction pathway. In their system proteins of interest are fused to two complementary 
fragments o f the catalytic domain o f Bordetella pertussis adenylate cyclase. Interaction 
between the two proteins results in functional complementation between the two adenylate 
cyclase fragments leading to cAMP systhesis which in turn can trigger the expression of 
several resident genes via interaction with the CAP protein.
Pelletier et al (1999) devised a similar system in which proteins are fused to two designed 
fragments of the murine enzyme dihydrofolate reductase (mDHFR). Interaction of the 
proteins results in reconstitution of mDHFR activity. Activity was detected by an E. coli 
based selection assay, in which the bacterial DHFR was specifically inhibited with 
trimethoprim, preventing the biosynthesis of purines, thymidylate, methionine, and 
pantothenate and therefore cell division. The reconstituted mDHFR, which was insensitive 
to the low trimethoprim concentration present in selection, restored the biosynthetic 
reactions required for bacterial propagation. As a result, the interaction between proteins 
was directly linked with cell survival and detected by colony formation.
1.6: Construction O f A Novel Prokaryotic Two-Hybrid System.
The purpose of the work undertaken for this thesis was to develop a novel P2H system 
based on the prokaryotic transcriptional activating protein NifA from Sinorhizobium 
meliloti 2011. This protein belongs to a unique class o f bacterial transcriptional regulatory 
proteins called Enhancer Binding Proteins (EBP's). These proteins activate transcription
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from a special class o f bacterial promoters that require the alternative bacterial sigma factor 
called a 54 Ixiund to core RNA polymerase (a 54-holoenzyme or E a 54). The EBP's bind to 
specific DNA sequences found upstream of promoters that they are responsible for 
regulating and activate transcription by a mechanism that more closely resembles that 
observed for eukaryotic transcription factors. Bacterial EBP's also resemble eukaryotic 
transcription factor modularity in that they have distinct functionally independent DNA 
binding and transcriptional activation domains. It was therefore proposed that these 
proteins could be utilized for the construction of a novel P2H system homologous to the 
Y2H system. Construction of a novel NifA based P2H system requires knowledge of both 
the mechanism by which EBP's activate transcription and an understanding of the specific 
characteristics o f the S. meliloti 2011 NifA protein itself. The following sections provide an 
overview of ct5 4  dependent transcription and of the EBP’s.
1.7: The Transcription Cycle And the Role Of Bacterial Sigma (a) 
Factors.
Transcription is a complex biological process that involves many different protein factors. 
In the eubacteria the core RNA polymerase contains four subunits with the stoichiometry 
P(3’a2. This core enzyme interacts with individual specificity proteins, known as sigma (a) 
factors, to form a holoenzyme with the minimal composition |3(3’a2 a . The a  factors are 
required for recognition and binding of specific promoter sequences and so only the 
holoenzyme can accurately initiate transcription at promoter sequences. Following 
transcription initiation, the a  factor is released and the core enzyme elongates an RNA 
chain. Transcription termination is subsequently triggered by interaction of the elongating 
RNA polymerase with an RNA termination structure or specific termination factors. This 
complex series o f reactions has been termed the transcription cycle.
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The majority o f cellular transcription requires the predominant, or primary, a  factor. In E. 
coli the primary a  factor is referred to as a 7 0  while in B. subtilis the primary a  factor is 
referred to as a 43. In addition to the most abundant a  factor, both gram-positive and gram- 
negative eubacteria employ alternative cr factors (reviewed by Helmann and Chamberlin, 
1988) that confer different promoter specificity's on the core RNA polymerase. These 
alternative a  factors are required for the transcription o f co-ordinately regulated sets o f 
genes from promoter sequences that are quite distinct from those recognised by the primary 
bacterial a  factors (see Table 1.7.1).
1.7.1: Alternative Bacterial Sigma Factors.
T a b le  1 .7 .1 : B a c te r ia l  a  F a c to r s  A n d  T h e ir  C o n se n su s  P ro m o te r  Se q u en ces 
(Helmann and Chamberlin, 1988).
Factor Gene Function C onsen sus sequence
Bacillus subtilis - 3 5 - 1 0
< / ’ rpoD , s ig A housekeeping functions T T G A C A T A T A A T
o-28 sigD flage llar synthesis/chem otaxis C I'A A A C C G A T A T
a 29 spoIIG B , s ig E sporulation genes T T -A A A C A T A T T
cr30 spoO H , sigH sporulation genes unknown
a 32 sigC unknown A A A T C TA -TG -T T -T A
a 31 sigB unknown A G G -T T G G -A T T G -T
g. spoil AC spoIIA C sporulation genes unknown
? spolIIC sporulation genes unknown
crEp2s S P O l 28 phage m iddle genes T -A G G A G A - - A  T T T -T T T
<t8p33/34 S P 0 1  33 ,3 4  phagc late genes 
Escherichia coli and R elated B acteria
C G T T A G A G A T A IT
a-70 rpoD housekeeping functions T T G A C A T A T A A T
<T54 gln F, ntrA, rpoN nitrogen-regulated genes ( +  
C 4-dicarboxylate transport in 
R. meliloti)
C T G G C A C  N 5 T T G C A
«x32 htpR, rpoH heat-shock genes C T T G A A C C C C A T -T A
? f lb B + f la l flage llar synthesis/chem otaxis T A  A  A G C C G A T A A
0-ÊPÎ5 T 4  gene 55 phage late genes none T A T A A A T A
? unknown flagellar genes (C. crescentus) T G G C -C  N 5 T T G C
43
All o f the alternative bacterial a  factors interact with the common core RNA polymerase 
and facilitate recognition o f distinct promoter sequences by making sequence-specific 
contacts with promoters. Most of the alternative bacterial a  factors resemble the primary E. 
coli a 7 0  factor in that they interact with blocks of conserved sequences in the -10 and -35 
regions of promoters (see Table 1.7.1) and that they do not bind tightly to DNA in the 
absence o f core RNA polymerase.
One model for the binding RNA polymerase holoenzyme to promoters which helps to 
account for this suggests that the holoenzyme first binds to the -35 region via specific 
interactions involving the a  factor, perhaps with core RNA polymerase contributing some 
contacts at the -10 region. This complex may then isomerize to a conformation allowing 
specific contacts between the a  factor and the -10 region (Helmann and Chamberlin, 
1988). The a  factor therefore requires core RNA polymerase in order to bind tightly to 
promoters. It is now known that the a  subunit of core RNA polymerase also plays a role in 
the recognition of promoters via binding to A/T rich sequences immediately upstream of 
core -10 and -35 core promoter sequences (Ross et al, 1993).
In addition to their role in the recognition and binding of specific promoter sequences 
bacterial a  factors can also display other activities such as DNA melting and inhibition of 
non-specific transcription by core RNA polymerase (Helmann and Chamberlin, 1988). 
Core RNA polymerase binds tightly and non-specifically to DNA but this non-specific 
binding is suppressed by a 70. Isolated P' subunit o f core RNA polymerase is able to bind to 
DNA in a non-specific manner. Upon addition of a 70, P' dissociates from DNA and 
complexes with the a 70 subunit. This is consistent with the fact that non-specific binding of 
core RNA polymerase is suppressed by a 70 and that the main contact site for ct70 on core 
RNA polymerase is located on p', although the C-terminal region of P is also involved in 
a 70 binding (Ishihama, 1992).
Individual alternative bacterial a  factors allow the transcription of sets of genes whose 
products have a common physiological role. For example, ct32 o f enteric bacteria is 
required for the transcription of genes whose products are required for protection from heat 
shock and certain other stresses while a  of B. subtilis is required for the transcription of 
genes involved in motility and chemotaxis. The alternative c  factor, a 54, differs from all
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other bacterial o  factors in several respects, one of which being that it allows the 
transcription o f genes whose products have diverse physiological roles (reviewed by Kustu 
et al, 1989).
a 54 (encoded by ntrA [glnF, rpoN]) was initially identified as a positive regulatory factor 
needed for the expression of the gene encoding glutamine synthetase, glnA, in enteric 
bacteria (Kustu et al, 1989). It was later found to be required for the expression of other 
genes whose products function in the assimilation of nitrogen. For example, a 54 is required 
for transcription of genes encoding amino acid transport components (such as the glnHPQ 
operon of E. coli encoding components for the glutamine transport system; Claverie- 
Martin and Magasanik, 1991), degradative enzymes (such as the hutUH operon encoding 
genes for the degradation o f histidine) and for transcription of the nitrogen fixation (nif and 
fix) genes from a number of bacteria, including Klebsiella pneumoniae, Rhodobacter 
capsulatus, and members of the genera Azotobacter, Azospirillum, Sinorhizobium, 
Azorhizobium and Bradyrhizobium.
It is now known that c 54-holoenzyme (E ct54) transcribes genes whose products have 
diverse physiological functions. Examples of such genes are;
•  The dctA gene of Rhizobia which encodes a transport component for 
dicarboxylic acids.
•  Genes on the TOL (toluene) plasmid of Pseudomonas putida that encode 
proteins required for the catabolism of toluene and xylenes.
•  Genes encoding two of the components of a formate-degradative pathway in E.
coli.
•  Genes encoding hydrogenases responsible for oxidation of molecular hydrogen 
in Alcaligenes eutrophus and Pseudomonas facilis.
•  Genes encoding the hook and filament proteins of Caulobacter flagella.
•  Genes encoding pilins in Pseudomonas aeruginosa and Neisseria gonorrhoeae 
that allow these organisms to adhere to human epithelial cells.
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In addition to the above, a 54 also differs structurally and functionally from all other 
bacterial a  factors and activates transcription by a unique mechanism which more closely 
resembles that observed for the transcriptional activation of eukaryotic RNA polymerase II. 
These characteristics o f a 54 are described in the following sections.
/ . 7.2: The A ltern a tive  B acteria l S igm a F actor o 54.
a 54 differs functionally from all other a  factors in that all known a 54-dependent promoters 
are subject to positive control rather than repression, and transcription initiation by RNA 
polymerase containing a 5 4  (a 54-holoenzyme or E a 54) is totally dependent on an activator 
protein. These activator proteins bind to palindromic or nearly palindromic sequences 
upstream of a 54 promoters (~ 1 0 0 bp to 2 0 0 bp) that have properties of eukaryotic 
transcriptional enhancers in that they can be moved more than a kilobase upstream and still 
mediate transcriptional activation (Reitzer and Magasanik, 1986; Buck et al, 1986; Ninfa et 
al, 1987). These sequences are called Enhancer-Like Elements (ELE) or Upstream 
Acitivation Sequences (UAS) and the bacterial activator proteins that bind to them are 
collectively called Enhancer Binding Proteins (EBP's). These activator proteins are 
described in detail in section 1 .8 .
Promoters recognized by a 54 lack the conserved -10 and -35 regions found in typical 
promoters and instead are characterized by a consensus sequence TGGCAC - N5 - TTGCA 
between -26 and -12 (Buck et al, 1985). Over 60 such promoters have been identified in a 
variety of genera. The GG doublet at -25/-24 and the GC doublet at -13/12 are the most 
invariant nucleotides amongst the a  4-dependent promoters. Mutational analysis (Buck et 
al, 1985) and E a 54-dependent methylation protection in DMS footprinting assays indicates 
that these nucleotides are important contact points for Ect54 (Morett and Buck, 1989).
Activity of the alternative sigma factor a 54 has been studied most intensively at the glnA 
and nif promoters. E g 54 has been demonstrated to bind to promoter sequences 
independently of activator proteins but interactions between E a 54 and promoter sequences 
(closed complexes) are nonproductive transcriptionally because the DNA remains double
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stranded (Ninfa et al, 1987; Popham et al, 1989; Moret and Buck, 1989; Buck and Cannon, 
1992a). In lh e  case of the glnA promoter open complex formation and initiation of 
transcription requires an activator called NtrC (encoded by ntrC [glnG]). NtrC binds to 
sites located upstream of the promoter and catalyzes the isomerization of closed complexes 
between E a 54 and the glnA promoter to transcriptionally productive open complexes in 
which the DNA strands are locally denatured in the region of the transcription start site 
(Popham et al, 1989). The isomerization reaction requires ATP hydrolysis by NtrC 
activator protein (Popham et al, 1989; Weiss et al, 1991; Austin et al, 1991; Austin and
W
Dixon, 1992). As is true for glnA, transcription of other g  -dependent promoters also 
requires an activator and hydrolysis o f ATP. Transcription of nif genes in a variety of 
bacteria requires the activator NifA and transcription of the dctA gene is dependent on 
DctD. The absolute requirement for an activator protein and hydrolysis o f ATP to catalyze 
closed E a 5 4  promoter complex to open complexes is in stark contrast to a 70-dependent
70promoters. Closed E a complexes can generally make the transition to the open complex 
without the aid of an activator and the process does not require the hydrolysis of ATP 
(Kustu et al, 1991).
In addition to the absolute requirement for an activator protein for initiation of 
transcription, a 54 also differs from other bacterial cr factors in the way it interacts with core 
RNA polymerase and promoter sequences. The ability of E g 54 to bind to promoter 
sequences and form detectable closed complexes was found to be dependent not only on 
the conserved GG and GC doublets found at positions -24 and -12 respectively but also on 
a tract o f thymine residues located at -15 to -17 in most (/^-dependent promoters. E g 54 was 
found to have a very low affinity for promoters lacking this stretch of thymine residues 
such as the nifH, nifB and nifU promoters o f Klebsiella pneumoniae. This made it more 
difficult to detect closed complexes between E g 54 and these promoters by DMS 
footprinting. In K. pneumoniae the wild type nifH promoter has a tract o f cytosine residues 
in place o f the thymine residues. Morett and Buck (1989) demonstrated the importance of 
the tract o f thymine residues for E g 54 binding by mutating the cytosine bases in the -15 to - 
17 region of the K. pneumoniae nifH promoter to thymines (see Figure 1.7.1). The 
formation of closed complexes between the resulting mutant K. pneumoniae nifH promoter 
sequence (Kp nifHA9) and E g 54 was readily detected by DMS protection footprinting
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indicating an increase in the binding affinity o f E g 54. It was initially thought that g 54, like 
other g  factors, interacted first with core RNA polymerase to form E g 54 which then 
interacted with promoter sequences to form closed complexes. However, Buck and Cannon 
(1992b) demonstrated that o 54, unlike other bacterial a  factors, was capable o f specifically 
binding to promoter DNA in the absence o f core RNA polymerase. Again binding of g 54 
was not detected for the wild type K. pneumoniae nifli promoter sequence and thus the -15 
to -17 tract o f thymine residues found in most a 54-dependent promoters was implicated as 
being important in determining the strength o f binding of g 54 to promoter sequences. The 
detection o f E g 54 binding when g 54 binding was not evident (i.e. for the K. pneumoniae 
wild type niJH promoter) indicated that core RNA polymerase in some way stabilized g 54 
binding to promoter sequences.
• Figure 1.7.1: g54 Recognition Sequences In Various a54 Dependent Promoters.
- 2 4  - 1 2
Consensus C T G G C A C G G C C T T T G C A
R m  nifH C T G G C A C G A C T T T T G C A
Kp nifH c T G G T A T G T T C C c T G c A
Kp nifH 49 C T G G T A T G T T T T T T G c A
Kp glnA p2 T T G G C A C A G A T T T C G c T
N.B: Region shown in yellow indicates base changes between the wild type 
and mutant K. pneumoniae nifH promoters
Bases shown in red are those that differ from the consensus sequence
Using DNasel footprinting and gel mobility assays Cannon et al (1993) demonstrated that 
core RNA polymerase afforded a significant binding advantage to g 54. They provided 
evidence that this was due to induced conformational changes in a 54 that improved its 
direct interactions with promoter sequences rather than to non-specific interactions 
between the core RNA polymerase with upstream DNA sequences. This was consistent
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with the observation that the DNasel footprint for E a i 4  is moved upstream towards the -12 
promoter element when compared with that o f a 54 {Buck and Cannon, 1992b). Casaz and 
Buck (1997) later provided further evidence that core RNA polymerase induced 
conformational changes in a 54 by demonstrating that core RNA polymerase caused changes 
in a 5 4  protease sensitivity. Cannon et al (1993) also demonstrated that the thymine tract at 
-15 to -17 favored a 5 4 binding and that the non-specific DNA binding activity o f core-RNA 
polymerase was inhibited by a 54.
Binding o f a 5 4  to promoter DNA may provide an advantage in the assembly of closed 
promoter complexes by favoring Ect54 formation at promoter sequences, to perhaps 
compensate for the apparently weak (compared to a 70) association of a 54 with core RNA 
polymerase in solution (Cannon et al, 1993). It is now known that a 5 4  remains bound to the 
bottom template strand at the promoter after core RNA polymerase begins elongation and 
DNA at the stall site remains open. This indicates that strong contacts between ct54 and 
promoter sequences formed as a result of conformational changes following transcriptional 
activation are not easily broken (Tintut et al, 1995). After polymerase and a 54 separate the 
system has the potential to re-initiate but new core RNA polymerase that comes in for re­
initiation cannot engage using a proper conformation, despite the fact that the start site is 
already open. Tintut et al (1995) suggested that a 54 either needs to be released or undergo a 
conformational change prior to re-initiation. This novel transcription cycle involving a 54 
raises interesting possibilities for transcriptional regulation, especially with regard to 
control at the level of re-initiation.
The above mentioned differences between a 5 4  and all other bacterial a  factors are reflected 
in the fact that amino acid sequence of a 54 shows no homology to that o f other bacterial a  
factors. It instead possess a number of conserved motifs more commonly associated with 
eukaryotic transcription factors (Sasse-Dwight and Gralla, 1990). These domains probably 
explain why a 54-dependent promoters can respond to remote activation by EBP's as do 
eukaryotic promoters (Reitzer and Magasanik, 1986).
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1.8; The Bacterial Enhancer Binding Proteins (EBP's).
As already described above the EBP's activate transcription from a 54-dependent promoters 
by binding to specific palindromic or nearly palindromic DNA sequences normally found 
between lOObp to 200bp upstream of a 5 4  promoters. These binding sites resemble 
eukaryotic enhancers in that they can be moved thousands of nucleotides upstream (Reitzer 
and Magasanik, 1986; Buck et al, 1986) or downstream (Reitzer et al, 1989) from the 
transcriptional start and still activate transcription. These binding sites have thus been 
termed Enhancer-Like Elements (ELE) or Upstream Activating Sequences (UAS). The 
EBP's bind as dimers (North et al, 1993) and once bound they cataylse the isomerization of 
transcriptionally inactive closed E a 54-promoter complexes to transcriptionally active open 
complexes in a reaction that requires the hydrolysis o f ATP (Popham et al, 1989).
It has been observed that certain strong promoters can be partially activated even if they 
lack an UAS. For example, NtrC was observed to weakly activate transcription form the 
nifH promoter, which is regulated by NifA, despite the fact that the nifH promoter lacked 
an NtrC UAS (Sundaresan et al 1983; Buck et al, 1985). Buck et al (1985) found that 
deleting the upstream NifA UAS from the nifH promoter diminished activation by NifA 
but that NifA could still weakly activate transcription. This activation occurs from solution 
within the cell and is now known to be related to the strength with which certain promoters 
independently bind a 54. This fact poses the question as to what the role of the UAS is? 
Most likely, the UAS serves to increase the local concentration of the EBP at the promoter 
and to tether it in the right position for activation. Since each EBP recognizes a specific 
UAS binding to these elements confers specificity to the initiation of transcription.
Like eukaryotic enhancer-binding proteins, prokaryotic EBP's have several domains. Most 
o f the prokaryotic E B P 's  have three domains, an amino-terminal (N-terminal) domain, a 
central domain and a carboxy-terminal (C-terminal) domain. Those proteins whose 
sequences are known (NtrC, NifA, DctD, and XylR) show a high degree of sequence 
similarity at the amino acid level (Buikema et al 1985; Drummond et al, 1986). This 
indicates both evolutionary relatedness (reviewed by Morett and Segovia, 1993) and that 
these proteins activate transcription by a common mechanism.
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The N-terminal domain of the EBP's is regulatory and is a true domain in that it is joined to 
the remainder of the protein by a flexible Q-linker (Drummond et al, 1986; Wootton and 
Drummond, 1989). While there is low homology between the N-terminal domains of the K. 
pneumoniae and S. meliloti NifA proteins, this is not shared with other EBP's. This reflects 
the fact that different EBP's are regulated by different mechanisms involving different 
proteins (Drummond et al, 1986). The sequences for the central and C-terminal domains 
exhibit a high degree o f homology, especially in the central domain. The central domain 
possess an ATP binding motif and appears to be directly responsible for nucleotide 
hydrolysis and transcriptional activation (.Drummond et al, 1986; Huala and Ausubel, 
1989; Weiss et al 1991; Austin et al 1991; Austin and Dixon, 1992; Cannon and Buck,
1992) and the C-terminal domain contains a helix-tum-helix DNA binding motif and is 
responsible for binding of the protein to specific UAS's (Drummond et al, 1986; Morett et 
al, 1988; Morett and Buck, 1988, Lee et al, 1993).
Prokaryotic EBP's reflect eukaryotic modularity. It was demonstrated for the NifA and 
DctD proteins that the central domain is an independent functional unit and that 
transcriptional activation and DNA binding are truly separable. In each case the C-terminal 
domain of the protein was removed without eliminating transcriptional activation, which 
due to the inability o f the proteins to bind DNA, occurred from solution (.Morett et al, 
1988; Huala and Ausubel, 1989; Huala et al, 1992). Conversely in the case of NifA the 
isolated C-terminal domain retained the ability to bind specifically (Lee et al, 1993). In 
both cases the N-terminal domain has also been removed, and the isolated central domain 
retains the ability to activate transcription (Huala and Ausubel, 1989; Huala et al, 1992). 
Moreover, a functional chimera has been constructed between the N-terminal and central 
domains of DctD and the C-terminal domain of NifA {North et al, 1993). This chimera 
seems to have the DNA binding specificity of NifA and can activate transcription.
Attempts to separate the DNA binding and transcriptional activation functions of NtrC 
have been unsuccessful. Although the isolated C-terminal domain of NtrC retains the 
ability to bind to DNA the remainder of the protein does not retain the ability to activate 
transcription. There are several lines of evidence to suggest that the reason for this is that 
the dimerization determinants for the NtrC protein lie in the C-terminal domain region 
while those for the other activators do not {North et al, 1993). The isolated C-terminal
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domain of Salmonella typhimurium NtrC recognizes its DNA binding site as a dimer and is 
a dimer in solution while the isolated C-terminal domain of K  pneumoniae NifA, which is 
also capable of binding to its DNA binding site at high concentrations (Lee et al, 1993), is 
largely monomeric in solution. Finally, although it was possible to produce an active 
chimera between the C-terminal domain of NifA with the upstream region of DctD, it was 
not possible to do so with upstream regions of NtrC (.Drummond et al, 1990). Failure to 
obtain active chimeras between NifA and NtrC might be explained by the fact that both 
portions of the chimera were monomeric. North and Kustu (1997) demonstrated the ability
b
of NtrC to activate transcription from solution by mutating the second helix in the C- 
terminal DNA-binding domain which was known to be required for recognition of specific 
DNA sequences. This abolished the ability of the mutant NtrC protein to bind DNA but it 
was still capable of dimerization and o f activating transcription from solution.
Control o f transcription at cr54-dependent promoters is accomplished by modulation of the 
activity state and abundance of the Enhancer Binding Proteins (EBP's). The amount of a 54 
does not vary much, at least under different conditions of nitrogen availability.
Each EBP allows a 5 4  to initiate transcription in response to a distinct physiological signal 
such as;
•  Limitation of combined nitrogen (NtrC)
•  Low oxygen tension (NifA)
•  Availability of dicarboxylic acids (DCTD).
The functions of the activators themselves are controlled by a variety of mechanisms. The 
best studied EBP's are NtrC and NifA that stimulate the expression o f genes required for 
nitrogen assimilation and nitrogen fixation, respectively, in a number of organisms. These 
EBP's and the mechanisms by which they regulate transcription are described in detail in 
the following sections.
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The related species K. aerogenes, E. coli, S. typhimurium and K. pnuemoniae regulate the 
expression of operons and genes whose products are involved in the assimilation of 
alternative nitrogen sources when ammonia, the preferred source, is lacking in the growth 
medium. Among the nitrogen-regulated operons are glnALG, which contains glnA, the 
structural gene for glutamine synthetase, the primary ammonia assimilating enzyme; argT  
and hisJQHP, which code for the components of the uptake systems for arginine and 
histidine; hutUH, which codes for enzymes required for the degradation of histidine; and 
nifLA which contains the ni/A gene whose product activates the expression of the structural 
genes for the proteins required in nitrogen fixation.
Activation of the Ntr (Nitrogen regulated) genes requires the product of the ntrA gene 
(encoding a 54), NtrC (product of ntrC [glnG]) (Pahel et al 1982) and on NtrB (product of 
the ntrB \glnL]) (Chen et al, 1982). The NtrC protein is often also referred to as NRJ 
(Nitrogen regulator I) and NtrB is often referred to as NRII (Nitrogen regulator II) and 
these terms are used in the following sections. The two regulator proteins are encoded by 
the glnALG (glnA ntrBC) operon which also contains the structural gene for gluamine 
synthetase (glnA).
NRI and NRII are part o f a two component regulatory system. NRI is initially synthesized 
as an inactive protein that is incapable of activating transcription. It is inter-converted 
between an active phosphorylated and inactive dephosphorylated forms through the activity 
of the NRII protein (Kustu et al, 1989) which in turn receives an accurate assessment of the 
availability of cellular nitrogen from the products of glnB (product of which is called Pn) 
and glnD (product of which is called uridylyltransferase [UTase]). The NRI protein has an 
ATP binding motif in its central transcriptional activating domain which is responsible for 
the hydrolysis of ATP. This ATPase activity is required to catalyze open complex 
formation (Weiss et al, 1991; Austin et al, 1991)) and was shown to be activated by 
phosphorylation of the N-terminal domain of NRI by NRII (Austin and Dixon, 1992). 
When nitrogen is present NRII associates with the small protein Pn to become a 
phosphatase which dephosphorylates NRI and thus inactivates it. When ammonia levels in 
the media drop off the intracellular level of glutamine drops. This enables the enzyme
1.8.1: The General Nitrogen Regulatory Protein NtrC.
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UTase to use UTP to uridylate Pn. The resulting Pu-UMP is released from its association 
with NRII "enabling it to phosphorylate and thus activate NRI. NRI then activates 
transcription from the glnALG operon encoding glutamine synthetase and NRI. The 
increased NRI concentration then induces the expression of several other operons encoding 
proteins facilitating the utilization of numerous alternative nitrogen sources (Magasanik,
1996). In the nitrogen fixing bacteria K. pneumoniae NRI is also responsible for activating 
the transcription of the nifLA operon which encodes the NifA EBP. The NifA protein then 
activates the expression of all other nitrogen fixation (nif) genes.
As mentioned above the NRI and NRII proteins are encoded by the glnALG {ginA ntrBC) 
operon. This operon is autogenously regulated by NRI at three promoters; glnApl, glnAp2 
and glnLp. Initiation o f transcription at the glnApl promoter is stimulated by the catabolite 
activator protein charged with cAMP. Transcription at this promoter serves to maintain a 
low intracellular level o f glutamine synthetase in cells growing in conditions o f carbon 
deficiency and nitrogen excess (see Figure 1.8.1). Initiation of transcription at glnLp 
promoter serves to maintain a low intracellular level o f NRI and NRII (see Figure 1.8.1). 
The glnAp2 promoter is a <j54 dependent promoter and is activated by phosphorylated NRI. 
Initiation o f transcription at this promoter results in high intracellular concentrations of 
glutamine synthetase and NRI (see Figure 1.8.1). NRI binds to the consensus sequence 
TGCACCA—TGGTGCA which is a perfect inverted repeat o f 7 bp separated by 3 bp. 
Binding sites for NRI overlap the start site and the TATA AT sequence of the glnLp 
promoter of E. coli and inhibits initiation of transcription from this promoter by ct70-RNA 
polymerase holoenzyme (Reitzer and Magasanik, 1986). Two binding sites lie llObp and 
140bp upstream of the glnAp2 promoter. The first of these, designated site 1, overlaps the 
portion of the glnApl promoter homologous to the canonical TTGACA sequence, and site 
2 overlaps the transcriptional start site. Binding of NRI to these sites thus inhibits the 
initiation of transcription from the glnApl promoter and results in the activation of 
transcription from the glnAp2 promoter (Reitzer and Magasanik 1986). These sites still 
activate transcription from the glnAp2 promoter when they are moved much further 
upstream of the promoter (Reitzer and Magasanik, 1986) and can activate transcription 
from either side of the promoter (Reitzer et al, 1989). The increase in the intracellular level 
of NRI caused by NRI activated transcription from the glnAp2 promoter because not all
54
transcripts initiated at glnAp2 are terminated at the end o f glnA and because the presence of 
NRI at the sites overlapping glnLp does not interfere significantly with the elongation of 
the transcripts (Magasanik, 1996). It can thus be seen that the NRI protein is capable of 
acting both as a repressor (o f a 70 dependent promoters glnApl and glnLp) and as an 
activator (of the cr54-dependent glnAp2 and other o 54-dependent promoters).
• Figure 1.8.1: Transcription Of The slnALG  Opcron Under Excess Nitrogen (High 
N) Or Limiting Nitrogen (Low N).
HighN_______________________________
NRI NRI NRI
^ T ■  i rd z
glnApl glaAp2 |
Terminator
glnL ghtG
LowN
Early experiments devised to address how EBP's bound far from the promoter could 
activate transcription showed that the relative position o f the UAS and the promoter was 
critical for activation. It was observed that activation of the K. pneumoniae nifH promoter 
by NifA (see section 1.8.2 below) only occurred efficiently when its UAS was located over 
a certain face o f the DNA helix (Buck et al, 1987). It was therefore proposed that EBP 
functions might be mediated by direct contact with bound E a 54 and that EBP's might 
simultaneously contact upstream UAS's and the E a 54 holoenzyme bound at the promoter 
causing looping o f DNA the intervening DNA. Reitzer et al (1989) reported the same 
findings for NRI-mediated activation o f the glnAp2 promoter and again proposed that 
activation o f transcription by NRI might involve loop formation. This hypothesis was 
elegantly demonstrated by direct observation o f such loop structures by electron 
microscopy with the glnAp2 promoter (Su et al, 1990). Claverie-Martin and Magasanik 
(1991) later demonstrated that activation o f the glnHPQ operon also involved loop
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formation but that in this case loop formation was assisted by a protein called integration 
host factor flHF). This protein had been demonstrated to play an important role in NifA- 
mediated activation of transcription from the K. pneumoniae nifH and nifU promoters 
(Hoover et al 1990) (see section 1.8.2 belowj. It was found to bind DNA between the 
promoter and the upstream NifA UAS. It then induced a bend in the DNA thus facilitating 
direct productive interactions between the upstream bound NifA and the promoter bound 
E g 54. IHF was found to perform a similar function in the case o f the glnHp2 promoter thus 
promoting expression of the glnHPQ operon. Claverie-Martin and Magasanik (1992) 
demonstrated that the ability of IHF to enhance transcription of the glnHp2 promoter 
required that all three protein (NRI, IHF and E a 54) were bound on the same face of the 
DNA helix which supported the fact that IHF exerts its effects through bending of the 
DNA.
1.8.2: The N itrogen  F ixation  R egu la tory  Protein  N ifA
The free living nitrogen fixing bacterium K. pneumoniae utilizes the enzyme nitrogenase to 
reduce dinitrogen (N2 ) to N l^ + under conditions of nitrogen starvation, low oxygen tension 
and an ambient temperature below 37 °C (Fischer and Hennecke, 1987). Nitrogenase is 
composed of polypeptides encoded by the genes nifH, nifD and nifK which are situated 
within an operon transcribed in the direction nifH to nifK. The nifHDK operon is itself 
located within a larger cluster of 20 contiguous nif genes which are organized into 7 or 8  
operons. One nif operon, the nifLA operon, codes for the regulatory proteins NifL and 
NifA. NifA is an EBP responsible for the activation of all other nif operons and, unlike 
NRI, NifA is initially expressed as a fully active protein (i.e. it is capable of activating 
transcription). The NifL protein is involved in modulating the activity of the NifA protein 
in response to certain physiological conditions (i.e. oxygen tension and nitrogen 
availability). The mechanism by which it does this is unknown (Sundaresan et al, 1983) 
but appears to involve the N-terminal domain of the NifA protein.
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The nif genes of the enteric bacterium K. pneumoniae are indirectly under the control of the 
ntr system-  Under conditions of nitrogen limitation the NR1 protein activates the 
transcription of the nif LA operon (Sundaresan et al, 1983). The nif A gene product then 
activates the transcription of all other nitrogen fixation (nif and fix) genes and also 
autogeneously activates the nifLA operon (Buck et al, 1985). The nifL gene product 
prevents NifA-mediated activation of other nif operons in response to high oxygen levels 
and intermediate concentrations of nitrogen. Expression of the nifLA operon is only 
partially repressed by oxygen but fully repressed by high concentrations of fixed nitrogen
-V»
(Fischer and Hennecke, 1987). The fact that nifLA expression itself is somewhat repressed 
upon aeration is due to the NifL protein preventing NifA-mediated autoactivation of the
nifLA operon (Fischer and Hennecke, 1987).
The NifA protein binds to the consensus sequence TGT-N4 -T-N5 -ACA located more than 
lOObp upstream of nif promoters (Buck et al, 1986; Morett and Buck, 1988). Buck et al 
(1987) found that NifA-mediated activation of transcription required that the NifA protein 
be bound upstream and to the correct face of the DNA helix in order to interact with 
downstream transcription factors (i.e. E a 54 bound at the promoter). It was proposed that 
this interaction was brought about by loop formation. Hoover et a l (1990) discovered that a 
protein called the integration host factor, IHF, bound to DNA between the nifH promoter 
and the upstream NifA UAS. They discovered that IHF greatly stimulated NifA-mediated 
activation of transcription from the nifH promoter and that it caused DNA adjacent to the 
nifH promoter to bend. They deduced that the IHF induced bend facilitated direct 
productive contacts between upstream bound NifA and Ect5 4  bound at the nifH promoter 
thus resulting in activation of transcription. They also demonstrated that IHF could bind to 
nif promoter regulatory regions in a variety of nitrogen fixing bacteria and that in each case 
it bound between the promoter and the upstream site(s) for NifA. Santero et al (1992) 
provided further evidence to support the role of IHF in NifA-mediated activation of 
transcription. They found that IHF greatly stimulated NifA-mediated transcription of the 
nifH promoter but that it did not enhance the level of activation of the nifH promoter 
caused by NRI (which had been observed to activate transcription from the nifH promoter). 
They proposed that this was because NRI did not bind to the nifH promoter and that it 
activated the nifH promoter from solution. They removed the upstream NifA UAS from the
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nifH promoter and replaced it with the UAS for NRI and found that IHF then enhanced 
NRI activation of the nifH promoter.
Genetic control o f nitrogen fixation by nitrogen status is much less rigorous in the legume 
root and stem nodule bacteria belonging to the genera Sinorhizobium, Bradyrhizobium and 
Azorhizobium even though these bacteria possess a nitrogen control circuitry for utilization 
o f amino acids and nitrate. In these organisms nif gene expression is primarily regulated in 
response to oxygen tension (Fischer and Hennecke, 1987). Unlike K. pneumoniae, S. 
meliloti and B japonicum only fix nitrogen in symbiotic nodules where microaerobic 
conditions prevail, and in free living cells under low oxygen tension (Fischer and 
Hennecke, 1987). The NifA gene has been identified in several Rhizobia species and is 
required for nif expression in all of them. It was initially thought that the activity of NifA 
might be modulated in response to oxygen in all o f these species by a similar mechanism to 
that observed in K. pneumoniae. This was supported by the observation that Kpneumoniae 
NifA could activate transcription of the S. meliloti nifHDK operon (Sundaresan et al, 1983). 
However, no nifL-like gene was identified in any Rhizobial species.
Fischer and Hennecke (1987) reported that the NifA protein from B. japonicum (NifAßj) 
was sensitive to oxygen in both a B. japonicum and an E. coli background while the K. 
pneumoniae NifA protein was not. Based on this observation they suggested that regulation 
of NifAßj activity in relation to oxygen tension might not be mediated indirectly through 
the action of another protein and that the NifAßj was itself inherently sensitive to oxygen. 
Comparison of the amino acid sequences of NifA from B. japonicum, S. meliloti, K. 
pneumoniae and Rhizobium leguminosrum bioxar viciae revealed that while these proteins 
exhibited a high degree of homology in their central and C-terminal domains that there was 
little homology between their N-terminal domians NifAßj (Fischer et al 1988)(see Figure
1.8.2). This supported the view that the activity of NifA in the Rhizobial species was 
regulated in a different manner to that observed in K. pneumoniae. Fischer et al (1988) also 
found that when the N-terminal domain of the NifAßj was deleted that the resulting deleted 
protein was still active and that it retained the oxygen sensitivity characteristic of the wild 
type protein. This supported the theory that the NifABj was itself inherently oxygen 
sensitive and that this sensitivity did not require the N-terminal domain of the protein. Like 
NifAßj, the S. meliloti NifA (NifAsm) was also reported to be oxygen sensitive. Comparison
58
of the amino acid sequences o f NifA from B. japonicum, S. meliloti, K. pneumoniae and 
Rhizobium Teguminosrum bioxar viciae also resulted in the identification of an interdomain 
linker region between the central and C-terminal domains of NifA that was conserved 
among all of the Rhizobial NifA proteins but absent from the K. pneumoniae NifA protein 
(see Figure 1.8.2). Within this interdomain region where two highly conserved cysteine 
residues (Fischer et al, 1988). Since cysteine residues are very often involved in redox- 
reactive processes Fischer et al (1988) decided to alter the two conserved cysteine residues 
in the NifABj to determine the functional importance of the conserved interdomain region 
and in particular the highly conserved cysteine residues. They also mutated two other 
conserved cysteine residues in the central domain (see Figure 1.8.2). They found that 
alteration o f any of the cysteine residues resulted in an inactive protein indicating that the 
interdomain region and in particular the four conserved cysteine residues were 
indispensible to NifABj function. Fischer et al (1988) also found that NifAej was sensitive 
to chelating agents and that this inhibition could be overcome by the addition of divalent 
metal ions. In light o f the above finding Fischer et al (1988) proposed a model in which the 
four conserved cysteines coordinated a metal cofactor and that the redox state of the NifA- 
metal complex was responsible for regulating NifAej activity. Morett et al (1991) found 
that oxygen inhibited the ability of NifAej to both bind to its UAS and its ability to activate 
transcription. They proposed that the redox-state of a NifA-metal complex might determine 
its conformation and thus its ability to activate transcription.
The inherent oxygen sensitivity of the NifABj protein plays a role in regulating the 
transcription of the nifA gene itself in response to oxygen. In B. japonicum expression of 
the nifA gene is autoregulated by NifAej. Under conditions of high oxygen tension nifA is 
only expressed at very low levels while under conditions of low oxygen tension the NifAgj 
is active and activates expression o f the nifA gene resulting in maximal expression of the 
NifA protein (Morett et al 1988). Like NifAej the S. meliloti N ifA  (NifAsm) is also 
inherently sensitive to oxygen and thus its activity in activating the transcription of nif 
genes is directly controlled by oxygen.. Transcription of the nifA gene is also regulated but 
in a different manner to that observed in B. japonicum. In S. meliloti nifA transcription in 
regulated by a two component regulatory system comprising of the proteins FixL and FixJ. 
FixL is a membrane bound protein which senses cellular oxygen status and under low
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oxygen tension it phosphorylates the FixJ protein. The phosphorylated FixJ protein then 
activates transcription o f the nifA gene (Agron et al, 1993).
Figure 1.8.2 :Comparison Of Deduced NifA Amino Acid Sequences
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FiRure 1. Comparison of the deduced amino acid sequences of the B.japonicum 
CIjTT R.mel i loti (Rm), R. leguminosarum biovar viciae (Rl) anti K.pneumoniae 
(Kp) NifA proteins. For references see text. Identical amino acids in all four 
proteins are marked by an asterisk (*) and identical amino acids occurring 
only in the rhizobial NifA proteins by the symbol (+). Functional domains ori 
ginally proposed by Drummond et al. (7) were modified to boxes termed central 
domain (CD), mterdoma in linker (IDL) and DNA binding domain (DBD). The conser 
veil liel ix-turn-helix (hth) inoti f common to many DNA binding proteins is deno 
ted by a horizontal bar within DBD. The endpoints of the truncated NifA pro­
teins encoded by the plasmids shown in Fig, 2 are indicated by the respective 
plasmid numbers. In the Bj NifA protein sequence the cysteine residues that 
were converted to serine residues by site-directed mutagenesis (see also lab If 
?) art' marked with vertical arrowheads.
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1.9: Project Outline.
As was already described in section 1. 6  the aim of the work undertaken in this thesis was to 
construct a novel P2H system based on the NifA protein of S. meliloti 2011. The planned 
system would be homologous in structure to the Y2H system.
The first step in the project would involve the construction of plasmid vectors for the P2H 
system. Three Prey plasmids would be constructed using the sequence for the 
transcriptional activating N-terminal domain-central domain (NC) portion of NifA. In these 
plasmids the NC portion of the NifA protein would be expressed from a strong ptac 
promoter. C-terminally to the sequence for the NC portion of NifA would be a multiple 
cloning site (MCS) into which a library of DNA fragments could be cloned to generate a 
library o f hybrid proteins bearing the activation domain of NifA. The NC portion of the 
NifA protein was used rather than just the central activating domain of the NifA protein by 
itself because the N-terminal domain of the protein had been shown to stabilize the protein 
when expressed in E. coli (Huala and Ausubel, 1989). The three Prey plasmids would 
differ from each other only in the reading frame of the multiple cloning site relative to the 
upstream sequence for the NC portion of NifA. Another Control plasmid expressing the 
whole NifA protein from the ptac promoter would also be constructed. This could be used 
as a positive control when performing P2H assays
In addition to the Prey plasmids two Bait plasmids would be constructed. The bait 
construct present on these plasmids would be constructed using the C-terminal DNA 
binding domain of NifA. It would consist o f a ptac promoter followed by a MCS into 
which the sequence for a protein of interest could be cloned. C-terminally to the MCS 
would be the sequence for the DNA binding domain of NifA. Cloning into the MCS would 
result in the expression of a hybrid protein bearing the DNA binding domain of NifA. In 
addition to the bait construct these plasmids would also contain reporter gene constructs. 
One o f the Bait plasmids would contain a nifH.lacZa reporter gene construct while the 
other would contain a nifH.genf (gentamycin resistance) reporter gene. These Bait 
plasmids would be compatible with the constructed Prey and Control Plasmids
In addition to the construction of these above mentioned plasmids a suitable strain of E. 
coli would also be developed in which the plasmids could be used. This strain would have
to have the glnG  gene deleted since the product o f  this gene, N trC, had been observed to 
activate On&hifH prom oter (Buck et al, 1985) and w ould thus could give rise fa lse  positives.
H aving constructed the p lasm ids and developed su itable strains for the P211 system , The 
system  w ould be tested  for it ability to detect protein-protein interactions in vivo  using a 
pair o f  proteins known to interact a s  a  m odel. The details o f  how all o f  the above plasm ids 
w ould be m ade can  be found in the fo llow ing chapters o f  this thesis.
■U
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Chapter 2
Methods And Materials.
The bacterial strains, primer sequences and plasmids used in this study are described 
in tables 2.1, 2.2, and 2.3 respectively.
2.1: Bacterial Strains, Primer Sequences And Plasmids.
Table 2.1: Bacterial Strains.
Strain Phenotype/Genotype
Sinorhizobium  m elilofi 201
Escherichia coli strains
DH5a
XL 1-Blue
F ,  recA 1, hsclR 1 7 ( i‘k\  mR4) ,  
supE44, (j)80d/c/cZAM 15 
A(lacZYA-argF)U 169.
ree A 1, hsclR 17(rK', m« ' ), 
supE44, lac, [F pro AD' , 
lacV , lacZòM  15::Tn 10(Tetr) |
INVaF'
YMC1
Fr, recA  1, hsclR 17(rK‘, niK ' ), 
supE44, (|)80c!/acZAM 15, 
A(lacZYA-argF)\J  169.
sup FA 4. hsclR 1 7(¡‘k‘, hik'), 
A(glnA-glnG)20Q0, AlacU 169.
YMC1 \r if  
YMC11/v/F'
Rifampicin mutant ofY M C l I
Same as Y M C 1 1 r i f  [F pro AB 1 , 
l a c f  , lacZ A U  15 : :Tn 10(Tetr)] .
Source / Reference
Meade el al, 1982.
Bethesda research 
Laboratories
Stratagene
lnviirogcn
Chen cl al, 1982.
This work 
This work
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Table2.1 continued
ET6016 A(glnG-glnL?)228, E. coli genetic
strR, A/acU169, stock center.
ET6016rif Rifampicin mutant of ET6016 This work
ET6016rzyF' Same as 6016rif, [F ',proAB+ , This work
la c ? , /ocZAM15::Tnl0(Tetr)].
Table 2.2: Primers Sequences.
Primer
Name
Primer Sequence
S' 3 ’
Cone.
(nmol/|il)
Tm
(°C)
gent- F (GAATTC) -A- TTA CGC AGC AGC AAC GAT GTT 0.60 62
gent- R (AAGCTT) - TTA GGT GGC GGT ACT TGG GT 0.60 62
nifH.'gent r-F (AAGCTT) - GCA TGC CTG CAG CGC CCA 0.60 62
ptac-F (TCTAGA) - GAG CTT ATC GAC TGC ACG GT 0.60 64
ptac- R (CCCGGG) - TTT CCT GTG TGA AAT TGT TAT CCG 0.60 62
NC-F1 TCCC (CCCGGG) - ATG GCC CCC ACT CGT CTT GAG 0.87 68
N C R CCG (GGATCC) - GGG CTC TTT CGG CGG 0.91 72
NC-F2 (CCCGGG) - ATG GCC CCC ACT CGT CTT GAG ACC ACG C 0.60 92
C-term-F (GGATCC) - GCA GGA GTG GCA TCC 0.63 70
C-term-R (AAGCTT) - GAC GGA GAA AAG AGG CGA CGC 0.65 68
Bate-F (CGGCCG) - ATC CGG AGC TTA TCG ACT 0.60 54
Bate-R ACG (GTCGAC) - GCG GAT ACA TAT TTG AAT GTA 0.60 56
/»'///-FI AAA A (CTGCAG) - CGC CCA TAC GAC ACT GTC CGT 0.86 68
nifH- F2 (GTCGAC) - GCA TGC CTG CAG CGC CCA 0.60 62
nifH- R CCA (GAATTC) - AA - CAT CTT GCT TCC TTT GTT GTT 0.82 58
HZ -F CC (AAGCTT) - GCA TGC CTG CAG 0.69 64
HZ -R (AAGCTT) - CGG CAT CAG AGC AGA TTG TAC 0.69 64
P1H-F (GGATCC) - GTT GTT CGC TCA ACC ATC TGG 0.60 60
tir- F (GGATCC) - CAC AGG AAA GAA TTC ATG CCT 0.60 80
tir- R (GGATCC) - AAC GAA ACG TAC TGG 0.60 66
280a-¥ (GGATCC) - ATT ACT GAG ATT AAG GCT 0.0095 48
280a- R (AAGCTT) - TTA TTT TAC ACA AGT GGC 0.0182 48
280C/Aa-R (AAGCTT) - TTA TTT TAC AGC AGT GGC 0.60 50
N o t e :  Underlined bases are bases included for maintenance of reading frames. 
Added restriction sites are in bold type and are bracketed.
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Table 2.3: Plasmids.
Plasmid Description Source/Rcfcrcncc.
pCR2.1TA Cloning Kit Vector: AmpR, KmR, 
lacZa
Invitrogen
pKK223-3 ptac promoter expression vector 
pBR322 derivative, AmpR.
Pharmacia
pACYCl 84 pi 5a origin of replication, CmR, TcR. New England Biolabs
pUC19 AmpR, lacZa Pharmacia
pJQ200ks GmR, sacB. Quandt (1993)
pSUP5011 pBR322 derivative, Tn5-mob, 
CmR, TcR, KmR.
Simon (1984)
pICCIO pGBT9 expressing tir Gift From Gad Frankel
pICC19 pGAD424 expressing int280a Gift From Gad Frankel
pICC20 pGAD424 expressing int280C/A a 
pCR2.1 Derived Vectors
Gift From Gad Frankel
pPCIA nifH promoter PCR product in pCR2.1 
(amplified as a Pstl-EcoRl fragment)
This work
pPClB nifH promoter PCR product in pCR2.1 
(amplified as a Sall-EcoRl fragment)
This work
pPC2 nifH:lacZa PCR product in pCR2.1 This Work
pPC3 NifA C-terminal domain PCR product 
in pCR2.1
This work
pPC4A. Bait construct PCR product in pCR2.1 
(amplified as a Safi fragment)
This work
pPC4B. Bait construct PCR product in pCR2.1 
(amplified as a Eagl-Sall fragment)
This work
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Table 2.3 continued
pPC5. _ nifA PCR product in pCR2.1
pPC6 A, B&C. NifA N-terminal-central domain PCR
product in pCR2.1 
pPC7 genf gene PCR product in pCR2.1
pPC 8  nifH:genf PCR product in pCR2.1
pPC9 ptac promoter PCR product in pCR2.1
pP C l0 nifH:lacZa PCR product in pCR2.1
(one-hybrid system reporter construct) 
pPC 11 int280a gene PCR product in pCR2.1
(amplified as a BamHl-Hindllll fragment) 
pPC12 int280 C/Aa gene PCR product in pCR2.1
(amplified as a BamHl-Hindllll fragment) 
pPC 13 tir gene PCR product in pCR2.1
(amplified as a BamHl fragment)
PKK223-3Derived Vectors.
pPC223 pKK223-3 with BamHl site outside the
MCS destroyed and replaced by a unique 
Xbal site.
pPC224 NifA C-terminal domain from pPC3
in pPC223.
pPC225 BamHl Fragment from pSUP5011
cloned in BamHl site o f pPC223. 
pPC226 genf gene from pPC7 inpPC223.
pPC227 nifH promoter from pPClB in pPC226.
pPC228 Final NifA Control Vector.
nifA from pPC5 in pPC223.
This work 
This work
This work 
This work 
This work 
This work
This work
This work
This work
This work
This work
This work
This work 
This work
This work
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Table 2.3 continued
pPC229A,J3&C
pPC230
pPC231A, B&C
pPC232
pPC233
pPC234
pPCl 84
pPC185A&B
pPC186A&B
pPC187A&B
Final Prey Vectors.
NifA N-terminal-central domain 
from pPC6 A, B&C in pPC223.
Alternative Control Vector.
ptac promoter from pPC9 in 
pPC228.
Alternative Prey Vectors.
ptac promoter from pPC9 in 
pPC229A,B&C.
tir gene from pICCl 0 in pPC223. 
int280a from pPCl 1 in pPC229A. 
int280C/Aa from pPCl2 in pPC229A.
PACYC184 Derived Vectors.
pACYC184 with its unique BamRl site 
destroyed. Plasmid is no longer TetR 
nifH:lacZa from pPC2 in pP C l84 
nifH:genf from pPC8  in pP C l84
Final nifH:lacZa Bait Vectors.
Bait construct from pPC4-B in 
pPC185A&B respectively
This work
This work
This work
This work 
This work 
This work
This work
This work 
This work
This work
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Table 2.3 continued
pPC  18 8 A & B  F in a l nifH '.genf B a it  V ecto rs.
B a it construct from  p P C 4 B  in 
p P C 1 8 6 A & B  respectively .
This work
p P C l89 O n e-H y b rid  S y ste m  B a it  V ector.
nijJL lacZ a  from pP C  10 in p A C Y C  184
This work
p U C  19 D erived  Vectors.
pP C 19 n if l i  prom oter from pPC  1A  in pU C  19 This work
2.2: Microbiological Media.
So lid  com plex m edia  contained 15g/L  O xoid #3 agar. So lid  m inim al m edia contained 
15g/L  O xo id # l purified technical agar. Tryptone and Y east extract w ere a lso  from 
O xoid . Other ch em icals were from  S igm a  C hem icals C o. and BD H  C h em icals LTD . 
A ll ch em icals were analar grade.
D istilled  water w as used to prepare all m edia and sterilisation  w as achieved by 
au toclav in g at 151b/in2 fo r20m in .
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U sed  fo r  the routine culturing o f  fast grow ing Sinorhizobium  strains.
Tryptone 5 g
Y east Extract 3 g
C aC l2 *2 H 2 0  0 .7  g
A d ju sted  to  pH  7 .0  with N aO H  and vo lum e brought to  1L  w ith dH20. The 
solution  w as then sterilised by autoclaving.
•  TY  Mediumf Beringer, 1974).
• Luna Bertani Broth (LB).
U sed  for routine culturing o f  E. coli.
Tryptone 10 g
Y ea sl Extract 1 g
N aC l 10 g
A djusted  to pH 7.0 with N aO H  and vo lum e brought to 1L with dlEO. The 
so lu tion  w as then sterilised  by autoclaving.
•  S O B  M ed iu m .
Tryptone 20  g
Y east Extract 5 g
N aCl 0.5 g
KC1 2.5 m M
dH 20  1 L
pH  7.0
A fter autoclav in g the solution w as allow ed to cool to 55 °C  and sterile solutions 
o f M g C h  and MgaSO-i were added to final concentrations o f  lOmM.
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•  SO C Medium.
A fter m aking S O B  a s  above 7.2m l o f  50%  sterile g lu cose  w as added to give a 
final concentration o f  20m M .
2.3: Solutions And Buffers.
T E  B u ffe r .
T ris-H C l 10 m M
N a 2-E D T A  1 m M
pH 8.0
T E S  B u ffe r .
T ris-H C L  10 mM
N a2-B D T A  1 m M
N aC l 50 m M
pH 8.0
S T E T  B u ffe r  (100  m i) (H olm es a n d  Q uigley, ¡981).
T ris-H C l 
N a2-E D T A  
T rit io n X  100 
Sucrose  
pH
50 m M  (5m l o f  1M solution)
50 mM  (10m l o f  0 .5M  solution) 
5 %  (5m l)
« % (8g)
8.0
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• Solutions For The 1,2,3 Method (Birnboim and Poly. 1979).
Solution 1
Solution 2
G lu co se  (0 .5M ) 1 ml
N a 2-E D T A  (0.1 M ) 1 m l
T ris-H C l (1M ) 0.25 ml
dH 20  7 .75 ml
N aO H  (IN )  2 ml
S D S  (10% ) 1 m l
dH 20  7 ml
m ade up fresh every month and stored at room  tem p.
Solution 3
Potassium  acetate 3 M
pH 4.8
T o  60m l o f  5M  Potassium  acetate add 11.5ml o f  g lacial acetic acid  and 28.5m l 
o f  dH 20 .  T he resulting solution is 3M  with respect to P o tassiu m  and 5M  with 
respect to acetate.
Kirby Mix
Phenol 100 ml
Chloroform  100m l
Isoam yl alcohol 4 ml
8-1 lydroxy Q uinolone 0 .8  g
Stored under lOOmM T ris-H C l, pH 7.5 at 4 °C .
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•  50 x Tris Acetate ED TA (TAE) Buffer.
EDTA (0.5M) 100 ml
Glacial Acetic Acid 57.1ml
Tris 242 g
pH 8.0
diluted to IX with dH20  before use.
• Gel Loading Dye (6X).
Bromophenol Blue 0.25 %
Xylene cyanol 0.25 %
Sucrose (w/v) 40 %
Made in dH20  and stored at 4 °C.
•  S o lu tio n s  F o r  G en e  C lean  P ro c ed u re  (M ath er e t aA 1993).
S o d iu m  Io d id e
Nal 90.8 g
dII2Oto 100 ml
Na2 S 0 3 1 g
The solution was stirred until as much of the sodium iodide as possible had
dissolved and was then filtered through a 0.45f.im filter. Then 0.5g o f Na2 SO} was
added (did not dissolve) and the solution stored at 4 °C in the dark.
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N ew  W ash  S o lu tio n
Ethanol 50 %
Tris-HCl, pH 7.5 10 mM
Na2-EDTA 1 mM
NaCl 100 mM
the solution was stored at -20 °C
T B  B u ffe r  F o r  C o m p ete n t C e lls  (Inoue et al< 1990).
Pipes 10 mM
CaCl2 15 mM
KCL 250 mM
dH20  1 L
pH with KOH 6.7
Once the pH had been adjusted, MnCl2 was added to a final concentration of 
55mM. The solution was then filter sterilised through a 0.45pm sterile filter and 
stored at 4 °C.
•  Z  B u ffe r  F o r  ß -G a la c to s id a se  A ctiv ity  A ssa y  fM iller . 1972).
Na2 HPO;| 16.1 g
NaH2 P04 5.5 g
KCL, 0.75 g
M gS0 4 0.246 g
Mercaptoethanol 2.7 ml
dH20  1 L,
Do not autoclave this solution
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• 8% L-Glutamine Stock Solution.
The solution had to be heated to 60 °C in order to get the glutamine to dissolve. 
The solution was then filter sterilised through a 0.28jim sterile filter. Upon 
cooling the glutamine precipitated out of solution. The solution therefore had to 
be heated to dissolve the glutamine prior to its addition to media.
2.4: Antibiotics.
Antibiotics used were from Sigma. Antibiotic stocks were prepared to a 
concentration of lOOmg/ml and stored at -20 °C
Ampicillin was prepared in dHaO and was used at a final concentration of lOOfig/ml 
in solid media and 25|.ig/ml in liquid broth.
Chloramphenicol was prepared in ethanol and used at a concentration of 25(ig/ml in 
both solid and liquid media.
Tetracycline was prepared in 50% ethanol and stored in the dark as it is light 
sensitive. It was used at a concentration of 1 0 (ig/ml in both solid and liquid media. 
Kanamycin was prepared in dHaO and was used at a final concentration of 50(ig/ml 
in both solid media and liquid media.
Rifampicin was prepared in methanol and was stored in the dark as it is light 
sensitive. It was used at a concentration of 100|j,g/ml in both solid and liquid media.
2.5: Storing And Culturing Bacteria.
Strains were stored as glycerol stocks. A 0.5ml aliquot of a late log phase culture was 
added to an equal volume of sterile glycerol in microfuge tube which was then mixed 
and stored at -20 °C. A duplicate set of long term stocks were stored at -80 °C. Where
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hosts were harbouring plasmids, the appropriate antibiotic was added to the stock 
medium. Working stocks were stored on plates at 4 °C.
2.6: Phenol Preparation.
A 500g container of phenol was placed in a 6 8  °C water bath and heated until the 
phenol had melted. 8 -hydroxyquinolone was added to a final concentration of 0 .1 %. 
This yellow compound is an antioxidant, a partial inhibitor of RNase and a weak 
chelator of metal ions. In addition the yellow colour provides a convenient way to 
identify the phenol phase during separations.
The melted phenol was then extracted several times with an equal volume of Tris 
buffer. The first extraction was carried out with 1M Tris pH 8.0. Subsequent 
extraction steps were carried out using 0.1M Tris pH 8.0 to which 0.2% P- 
mercaptoethanol had been added. This was continued until the pH of the aqueous 
phase was >7.6. The phenol solution was then stored at 4 °C under lOOmM Tris-HCl 
pH 8.0.
2.7: Plasmid Preparation By The 1,2,3 Method.
This method was described by Birnboim and Doly (1979). A 1.5ml aliquot of a 
bacterial culture grown in selective media was pelleted at 4000rpm in a microfuge 
and the supernatant removed. The pellet was resuspended by vortexing in 200|j.l of 
solution 1 and was then left for 5min at room temperature. Then 2 0 0 (0.1 of solution 2 
was added, the tube was mixed by inversion and placed on ice for 5min. Then 200(.il 
o f solution 3 was added, the tube was mixed by inversion and placed on ice for 
lOmin. A clot of chromosomal DNA formed and was pelleted by centrifugation at 
13,000rpm in a microfuge for lOmin. The supernatant (600(j.l) was placed into a fresh 
tube and 400jli1 of Kirby mix was added and mixed by vortexing. After centrifugation
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at 13,000rpm for 5min the aqueous layer was removed to a fresh tube and an equal 
volume of isopropanol was added. After lOmin at room temperature the tube was 
centrifuged for lOmin at 13,000rpm to pellet plasmid DNA. The pellet was washed 
twice with 70% ethanol, dried briefly in a vacuum dryer and resuspended in 50/al of 
TE buffer. Plasmid preps were stored at 4 °C.
2.8: P lasm id P reparation  By R apid  Boiling M ethod.
I*
This method was described by Holmes and Quigley (1981) and used instead of the 
1 ,2 ,3 , procedure outlined above for the screening of large numbers of transformants. 
A 3ml aliquot of an overnight culture was spun at 4000rpm in a microfuge for 5min 
and the supernatant removed. The pellet was resuspended in 350(.il of STET buffer. A 
2 0 (0,1 aliquot of a 10mg/ml lysozyme solution (prepared fresh in STET buffer) was 
added and the microfuge tube incubated at 30 °C for lOmin. The tube was then 
placed in a boiling water bath for 6 Osec and then spun at 10,000rpm for lOmin. The 
supernatant was removed to a fresh microfuge tube and an equal volume of 
isopropanol was added. The tube was left at room temperature for lOmin and then the 
plasmid DNA was pelleted by centrifugation at 13,000rpm for lOmin. The pellet was 
washed twice with 70% ethanol, dried briefly in a vacuum dryer and then dissolved 
in 50(0.1 of TE buffer. Plasmid DNA was then stored at 4 °C.
2.9: P reparation  O f T otal Genom ic DIVA From  S in o r h iz o b iu m .
Ten ml of an early stationary phase culture of Sinorhizobium meliloti 2011 was 
sedimented in a Bechman J2-21 centrifuge at 10,000rpm for 5min. The cells were 
washed with an equal volume of TES buffer and then resuspended in 5ml of TE 
buffer. A 0.5ml aliquot of freshly prepared lysozyme solution (2mg/ml in TE) was 
added and the suspension incubated at 30 °C for 20min. A 0.5ml aliquot of a
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sarkosyl/proteinase solution (10% sarkosyl in TE containing 5mg/ml proteinase) was 
then added and the suspension was incubated for 1 hour. Lysis was evident by an 
increase in the viscosity of the suspension. A 0.7ml aliquot of 3M sodium acetate was 
added and the suspension mixed gently. Then 2.5ml of Kirby mix was added and the 
suspension was mixed slowly by inversion for 15min. After centrifugation at 
10,000rpm for lOmin the aqueous phase was removed to a glass corex tube and 
centrifuged at 10,000rpm for another 15min. The supernatant was removed to a clean 
plastic centrifuge tube and 2.5ml of Kirby mix was added. The suspension was mixed 
gently for 15min and before extraction with chloroform:isoamylalcohol(24:l). The 
DNA was precipitated by the addition of an equal volume of isopropanol and was 
evident as a coiled thread. The DNA was sedimented by centrifugation at 10,000rpm 
for 15min, washed twice with 70% ethanol, dried under vacuum and resuspended in 
400^1 ofTE.
2.10: A garose  Gel E lectrophoresis F o r  DNA C haracterisation .
DNA was analysed by running on agarose gels in a horizontal gel apparatus. Gels 
were prepared by dissolving agarose in lxTAE buffer to the required concentration 
(typically 0.7-1.2%) and boiling until the solution went clear. The lxTAE buffer was 
also used as the running buffer. A tracker dye was incorporated into DNA samples 
(2(J.l to 5-7fJ.l of sample) to facilitate loading of samples. Mini-gels were frequently 
run at lOOVolts for lhour or until the tracker dye reached the base of the gel while 
maxi gels were frequently run at 40Volts overnight. Gels were stained by immersing 
in a bath of ethidium bromide for 30min and then destaining in a water bath for 
lOmin. Gels were then visualised on a UV transilluminator and photographed using 
a UV image analyser.
All agarose gels shown in the results chapters of this thesis were 0.7% agarose 
unless otherwise stated. A standard 1Kb ladder was run on all gels to facilitate 
estimation of DNA fragmnent size. Figure 2.10.1 below shows a photograph of this 
ladder run on a 1% agarose gel and indicates the fragment sizes within the ladder.
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Figure 2.10.1: Fragment Sizes Within The 1Kb ladder.
2.11: P reparation  O f Ethidium  Brom ide.
One lOmg tablet of ethidium bromide was added to 1ml of water. The container was 
wrapped in tin foil and stored at 4 °C. A 100|ul aliquot of this stock solution was 
added to 1L of dfbO for staining agarose gels. Gloves were worn at all time when 
handling solutions containing ethidium bromide. Ethidium bromide waste was 
collected and treated with activated charcoal before being filtered through 3mm 
Whatman filter paper. The clear liquid was disposed of normally and the solids 
contained on the filter paper were incinerated.
2.12: P reparation  O f Silica 325 M esh G lass B ead s F or Gene Clean 
Procedure.
Approximately 250ml of silica powder was suspended in distilled water and the 
volume made up to 500ml in a 600ml beaker. The suspension was stirred for 1 hour 
and then allowed to settle for 1 hour. The supernatant was then removed to two 
centrifuge tubes and spun at 5000rpm in a Bechman J2-21 centrifuge for 5min. The 
pellet was resuspended in 1 0 0 ml of distilled water and transferred to a 600ml beaker
79
and the volume adjusted to approximately 140ml. Then 350ml of 70% HNO3 was 
added to give a final concentration of 50% HNO3. The suspension was heated to near 
boiling on a hot plate with continuous stirring. The suspension was then transferred 
to two centrifuge tubes and spun at 5000rpm for 5min. Each pellet was then 
resuspended in 100ml of distilled water and spun down at 5000rpm for 5min. This 
was repeated three times. The volume of the final pellet was then estimated, 
resuspended in an equal volume of distilled water and the suspension stored at 4 °C.
2.13: G ene C lean Procedure F o r  Isolation O f PN A  From  A garose 
Gels.
This method was described by Mather et al (1993). The band to be isolated from an 
agarose gel was excised with a clean sharp scalpel and placed in a microfuge tube. 
The excised piece of agarose was weighed and then 2-3 volumes of saturated Nal was 
added to the agarose. The agarose was then incubated at 55 °C for 15 min or until the 
agarose had dissolved. Approximately 2(xl of silica 325 mesh glass beads were added 
and mixed by vortexing. This suspension was then left at -20 °C for approximately 
15min and then spun for 5sec at 13,000rpm in a microfuge. The supernatant was then 
removed and discarded. The pellet was washed three times with 300f_il of ice cold 
New Wash solution to remove residual agarose and salt contaminants. The pellet was 
resuspended in a desired volume of TE buffer and incubated at 55 °C for 15min to 
elute the DNA. The suspension was spun at 13,000rpm for lmin in a microfuge to 
pellet the Silica beads. The supernatant was removed to a fresh microfuge tube and 
stored at 4 °C.
2.14: P reparation  O f C om petent Cells By C aC h  Treatm ent.
One ml of a 5ml overnight culture of an appropriate strain of E. coli was added to 
100ml of LB broth and grown with shaking at 37 °C until an OD600 of 0.3-0.4 was
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reached. The culture was then chilled on ice for 30min. A 10ml aliquot was then 
pelleted by centifugation in a Bechman J2-21 centrifuge at 4000rpm and 4 °C for 
5min. The pellet was then resuspended in 5ml of ice-cold lOOmM MgCl2 in order to 
wash the cells. The cells were pelleted as before and then resuspended in 5ml of ice- 
cold 50mM CaCh and the suspension was placed on ice for 30min. The cells were 
pelleted again, resuspended gently in 1ml of ice-cold 50mM CaCL and placed on ice 
overnight. The cells were then competent.
For storage the cells were mixed with an equal volume of sterile glycerol, split into 
200(J,1 aliquots in microfuge tubes, flash frozen to -80 °C and then stored at -80 °C.
2.15: T ran sform ation  O f Com petent Cells P repared  By CaCI? 
Treatm ent.
A 3-5 jal aliquot of a ligation mixture was added to 200f.il of competent cells that had 
been allowed to thaw on ice. The cells were left on ice for 30min and were then heat 
shocked at 42 °C for exactly 2min before being returned to ice for a further 2min. A 
0.8ml aliquot of fresh SOC medium was added to the cells and the cells were 
incubated at 37 °C for 1 hour. A 100-200/al aliquot of the resulting transformation 
mixture was then plated on appropriate selective media and plates were incubated at 
37 °C for 24 hours.
2.16: P reparation  O f High Efficiency Com petent Cells.
This method was described by Inoue et al (1990). A frozen stock the appropriate E. 
coli strain was thawed, streaked on LB agar and incubated at 37 °C overnight. 
Approximately 10 to 12 large colonies were removed with an inoculating loop and 
inoculated into 250ml of SOB medium in a 2L baffled flask. The culture was grown 
at 18 °C with vigorous shaking (200-250rpm) until an OD600 of 0.6 was reached. The
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flask was then placed on ice for lOmin. The culture was transferred to a 500ml 
centrifuge bottle and spun in a Bechman J2-21 centrifuge at 4,000rpm and 4 °C for 
5min. The pellet was resuspended in 80ml of ice-cold TB buffer, placed on ice for 
lOmin and then spun down as before. The cell pellet was gently resuspended in 20ml 
of ice cold TB buffer and DMSO was added slowly with gentle swirling to a final 
concentration of 7%. After incubation in an ice bath for lOmin the cell suspension 
was dispensed in 1ml aliquots into microfuge tubes. The cells were then flash frozen 
in liquid nitrogen and stored at -80 °C. Cells prepared in this manner frequently gave
n q t
transformation efficiencies of the order of 10 -10 transformants/|j.g DNA which is 
comparable with those attainable by electroporation.
2.17: T ran sform ation  O f High Efficiency Com petent Cells.
A l-5|il aliquot of a plasmid preparation was added to 200pl of competent cells 
prepared according to the procedure outlined in section 2.16. Polypropylene tubes 
were used as glass tubes decreased (10 fold) the competence of cells. The cells were 
incubated in an ice bath for 30min. The cells heat shocked at 42 °C for 30sec and 
then transferred back to ice for 2min. After the addition of 0.8ml of fresh SOC 
medium the cells were incubated at 37 °C with vigorous shaking for 1 hour. A 100j.il 
aliquot of the resulting transformation mixture was plated on an appropriate selective 
media and the plates were incubated at 37 °C overnight.
2.18: TA  C loning O f P C R  Products.
PCR products were routinely cloned using Invitrogens Original TA Cloning Kit 
vector pCR2.1. The diagram below shows the concept behind the TA Cloning 
method.
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• Figure 2.18.1: Principle Of TA Cloning
3 ’
■
Vector
The method is dependent on the fact that thermostable polymerases like Taq DNA 
polymerase, which lacks 3-5' exonuclease activity, leave 3' A-overhangs. PCR 
products generated with Taq DNA polymerase have a high efficiency of cloning in 
the TA Cloning system. Other thermostable polymerases like Vent and Pfu, which 
have 3'-5' exonuclease activity, do not leave these 3' A-overhangs.
PCR products were amplified using a standard PCR reaction mixture (see section 
2.21 ) and using Taq DNA polymerase from Promega. They were subsequently 
ligated with the TA pCR2.1 vector. The ligation was set up as follows;
Fresh PCR Product 2 j j .1
PCR2.1 Vector (25ng/|j,l) 2 (il
1 OX Ligation Buffer 1 jal
Sterile dH20  4 fil
T4 DNA Ligase (4.0 Weiss units) 1 ul
Total Volume 10 (al
The reaction was then incubated at room temperature overnight. Following 
incubation, 2-5 jj.1 of the ligation was used to transform either DH5a cells prepared by 
the high efficiency method (section 2.17) or INVaF' one shot competent cells that 
were supplied with the TA Cloning Kit.
To transform INVcxF' cells, the cells were first thawed on ice. Then 2pl of P- 
mercaptoethanol (0.5M) was added and mixed gently with the pipette tip. Between 2- 
5|ol o f the ligation reaction mixture was added to the cells and mixed in gently with 
the pipette tip. The cells were incubated on ice for 20min and then heat shocked at
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42 °C for 30sec. The cells were placed back on ice for 2min and then 250fxl of SOC 
media was added. The cells were incubated at 37 °C for 1 hour. A 50|_il aliquot of the 
transformation mixture was plated on LB agar containing ampicillin (lOO^g/ml) and 
Xgal to select for transformants and to test for a-complementation of p- 
galactosidase. In addition to an ampicillin resistance gene the TA pCR2.1 vector also 
contained a kanamycin resistance gene. Kanamycin (50|j,g/ml) was thus used to select 
for transformants instead of ampicillin when PCR products amplified from ampicillin 
resistant plasmids were being cloned.
2.19: T esting F o r  q-Com plcm entation  O f B-Galactosiclase.
Cloning in the TA vector works on the same basis as cloning in pUC based vectors. 
Transformants bearing plasmids with inserts, or PCR products in the case of TA 
cloning, were distinguished from transformants bearing recircularised plasmids 
without inserts by plating on media containing Xgal to test for a-complementaion of 
P-galactosidase. Transformants harbouring plasmids with inserts did not express a 
functional lacZa  gene product, which is the a  peptide of P-galactosidase, and 
therefore appeared white on X-gal plates because a-complementation could not 
occur. Transformants harbouring recircularised plasmid DNA without any inserts 
expressed a functional lacZa gene product and thus appeared blue on Xgal plates 
because a-complementation of P-galactosidase occurred resulting in the cleaving of 
X-gal. White colonies were thus picked from plates and screened for the presence of 
inserts.
In order to test for a-complementation transformations were plated out on LB agar 
containing an appropriate antibiotic, usually ampicillin in the case of TA cloning, and 
Xgal as mentioned above. The Xgal was not incorporated into the media. Instead 
40^ .1 of a stock solution of Xgal (40mg/ml in dimethylformamide) was spread on the 
surface of premade LB agar plates containing ampicillin and the plates were allowed 
to dry. The stock solution of Xgal was not filter sterilised. It was stored at -20 °C and 
in the dark in order to prevent damage by light. Transformations were plated out on
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the LBampieillin/Xgal plates and the plates were then incubated at 37 °C for 12-16 
hours. The plates were then removed from the incubator and stored at 4 °C for several 
hours in order to allow colour development. White colonies were then picked off 
plates and screened for the presence of plasmids bearing inserts.
IPTG was not required in the media when transforming strains DH5a or INVaF' 
because these strains did not contain the lacP allele. The lacl gene encodes the Lac 
repressor which represses expression of the lacZ gene from the lac promoter. IPTG 
can be used to relieve this repression and to induce expression of the lacZa gene 
from the lac promoter. However, plasmids like pUC18 and pCR2.1 are such high 
copy number plasmids that the amount of the Lacl repressor produced in cells is 
insufficient to repress expression of all copies of the lacZa gene present on the 
vectors and thus IPTG is not required to induce expression of the lacZa gene. On the 
other hand the lacP allele expresses 1 0  times as much Lacl repressor than the normal 
lacl gene. In strains bearing this allele IPTG has to be used to induce expression and 
therefore has to be added to the media when testing for a-complementation. A stock 
solution of IPTG (lOOmM) is prepared by dissolving IPTG in water. The solution has 
to be filter sterilised and can then be stored at -20 °C. A 4j.il aliquot of this stock 
solution can be spread on the surface of pre-made LB agar plates along with Xgal 
when testing for a-complementation.
2.20: M iller A ssay  F o r [3-Galactosidase Activity.
The method used was as described by Miller (1972). A lml aliquot of the culture to 
be tested was centrifuged at 5000rpm in a microfuge for 5min and the cell pellet was 
resuspended in 0.75ml of Z buffer. The cells were permeablised by the addition of 
lOOjil of chloroform and 50fol of 0.1% SDS. The tube was vortexed for 10sec and 
then equilibrated at 30 °C for 5min. The reaction was started by the addition of 0.2ml 
of ONPG (4mg/ml in Z buffer, prepared fresh) and the tube was vortexed again for a 
10sec. The reaction was timed for 10-20min and then stopped by the addition of 
0.375ml of 1M Na2C0 3 . The cells were then pelleted by centrifugation at 13000rpm
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in a microfuge and the OD420 of the supernatant recorded. |3-galactosidase activity 
was calculated using the equation below.
Miller units = OD42Q * 1000
V * T * OD6 ÜO
OD420 = the absorbance o f  the supernatant at 420nm
OD 6 OO = the absorbance o f  the culture used al 600nm
V =  the volume o f  the culture used in ml
T =  the time o f  the reaction in minutes
2.21: Enzym atic R eactions.
•  Klenow Reaction.
DNA 18 \i\
dNTPs (0.5mM) I |il of each
Klenow Buffer (1 OX) 3 |xl
Sterile dHiO 4 pi
Klenow (0.5u/pi) 1 pi
Incubated at room temperature for 1 hour and then the enzyme was heat 
inactivated at 65 °C for 30min.
•  Calf Intestinal Phosphatase (CIP) Reaction.
DNA 13 j l i I
CIP Buffer (1 OX) 1.5 pi
CIP 0.5 jil
Incubated at 37 °C for 30min and then the enzyme was heat 
inactivated at 65 °C for 30min.
8 6
I
•  Standard PCR Reaction Mixture.
MgCl2 (25mM) 3 (il
dNTPs (lOmM) 1 (¿1 of each
Thermo Buffer (IOX, Mg21 free) 5 (il
Primers (0.6nm/|il) 1 fil of each
Template DNA 1 (al
Sterile dH20  34.5 |il
•• Taq Polymerase (5u/ul) 0.5 p,l
The reaction was then overlayed with 50p.l of sterile mineral oil. Total genomic 
DNA from S. meliloti 2011 was used as a source of template DNA for PCR 
reactions unless otherwise stated.
Standard PCR Program Cycle.
Stage 1: Step 1: 95 °C for 10 min.
Stage 2: Step 1: 95 °C for 1 min.
Step 2: Annealing Temperature for 30sec.
Step 3: 72 °C for lmin for every Kb to be synthesised. 
(Stage 2 was usually repeated for 30 cycles)
Stage 3: Step 1: 72 UC for lOmin.
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Chapter 3
Construction O f The Prey And The Control 
Plasmids For The Prokaryotic Two-Hybrid
System.
8fi
3.1: Introduction.
As described in chapter one the proposed NifA based Prokaryotic Two-Hybrid
(P2H) system would consist of the following components;
•  Three Prey plasmids into which genes of interest could be cloned in the
appropriate reading frame to generate hybrid proteins containing the
transcriptional activating N-terminal-central (NC) domain of Sinorhizobium 
meliloti 2011 NifA.
•  A Bait plasmid carrying a reporter gene construct consisting of the nifH 
promoter fused to the lacZa  gene. In addition to this it would also carry a 
Bait construct into which genes of interest could be cloned to generate 
hybrid proteins containing the C-terminal DNA binding domain of NifA.
•  A Control plasmid expressing the whole S. meliloti 2011 NifA protein.
•  Suitable E. coli strains bearing glnG (ntrC) mutations in which the newly 
constructed plasmids could be used.
The construction of each of these components is described in the following chapters. 
This chapter describes the strategy employed for the construction of the Prey 
plasmids and the Control plasmid as all of these plasmids are related and were 
constructed in a similar manner.
3.2: Selection O f A  Suitable Startin g  P lasm id F o r The Construction 
O f The Prey P lasm ids.
The first step in the construction of the Prey plasmids involved the selection of a 
suitable starting plasmid upon which the Prey plasmids would be based. The 
expression plasmid vector pKK223-3, which was commercially available from 
Pharmacia, was selected as the starting plasmid. This plasmid has the following 
features (see Figure 3.2.1);
•  A strong ptac promoter that would permit IPTG inducible expression of 
proteins.
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• Figure 3.2.1: The pKK223-3 Protein Expression Plasmid.
11 4584 4552
I I I
3'- TCCTTTGTCTTAAGGGCCCCTAGGCAGCTGGACGTCGGTTCGAA -5'
5‘* [AGG^AACAGAATTCCCGGGGATCCGTCGACCTGCAGCCAAGCTT -3‘
EcoR 1—------- — I ' 0 . 1 Pst I Hind III
Sm a I Bam HI* baMYrw-i I
Sph I
Sal I (532)'
Acc I*
Hinc i r
Hinc II 
BamH I (256)*
Hinc II (3785)* 
Pvu I (3613)
Pvo II ( I f>45)
Acc I (2125)*
pBH322
(in
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•  A pUC8 multiple cloning site (MCS) adjacent to the ptac promoter that 
could be used for the cloning of the transcriptional activation domains of the 
NifA protein.
•  A ribosome binding site (RBS) for expression of genes cloned in the MCS.
•  An ampicillin resistance gene to allow independent selection for the 
plasmid.
•  A strong rr«BTiT2 transcriptional termination sequence to prevent read 
through transcription induced from the ptac promoter into the ampicillin 
resistance gene.
If a gene is cloned into the MCS of the pKK223-3 plasmid so that its start codon is 
within 13 base pairs of the EcoRl in the MCS, the plasmid’s RBS could be used for 
expression of the protein.
The above features of pKK223-3 made it a desirable starting plasmid for the 
construction of the Prey and the Control plasmids.
3.2.1: Preparation O f The pKK223-3 Plasm id For Use In The 
C onstruction O f The Prev P lasm ids.
Inspection of Figure 3.2.1 shows that the pKK223-3 plasmid has two BamHl sites, 
one within the MCS of the plasmid and one outside of the MCS. A preliminary step 
in the construction of the Prey plasmids was the elimination of the second BamHl 
site outside the MCS. This made the BamHl site within the MCS a unique restriction 
site which was then used for the cloning of the NC domain of the NifA protein to 
form the Prey plasmid.
The elimination of the BamHl site involved the use of partial digests to generate 
pKK223-3 plasmid DNA cleaved at only one of its two BamHl sites. A set of serial 
dilutions of BamHl was set up to determine which concentration of BamHl would 
yield the greatest proportion of partially digested plasmid DNA. Figure 3.2.2 shows 
how the set serial dilutions was set up.
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• Figure 3.2.2: Preparation Of BamHl Partial Digests By Serial Dilution.
Tube A Tube B Tube C TubeD
An initial BamHl digest was set up as follows;
Tube A Digest.
pKK223-3 plasmid DNA 34 pi
React Buffer 2 (10X) 4 (al
BamHl enzyme ( 1 Ou/pl) 2 pi
Eight other tubes designated tubes (B) to (I) were set up as follows;
Tube B to I Reaction Mixtures.
pKK223-3 plasmid DNA 18 jal
React 2 Buffer (10X) 2 pi
As illustrated in Figure 3.2.2, 20pl was taken from the Tube A digest and added to 
the Tube B reaction mixture. The concentration of BamHl in the resulting Tube B 
digest was half that of the Tube A digest. Then 20pl was taken from the Tube B 
digest and added to the Tube C reaction mixture. The concentration of BamHl in the 
resulting Tube C digest was half that in the preceding Tube B digest. This procedure 
was continued until a complete set of BamHl digests, A to I, in which each digest
had half the concentration of BamHl o f the preceding digest, was obtained. These
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digests were then incubated at 37 °C for 30min and then separated on a 0.7% agarose 
gel. A photo of the gel obtained is shown in Figure 3.2.3 below.
•  Figure 3.2.3: BamW\ Partial Digests Of pKK223-3.
L an e  No. Sam ple B am H l Cone.
1 Tube A Digest 0.5u/|J.l
2 Tube B Digest 0.25u/fj.I
3 Tube C Digest 0.125u/(J.I
4 Tube D Digest 0.062u/nl
5 Tube E Digest 0.031u/|d
6 Tube F Digest 0 .015u/fal
7 Tube G Digest 0.007u/(il
8 Tube H Digest 0.003u/(ol
9 Tube I Digest 0 .0 0 1 u/nl
10 lkb  Ladder
I'lrfhDyOii I 
J-KK223-3 i.
fKK123-3 '
As can be seen from the photo of the gel in Figure 3.2.3, the Tube B digest gave two 
bands that ran very close together. The lower band corresponded to fully digested 
pKK223-3 DNA that had been cleaved at both of its BamHl sites. The upper band 
corresponded to partially digested pKK223-3 DNA that had been cleaved at only one 
of its two BamHl sites. As the concentration of Bam\ II became more dilute the 
proportion of partially digested DNA present in the digests increased. It was 
estimated that the Tube F digest in lane 6  of the gel seen in Figure 3.2.3 gave the 
greatest proportion of partially digested pKK223-3 plasmid DNA. This digest was 
therefore set up on a larger scale to give a total volume of 80pl and was incubated at 
37 °C for 30mins. The digest was then cleaned by treatment with kirby mix to 
remove protein followed by precipitation with isopropanol. The plasmid DNA was 
then resuspended in TE buffer and a Klenow reaction was set up in order to fill in the 
5' cohesive ends generated by cutting with BamHl. The DNA was then cleaned again 
and a ligation with an Xbal linker was set up. The DNA was again cleaned and then 
restricted with Xbal. The pKK223-3 plasmid itself did not have any restriction sites 
for the Xbal enzyme and thus digesting with this enzyme only resulted in the 
cleaving of the linker molecules. This generated Xbal cohesive ends on the ends of
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the linearised pKK223-3 plasmid DNA. Finally the DNA was cleaned, ligated and 
then transformed into the E. coli strain DH5a. The transformation was plated on LB 
ampicillin plates to select for transformants containing the recircularised pKK223-3 
plasmid DNA.
The above process resulted in the elimination of one of the two BamHI sites present 
on the original pKK223-3 plasmid, replacing the destroyed site with a unique Xbal 
site. As partial digests were used the partially digested pKK223-3 plasmid DNA 
would have been cut at either one of the BamHI. Transformants could therefore 
contain plasmid DNA with either one of the two BamHI sites destroyed. 
Transformants therefore had to be screened to identify clones containing plasmid 
DNA with the desired BamHI site destroyed.
In order to identify transformants containing plasmid DNA with the desired BamHI 
site destroyed, plasmid DNA was prepared from several transformants. The DNA 
was initially digested with Xbal to verify the presence of linker. BamHI digests were 
also performed on the plasmid DNA from each of the transformants to verify that in 
each case only one of the BamHI sites had been destroyed. Having verified this, Sall- 
BamHl double digests were performed in order to determine which of the two 
possible BamHI sites had been destroyed in each case. Examination of Figure 3.2.1 
shows that performing such a digest on plasmid DNA with the desired BamHI site 
destroyed (the one lying outside of the MCS) was expected to yield two bands on an 
agarose gel, one band at approximately 4036bp and one at approximately 543bp. 
Performing such a Sall-BamHl double digest on plasmid DNA in which the other 
BamHI site was destroyed (the one in the MCS) was expected to yield 3 bands, one 
at 4036bp and a doublet at around 280bp. Screening transformants in this manner 
thus resulted in the identification of the desired plasmid which was called pPC223 
(see Figure 3.3.2) and the results of the above mentioned digests on this plasmid can 
be seen in Figure 3.2.4 below.
As will be described in section 3.3 of this chapter it was intended that the NC domain 
of the NifA protein was to be amplified by PCR as an Xmal-BamHI fragment and 
then cloned into the pPC223 plasmid as a Xmal-BamHl fragment to generate the 
Prey plasmid. However, examination of Figure 3.2.1 shows that the Xmal and 
BamHI recognition sites in the MCS of the plasmid partially overlap. Cutting the 
plasmid with either one of the enzymes therefore prevented the other enzyme from
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cutting at its site. It was therefore impossible to generate restricted pPC223 plasmid 
DNA with the correct cohesive ends to facilitate cloning of the NifA NC domain as
-4»
an Xmal-BamHl fragment. In order to overcome this problem, a BamHl fragment 
approximately 1.8kb in size was cut from plasmid pSUP5011 and cloned into the 
BamHl site of the pPC223 plasmid to generate plasmid pPC225 (see Figure 3.3.2). 
Figure 3.2.5 shows the verifying restriction analysis of the pPC225 plasmid.
•  Figure 3.2.4: Restriction Analysis On Plasmid pPC223.
Lane No. Sample.
1 pPC223 uncut
2 pPC223 cut with Xbal
3 pPC223 cut with BamHl
4 pPC223 cut with Sail
5 pPC223 cut with Sall-Bamlll
6  1Kb Ladder
•  Figure 3.2.5: Restriction Analysis Of Plasmid pPC225. 
Lane No. Sample.
1 1Kb Ladder
2 pPC225 uncut
3 pPC223 uncut
4 pPC225 cut with BamHl
5 pSUP5011 cut with BamHl
6  pPC223 cut BamHl
7 1 Kb Ladder
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As can be seen from Figure 3.2.6 below, cutting the 1.8 Kb insert back out of plasmid 
pPC225 by sequential digestion first with Xmal and then with BamHI would 
generated pPC223 plasmid DNA with the appropriate cohesive ends to facilitate 
cloning of the NifA NC domain as an Xmal-BamHl fragment. Plasmid pPC225 was 
thus used as the starting plasmid for the construction of the Prey plasmids
Figure 3.2.6: Sequential Digestion Of Plasmid pPC225 With Xm al And 
BamHI.
Ba TO HI fragment
Plasmid CCC GG 
GGGCC
GGATCC
CCTAGG
Xmal Site
GGATCC
CCTAGG
Piai mid
Cut First With Xmal
V
~ l,8 kb Bam H I fragment
Plasmid
C
GGGCC
tXmal
Cohesive End
CC GG GGATCC GGATCC
Plasmid
CCTAGG CCTAGG
V
Cut With 5 l3toHI
-1,8Hj Bamim fragment
CPlasmid
GGGCC
CCGG GGATCC 
CCTAGG
"C L
CCTAG
Xmal 
Cohesive End
GATCC 
G
Plasmid
t
5 qtoHI 
Cohesive End
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Figure 3.3.1: Basic Structure Of The Planned Prey And Control Plasmids.
a,) Prey Plasmid Expressing The Activating NC Domain Of NifA
K ey
■ = Ampicillin Resistance Gene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ - ptac Promoter
■ = Strong mtB Ribosomal
Terminator
E = EcoKl
Xm = Xmal
S = Sail
B = ifamHI
P =
H = Hiitdm
Xh = Xbal
b.) Control Plasmid Expressing The Whole NifA Protein
Key
■ = AmpieUlin Kiiùtanie Cene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = C-Terminal Domain Of NifA
■ = ptac Promoter
■ = Strong miB Ribosomal Terminator
E = ¿TcoRI
Xm = Xmal
S = Sali
B = Bamìfl
P = Pstl
H = HiìtiUl
Xh = Xbal
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• Figure 3.3.2: Strategy For The Construction Of The Prey Plasmid
PPC229-A.
Total Genomic DNA 
From S. meliloto, 2011
Xmal
É S E
PCR
V
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Bam HI
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domains of NifA
Cloned Into The TA
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Vector To FormpPC6
V
Elimination Of 
SamHI external to 
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unique JS>aIsite
Activatinq TT-Tcrroinal 
A nd  Central Domains
□f NifA
cut (irst with Xmal. 
clean and then 
cut will) Bam HI
Clone in  BamUl 
Fragment
V
cut (irst with Xmal, 
clean and then 
cut with BamW
V
Xm al BamfO.
I ____________I
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Activating Domain of NifA
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Figure 3.3.3: Strategy For The Construction Of The Control Plasmid
pPC228.
Total Genomic DNA
From S. meliloti 2011
Xmal
PCR
V Hindm
I X K M  Central I C -T erm lH l 
Whole fli/A Gene
Cloned Into Hie TA 
pCR^ n 
Vector To FomvpPt'5
Elimination Of 
BamWi external to 
M C S— replaced by 
unique Xbs I site
cut first with Xmal, 
clean and then 
cut with HindUl
V
V
Clone in Bam HI 
Fragment
V
cut first with Xmal, 
clean and then 
cut with HindiH
9 9
Figure 3.3.1 depicts the structure of the planned Prey and Control plasmids. 
Schematic representations of the cloning strategies employed for the construction of 
the Prey and Control plasmids can be seen in Figure 3.3.2 and Figure 3.3.3 
respectively. These strategies are discussed in detail in the following sections of this 
chapter.
3.3: C onstruction O f The Prey Plasm ids - O verview  O f Strategy.
The transcriptional activating N-terminal-central (NC) domain portion of the S. 
meliloti 2011 NifA protein was used in the construction of the Prey plasmids. The 
NC domain was amplified by PCR as an Xmal-BamHl fragment using the primers 
NC-F1 and NC-R1 shown in Figure 3.3.4 below. This fragment was first cloned into 
the TA pCR2.1 vector and then sub-cloned into the pPC225 plasmid as an Xmal- 
BamHl fragment to generate the Prey plasmid (see Figure 3.3.1a and Figure 3.3.2)). 
The BamHl site and the downstream Pstl and Hindlll sites of the Prey plasmid could 
then be used for cloning genes C-terminally to the NifA NC domain sequence to 
generate hybrid proteins.
The forward primer NC-F1 was designed to incorporate an Xmal site into the NC 
domain PCR product and to amplify the NC domain sequence from a second internal 
start codon rather than from the natural start codon for the NifA protein. The reason 
for this was that it had been previously shown by Huala and Ausubel (1989) that the 
S. meliloti 2011 NifA protein was more stable in E. coli when expressed from the 
second internal start codon. The sequence of the NC-F1 forward primer is given in 
Figure 3.3.4 and the region of the nifA sequence for which this primer was designed 
is shown in Figure 3.3.5.
The EcoRl site in the MCS of the pKK223-3 plasmid could not be used for the 
cloning of the NifA NC domain as there was an EcoRl site within the nifA sequence 
(see Figure 3.3.5). The Xmal site therefore had to be used for cloning in order to 
place the start codon of the NifA NC domain PCR product close enough to the RBS 
on the pPC225 plasmid (essentially the same MCS as pKK223-3) to allow 
expression.
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The reverse primer, NC-R1, was designed for the inter-domain region separating the 
central and C-terminal domains of the NifA protein. This region possessed a natural 
Bam\\\ site so the primer did not have to be designed to incorporate a BamHI site. 
The sequence of the reverse primer NC-R1 is shown in Figure 3.3.4 and the region of 
the ni/A sequence for which this primer was designed is shown in Figure 3.3.5.
Three Prey vectors were constructed which differed only in the reading frame of the 
BamHI site relative to the upstream NifA NC domain sequence, one plasmid for each 
possible reading frame. The availability of these three plasmids would facilitate easy 
construction of libraries of Prey hybrid proteins containing the transcriptional 
activating NifA NC domain. The three plasmids were generated by amplifying the 
NC domain sequence with three different reverse primers, NC-R1, NC-R2 and NC- 
R3, to generate three separate PCR products. The reverse primers NC-R2 and NC-R3 
were designed to incorporate additional bases to shift the reading frame of the 
BamHI site relative to the upstream NC domain sequence (see Figure 3.3.4). Each of 
the resulting PCR products was cloned into the TA pCR2.1 vector and then sub­
cloned into pPC225 plasmid to generate the three proposed Prey plasmids.
•  Figure 3.3.4: Primers Used For The Amplification Of The NifA NC 
Domain Sequence.
NC-F1: C C C G G G - A T G  GCC CCC ACT CGT CTT GAG
NC-F2: C C C  G G G  - A TG  GCC CCC ACT CGT CTT GAG ACC ACG C
Xmal
NC-R1
NC-R2
NC-R3
G G A T C C - G G G  CTC TTT CGG CGG 
G G A  T C C  - T  - GGG CTC TTT CGG CGG 
G G A T C C -  T T -G G G  CTC TTT CGG CGG 
BamHI
C-term-R: A A G  C T T  - GAC GGA GAA AAG AG G  CGA CGC
Hindlll
U nderlined bases in red are bases incorporated to shift the reading frame o f the BamHI site 
relative to the upstream  N ifA  N C  dom ain sequence.
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The Control plasmid was constructed in a similar manner to the Prey plasmids and 
expresses the whole S. meliloti 2011 NifA protein. The entire nifA gene was 
amplified as an Xmal-Hindlll fragment, cloned first into the TA pCR2.1 vector and 
then sub-cloned as an Xmal-Hindlll fragment into plasmid pPC225 to form the 
Control plasmid (see Figure 3.3.1b and Figure 3.3.3). The nifA gene was amplified 
using the same NC-F1 forward primer that was used for the amplification of the 
NifA NC domain. The sequence of the reverse primer used, C-term-R, is given in 
Figure 3.3.4 and the region of the nifA sequence for which this primer was designed 
is shown in Figure 3.3.5. The C-term-R reverse primer was designed to incorporate a 
Hindlll site into the nifA  PCR product.
Figure 3.3.5: Primed Regions Of The S. meliloti 2011 nifA Sequence.
Natural Start 
Codon
181 tctgtacctt cacaaagaga c|atg|cgcaaa caggacaagc gctccgccga aatttacagc
NC-Fl Primer
241 atatcaaagg ctctg a tg g c  ccccactcgt cttgag accacgc ttaacaa tttcgtgaat
301 accctctctt tgattctgcg catgcgccgc ggcggactcg agattccggc gtcggaagga ...
661 gcggggaggg ccattcggcttcatcgcaca atcagcaggc gtgagcggac atttgccgaa
721 gagcagcaag aacaaca gaattc acgtgat gagcagagcc agagttccgc ccgccagcgg
781 ctgctcaaga atgacgggat catcggggaa agtaccgccctcatgacggc ggtagatacc ...
NC-Rl Primer using 
natural Bam HI site
1621 ttgctcggag cgccagccaatgacgttccg ccgaaagagc cc ggatccjgc aggagtggca 
1681 tccaatctga tcgagcgcga ccggttgatc agtgcgctgg aggaggccgg ttggaatcag 
1741 gcaaaggcag ctcgcatcct cgaaaaaacg ccccggcagg tcgggtatgc tctacgtcgg
1801 catggtgtgg acgtgagaaa gctctaag ct gccggtgaga taaaggcgtc g c g a |gcgtcg 
C-term-R Primer
1861 cctcttttct ccgtc
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3.3.1: Am plification O f The N ifA  NC Dom ain Bv PCR.
Having manipulated the initial starting plasmid pKK223-3 to give plasmid pPC225 
that would permit the cloning of the NifA NC domain as an Xmal-BamHl fragment, 
the next step in the construction of the proposed Prey plasmids was the 
amplification of the NifA NC domain sequence by PCR. The NC domain sequence 
was to be amplified using the forward NC-F1 and reverse NC-R1 primers described 
earlier. Total genomic DNA was prepared from S. meliloti 2011 and was used as 
the template DNA in the PCR (see Figure 3.3.2). Figure 3.3.6 below shows the 
results of the PCR and the optimized annealing and extension times that were used 
for the reaction.
•  Figure 3.3.6: PCR Amplification Of The NifA NC Domain With The NC- 
F1 Forward Primer.
lift* iHeni'fF
Lane No. Sample 1 I
1 NifA NC Domain PCR P |
2 1Kb Ladder
Gif*Naur tanJ "' ^  4hM£
PCR Conditions.
Annealing temperature 61 °C *0#
Annealing time 1 min
Extension time 2 min
As can be seen from Figure 3.3.6 the PCR reaction yielded several smaller non­
specific bands in addition to the desired 1418bp PCR product. These non-specific 
products could not be eliminated through manipulation of PCR conditions. As total 
genomic DNA was used as template in the initial PCR reactions, it was thought that 
the non-specific bands could be eliminated by purifying back the desired NifA NC 
domain PCR product from an agarose gel by the gene clean procedure and using the 
purified NifA NC domain PCR product as template DNA in a second PCR reaction. 
However, this did not eliminate the non-specific PCR products completely indicating
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that they were caused by non-specific binding of the primers within the NifA 
sequence itself. The same NC-F1 forward primer was also used in conjunction with 
the C-term-R primer for the amplification of the whole nifA gene sequence and as 
can be seen from Figure 3.3.10 a similar pattern of non-specific PCR products was 
obtained. As with the NifA NC domain PCR reaction the non-specific bands could 
not be eliminated by using purified NifA PCR product as template DNA in a second 
PCR reaction. It was therefore determined that the specificity problem was due to 
non-specific binding of the forward NC-F1 primer within the nifA gene sequence 
itself as this was the common primer to both the NifA NC domain PCR reaction and 
the whole nifA PCR reaction. The non-specific bands were eventually eliminated by 
designing a new forward primer, NC-F2, that was extended a further 7 bases at the 3' 
end. The sequence of this primer is shown in Figure 3.3.4. The NifA NC domain 
PCR was repeated using the NC-F2 forward primer and using the same conditions 
described in Figure 3.3.6 above. The results of this PCR reaction can be seen in 
Figure 3.3.7. As can be seen from Figure 3.3.7, performing the PCR with the longer 
NC-F2 primer eliminated the non-specific PCR products. Using the longer NC-F2 
primer for the amplification of the whole nifA had the same effect of eliminating 
previously obtained non-specific PCR products.
•  Figure 3.3.7: PCR Amplification Of The NifA NC Domain With The NC- 
F2 Forward Primer.
Lane No. Sample
1 1Kb Ladder
2 Whole nifA PCR
3 NifA NC Domain PCR
PCR Conditions.
Annealing temperature 61 °C
Annealing time 1 min
Extension time 2 min
1 2  3
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Having eliminated the non-specific PCR bands from the NifA NC domain PCR 
reaction, two more PCR reactions were performed using the NC-F2 primer with each 
of the NC-R2 and NC-R3 reverse primers. In this way three NifA NC domain PCR 
products were obtained, one amplified using the NC-R1 reverse primer (this PCR 
product was called NC-A), one amplified with the NC-R2 primer (this PCR product 
was called NC-B) and one amplified using the NC-R3 primer (this PCR product was 
called NC-C).
3.3.2: C loning O f The NifA NC Dom ain PCR Products Into The TA  
V ector To Form Plasm ids pPC6-A, pPC6-B and pPC6-C.
Having optimized the NifA NC domain PCRs and obtained the three desired PCR 
products NC-A, NC-B and NC-C the next step was to clone each of the PCR 
products into the TA pCR2,l vector (see Figure 3.3.2). Ligations were set up 
according to the TA protocol (see section 2.18 of Chapter 2) using the PCR reaction 
mixtures directly without any purification. The ligations were used to transform 
INVaF' cells that came with the TA cloning kit and the transformations were plated 
out on LBamp/Xgal plates. White colonies were picked off plates and screened to 
identify clones containing the TA pCR2.1 vector with inserted NifA NC domain 
PCR products. However, the desired clones could not be identified despite extensive 
screening. All of the clones screened, although white in color, appeared to contain 
recircularised pCR2.1 vector DNA.
The TA vector only recircularises to give white colonies at a very low frequency yet 
a very large number of white colonies were obtained from transformations. It was 
therefore deduced that the NifA NC domain PCR reaction, although it appeared to be 
specific and to only contain the desired 1418bp NifA NC domain PCR product, must 
have contained a very small PCR product that was causing recircularisation of the 
TA pCR2.1 vector to yield white colonies. It was decided that the best way to 
overcome this problem was to purify the desired NC domain PCR products from an 
agarose gel and to then ligate the purified products with the TA pCR2.1 vector. 
Attempts to ligate PCR products purified from 0.7% agarose gels by the gene clean 
procedure failed to yield any transformants. It was felt that the silica beads used to
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absorb DNA in gene clean procedure may have been too abrasive and that the 3'A 
overhangs on the ends of the PCR products required for TA cloning may have been 
sheared off during the purification procedure. The procedure was therefore modified 
in that rather than using the silica beads to absorb the DNA, a spin column with a 
DNA absorbing filter was used. It was felt that this would be a more gentle 
procedure and this adjustment to the protocol overcame the problems. Large numbers 
of white transformants were obtained when the resulting ligations were used to 
transform INVaF' cells. Screening of the colonies obtained by performing Xmal- 
BamHI double digests on plasmid DNA prepared from each clone resulted in the 
identification of the large numbers of clones containing the desired plasmids. The 
NC-A PCR product was cloned into the pCR2.1 vector to give plasmid pPC6 -A, and 
each of the NC-B and NC-C PCR products were also cloned into the TA vector to 
yield plasmids pPC6 -B and pPC6 -C respectively. Figure 3.3.8 below shows the 
results of the verifying restriction analysis of these plasmids.
•  Figure 3.3.8: Restriction Analysis Of Plasmids p P C 6 -A , p P C 6 -B And p P C 6 -C .
ane No. Sample
1 1 Kb Ladder
2 pPC 6 -A uncut
3 pPC6 -B uncut
4 pPC 6 -C uncut
5 pPC 6 -A cut Xmal-Bam HI
6 pPC 6 -B cut Xmal-Bam HI
7 pPC 6 -C cut Xmal-Bam HI
8 NifA NC domain PCR
9 1 Kb Ladder
1 2 3 4 5 6  7 8
3.3.3: Sub-cloning O f The N ifA  NC D om ains Into p P C 225 To Form  
The Prey Plasm ids pPC 229-A , pPC 229-B  And pPC 229-C .
Having successfully cloned the 3 PCR amplified NifA NC domains into the TA 
pCR2.1 vector to form plasmids pPC6 -A, pPC6 -B and pPC6 -C, the next step in the
106
construction of the Prey plasmids was to sub-clone each of the NC domain fragments 
into plasmid pPC225 (see Figure 3.3.2). Plasmid pPC6 -A was digested first with 
Xmal and then with BamHl and the digest was separated on a 0.7% agarose gel. The 
1.4Kb band corresponding to the excised NC-A fragment was then purified from the 
gel using the gene clean procedure. The pPC225 plasmid was digested first with 
Xmal and then with BamHl as described earlier in section 3.2.1 and illustrated in 
Figure 3.2.6. The digested pPC225 DNA was then separated on a 0.7% agarose gel 
and the 4.5Kb band corresponding to the pPC223 portion of pPC225 was cleaned 
back from the gel by the gene clean procedure. This cleaned plasmid DNA was 
ligated with the purified NC-A fragment and the ligated DNA was used to transform 
DH5a. Clones were screened by performing Xmal-BamHl double digests on the 
plasmid DNA prepared from each clone. In this manner the desired Prey plasmid, 
pPC229-A was obtained. The NC-B and NC-C products were sub-cloned from 
plasmids pPC6 -B and pPC6 -C into pPC225 in the same manner to give Prey 
plasmids pPC229-B and pPC229-C respectively. Figure 3.13 below shows the 
verifying restriction analysis of plasmids pPC229-A, pPC229-B and pPC229-C and 
detailed restriction maps of the plasmids can be seen in Figure 3.5.1.
•  Figure 3.3.9: Restriction Analysis Of The Prev Plasmids pPC229-A, 
DPC229-B And pPC229-C.
L ane No.
1
2
3
4
5
6
7
8
9
10
Sam ple
1Kb Ladder 
pPC223 uncut 
pPC229-A uncut 
pPC229-B uncut 
pPC229-C uncut 
pPC229-A cut Xmal-BamHl 
pPC229-B cut Xmal-BamHl 
pPC229-C cut Xmal-BamHl 
NifANC domain PCR 
1Kb Ladder
1 2 3 4 5 6  7 8 9 10
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3.3.4: Construction Of The Control Plasmid pPC228.
In addition to the Prey plasmids discussed up to this point, a Control plasmid also 
had to be constructed. The proposed Control plasmid (see Figure 3.3.1b) would 
express the whole S. meliloti 2011 NifA protein. It could be used to test the planned 
P2H system reporter constructs and would also be used as a positive control in any 
two-hybrid tests.
The Control plasmid was constructed in a very similar manner to the Prey plasmids 
(see figure 3.3.3). The entire nifA gene was amplified by PCR as an Xmal-HindUl 
fragment as described earlier in section 3.3. Initially the PCR was carried out using 
the NC-F1 forward primer and the C-Term-R reverse primer and the same PCR 
conditions as those used for the amplification of the NifA NC domain. The results of 
this PCR can be seen in Figure 3.3.10 below.
•  Figure 3.3.10: PCR Amplification Of The Whole nifA Gene Using The NC- 
F1 Primer.
Lane No. Sample
1 Whole nifA PCR
2 1 Kb Ladder
PCR Conditions.
Annealing temperature 61 °C
Annealing time 1 min
Extension time 2 min
As with the PCR for the NifA NC domain PCR reaction, several non-specific PCR 
products were obtained in addition to the desired 1631 bp whole nifA PCR product. 
As with the PCR reaction for the NifA NC domain PCR reaction these non-specific 
PCR products were eliminated by the use of the NC-F2 forward primer. The results 
of the PCR for the entire nifA gene using this forward primer can be seen in Figure 
3.3.7.
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Having optimized the nifA PCR, the next step was to clone the nifA PCR product into 
the TA pCR2.1 vector. The same problems that were encountered when trying to 
clone the NifA NC domain PCR products into the TA vector were encountered when 
trying to clone the nifA PCR product. However, these problems were also overcome 
in exactly the same way. The nifA PCR product was separated on a 0.7% agarose gel, 
the desired 1.6Kb nifA band was cleaned back using the modified gene clean 
procedure described earlier in section 3.3.2. The purified nifA PCR product was 
ligated with the TA pCR2.1 vector and transformed into INVaF' cells. The 
transformation was plated on LBamp/Xgal plates and white colonies were picked off 
and screened. Clones were screened by performing Xmal-Hindlll double digests on 
plasmid DNA prepared from each clone. In this way the desired clone, pPC5, was 
obtained. Figure 3.3.11 below shows the verifying restriction analysis of plasmid 
pPC5.
•  Figure 3.3.11: Restriction Analysis O f Plasmid pPC5. »
1 2 3 4 5
Lane No.
1
Sample
1Kb Ladder *•—
m
2 pPC5 uncut ZZ-
3 pPC5 cut Xmal to
4 pPC5 cut Xmal-Hindlll . M *tifc  «A, '
5 PCR for whole nifA rtflMS*
6 1 Kb ladder
The last step in the construction of the Control plasmid pPC228 was the sub-cloning 
of the nifA gene from pPC5 into pPC225. Plasmid pPC5 was digested first with Xmal 
and then with Hindlll. The digested DNA was separated on a 0.7% agarose gel and 
the desired 1.6KB nifA fragment was purified using the gene clean procedure. 
Plasmid pPC225 was digested with Xmal and then with Hindlll and the digested 
DNA was separated on a 0.7% agarose gel. The 4.5kb band corresponding to the 
pPC223 portion of plasmid pPC225 was purified by the gene clean procedure and
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ligated with the purified nifA fragment. The ligated DNA was used to transform 
DH5a and the transformation was plated on LB ampicillin plates. Clones were 
screened by performing Xmal-Hindlll double digests on plasmid DNA isolated from 
each clone. In this manner the desired Control plasmid, pPC228, was identified. 
Figure 3.3.12 below shows the results of the verifying restriction analysis of plasmid 
pPC228.
•  Figure 3.3.12: Restriction Analysis Of The Control Plasmid pPC228. 
Lane No. Sample.
1 1Kb Ladder
2 pPC228 Uncut
3 pPC228 cut Xmal-Hindlll
4 pPC225 cut Xmal-Hindlll
5 pPC5 cut Xmal-Hindlll
6  nifA PCR Product
7 1Kb Ladder
, TS S 4 i"~ 4
3.4: Testing Expression O f N ifA  Protein From The Control Plasm id  
PPC228.
Having constructed the Control plasmid pPC228, expression of the NifA protein 
from the plasmid had to be verified. This was done by testing for NifA induced 
transcriptional activation of a nifH.lacZa reporter gene. The construction of this 
reporter gene is discussed in chapter 4. The reporter gene is maintained on a 
pPCYC184 based plasmid called pPC185-A. This plasmid is compatible with the 
pKK223-3 plasmid upon which the pPC228 Control plasmid is based. The 
pPC185-A plasmid also had a chloramphenicol resistance gene that allows it to be 
selected for independently of the pPC228 plasmid which has an ampicillin resistance 
gene.
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Plasmids pPC228 and pPC185-A were co-transformed into DH5a. The 
transformation was plated on LB media to which ampicillin and chloramphenicol had 
been added to select for the presence of the two plasmids. IPTG was also added to 
the media to a concentration of 0.5mM to induce expression of the NifA protein from 
the ptac promoter on pPC228. Xgal was also incorporated into the media to detect 
NifA induced expression of the nifH:lacZa reporter. Plates were incubated at 30 °C. 
After 48 hours at 30 °C colonies began to develop a blue color but plates had to be 
incubated for a total o f 72 hours at 30 °C for significant color development.
It was felt that the slow color development was due to poor expression of the nifA 
gene from the ptac promoter on plasmid pPC228. It was thought that this may have 
been due to the start codon on the Xmal-Hindlll cloned nifA fragment being too far 
away from the plasmid borne RBS. The ptac promoter region of plasmid was 
sequenced to verify the distance of the start codon from the RBS and sequence of the 
N-terminal region of the cloned nifA gene. The sequence obtained can be seen in 
Figure 3.4.1 below.
•  Figure 3.4.1: Sequence Of The ptac Promoter And The N-Terminal Of 
NifA From pPC228 .
I
cactgcataa ttcgtgtcgc tcaaggcgca ctcccgttct ggataatgtt ttttgcgccg a 
catcataacg gttctggcaa atattctgaa atgagctgtt gacaattaat catcggctcg t
49 | nifA
ataatgtgtggaattgtgagcggataacaatttcacac aqga aaca gaatt eecgqg [atqj — ►
1----------- “ _ l888 E eo R I L
Xm al
gcccccactc gtcttgagac cacgcttaac aatttcgtga ataccctctc tttgattctg c
gcatgcgccg cggcggactc gagattccgg cgtcggaagg agagacaaag ataacagcgg c
tacccgcaac agcgggtctc cttctgccgc tgattatact gtaccaaagg ccgcaataga c
ca agtcatga ctgccgggcg gctggtcgta ccagacgttt gcaactctga gctgttcaag g
atcagataaa atggcgcgga attggtccga ctgccttcat cgctgcggcg gtggaggtcg a
tcacgatacg ggcgg
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Figure 3.4.2: Strategy For The Manipulation Of The ptac Promoter Of The
Control Plasmid pPC228 To Form pPC230.
ECR
Xbal
[ i r
Xmal
Pias Promoter Region OfpPC'229 Laddng 
An EcoRI site And Two Other Base Pairs
Cut W ith Xbal 
and XnÜll Cloned Into The TA 
pCR*XI Vector
V
pPC9
N/
Cut With Xbal 
and Xmal
NK
The sequence of the ptac promoter and the nifA 5’ end, encoding the N-terminal 
domain of NifA, obtained for plasmid pPC228 was as expected. The RBS, EcoRl 
site, Xmal site and the start codon are all highlighted in Figure 3.4.2 and it can be 
seen that there are 15 bases between the start codon and the RBS. For most known 
promoters the start codon is within 13 base pairs of the RBS (Gold, 1988) with 
spacings of about 9 bases being optimal. It was therefore felt that the nifA start codon 
on plasmid pPC228 was fractionally too far away from the RBS to allow efficient 
translation of the NifA protein. It was thus decided that the ptac promoter would be 
manipulated to reduce the distance between the nifA start codon and the RBS.
A schematic representation of the strategy employed for the manipulation of the ptac 
promoter region of plasmid pPC228 can be seen in Figure 3.4.2. The strategy made 
use of the unique Xbal site incorporated into pPC223 and thus the pPC225 starting 
plasmid when the second BamlU site outside the MCS on plasmid pKK223-3 was 
destroyed. The ptac promoter was amplified by PCR as an Xbal-Xmal fragment 
using the primers shown in Figure 3.4.3.
•  Figure 3.4.3: Primers Used For The Amplification Of The ptac Promoter.
ptac - F: (TCT AGA) GAG CTT ATC GAC TGC ACG GT
X bal site
ptac - R: fCCC GGG) TTT CCT GTG TGA AAT TGT TAT CCG
Xm al site
The ptac-R  reverse primer was designed to eliminate 7 of the bases between the nifA 
start codon and the RBS. The bases that were eliminated are shown in Figure 3.4.4 
below as are the regions of the pPC228 sequence for which the ptac-F and ptac-R 
primers were designed. Elimination of the 7 bases indicated in Figure 3.3.4 resulted 
in the elimination of the .EcoRI site in the ptac promoter region on the resulting ptac 
PCR product. This PCR product was first cloned into the TA pCR2.1 vector and then 
sub-cloned into the pPC228 plasmid as an Xbal-Xmal fragment thus replacing the 
original ptac promoter region on the pPC228 Control plasmid with the manipulated
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PCR amplified ptac promoter with it’s deleted bases. The resulting alternative 
Control plasmid thus formed was called pPC230. Similarly the ptac PCR product 
was cloned into each of the pPC229-A, pPC229-B and pPC229-C Prey plasmids to 
generate three new alternative Prey plasmids called pPC231-A, pPC231-B and 
pPC231-C respectively.
Figure 3.4.4: Primed Regions Of The pPC228 Sequence Used For The 
Amplification Of The ptac Promoter.
255 ptac - F primer
ga gcttatcgac tgcacggt gc a
ccaatgcttc tggcgtcagg cagccatcgg aagctgtggt atggctgtgc aggtcgtaaa t
I
cactgcataa ttcgtgtcgc tcaaggcgca ctcccgttct ggataatgtt ttttgcgccg a
catcataacg gttctggcaa atattctgaa atgagctgtt gacaattaat catcggctcg t
49
Iataatgtgtggaattgtgag
ptac -R primer
cggataacaatttcacac aqqa aa
1 nifA
ca g a a t t  cccqqq [a tg ]
Bases To Be 
Eliminated
3.4 .1 : P C R  A m plification  A nd C loning O f The p ta c  Prom oter.
The ptac promoter was amplified from pPC228 using the primers ptac-F  and ptac-R 
described above. The results o f this PCR and the PCR conditions used are shown in 
Figure 3.4.5 below. As can be seen from Figure 3.4.5, a single band of approximately 
262bp corresponding to the desired ptac promoter PCR product was obtained.
114
• Figure 3.4.5 : PCR Amplification Of The ptac Promoter From nPC228.
Lane No.
1
2
Sample.
1 Kb Ladder 
ptac Promoter PCR
PCR Conditions.
Annealing Temperature 
Annealing Time 
Extension Time
58 °C 
30 sec 
1 min
Having optimized the ptac PCR and obtained the desired PCR product the next step 
was to clone the PCR product into the TA pCR2.1 vector. A ligation was set up 
according to the TA protocol given in section 2.18 and the ligated DNA was used to 
transform INVaF' cells. The transformation was plated on LBamp/Xgal plates and 
incubated at 37 °C overnight. White colonies were picked off and screened by 
performing £coRI digests on plasmid DNA isolated from each clone. EcoRI sites 
flank the insertion site for the PCR product in the TA vector and thus EcoKl 
digestion was expected to excise cloned PCR products as there were no EcoRI sites 
within the desired ptac PCR product. Screening in this manner resulted in the 
identification of the desired plasmid called pPC9. The results of the verifying 
restriction analysis of this plasmid can be seen in Figure 3.4.6 below.
Figure 3.4.6: Restriction Analysis Of Plasmid pPC9
Lane No. Sample.
1 1Kb Ladder
2 pPC9 Uncut
3 pPC9 cut Xmal
4 pPC9 cut EcoRI
5 pPC9 cut Xmal-Xbal
6 ptac promoter PCR product
7 1Kb ladder
3 4 5 6 7
1 15
3.4.2: Sub-cloning Of The ptac Promoter Into pPC228 To Form The
A lternative Control Plasm id pPC230.
Plasmid pPC9 was digested with Xmal and Xbal and the digested plasmid DNA was 
separated on a 1% agarose gel. The desired 262bp band corresponding to the ptac 
promoter PCR product was purified from the gel using the gene clean procedure. 
Plasmid pPC228 was also digested with Xmal and Xbal to excise its existing 272bp 
ptac promoter region. The digested pPC228 DNA was separated on a 1% agarose gel 
to verify complete digestion. The 5931 bp band corresponding to the remaining 
portion of the pPC228 plasmid was purified from the agarose gel and ligated with the 
purified ptac PCR product. The ligated DNA was used to transform DH5a cells and 
the transformation was plated on LBamp agar. Colonies obtained were screened by 
performing £coRI digests on plasmid DNA isolated from each clone. £coRI 
digestion of plasmid pPC228 yields two bands on an agarose gel, one of 493bp and 
one of approximately 5710bp. This is because it possesses two .EcoRl sites, one 
within the nifA sequence itself and one in the upstream ptac promoter region EcoRl 
digestion thus cleaves off the 493bp NifA N-terminal domain sequence. £coRI 
digestion of the desired clone with the manipulated PCR amplified ptac promoter 
region was expected to generate a single band corresponding to linearised plasmid 
DNA as the EcoRl site in the original ptac promoter region would not be present in 
the PCR amplified ptac promoter region as described earlier. Screening clones using 
.EcoRI digestions resulted in the identification of the desired plasmid called pPC230. 
Figure 3.4.7 below shows the results of the verifying restriction analysis of plasmid 
pPC230 and Figure 3.5.1(A) shows a detailed restriction map of the plasmid.
When the newly constructed control plasmid pPC230 was introduced into DH5a 
with plasmid pPC185-A (bearing the nifH:lacZa reporter gene) and plated on 
selective media containing IPTG and Xgal much stronger colour development of 
colonies was observed than that observed for the initial control plasmid pPC228. 
This indicated that the manipulation of the ptac promoter region of plasmid pPC228 
to reduce the distance between the plasmid borne RBS and the ATG start codon of 
the cloned nifA gene (thus generating the control plasmid pPC230) had the desired 
effect of improving the efficiency with which the NifA protein was translated.
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• Figure 3.4.7: Restriction Analysis Of Plasmid pPC230.
Lane No. Sample.
1 1Kb Ladder
2 pPC228 Uncut
3 pPC230 uncut
4 pPC228 cut .EcoRI
5 pPC230 cut EcoKl
6 U pPC230 cut Xbal
7 1Kb Ladder.
3.4.3: Construction  O f The A lternative Prey P lasm ids pPC231-A, 
PPC231-B And pPC231-C.
In each of the previously constructed Prey vectors pPC229-A, pPC229-B and 
pPC229-C the start codon of the cloned NifA NC domain was the same distance 
from the RBS as it was for the nifA gene in plasmid pPC228. Therefore, the ptac 
promoter region of each of these plasmids also had to be replaced with the modified 
ptac promoter PCR product and this was done in the same way as for plasmid 
pPC228.
Plasmid pPC229-A was digested with Xmal and Xbal to excise its existing 272bp 
ptac  promoter region and the digested plasmid DNA was separated on a 1% gel to 
verify complete digestion. The 5738bp band corresponding to the remaining portion 
of the pPC229-A plasmid was purified back from the agarose gel using the gene 
clean procedure and ligated with the purified Xmal-Xbal ptac promoter fragment cut 
from pPC9. The ligated DNA was used to transform DH5a cells and clones obtained 
were screened by ÆcoRI digestion as with the manipulation of the ptac region of 
pPC228. In this manner the desired plasmid pPC231-A was obtained. The modified 
ptac promoter PCR product was also sub-cloned from pPC9 into plasmids pPC229-B 
and pPC229-C in the same way to yield plasmids pPC231-B and pPC231-C 
respectively. The results of the verification restriction analysis of these plasmids can
be seen in Figures 3.4.8 and Figure 3.5.1(B-D) shows detailed restriction maps of the 
alternative Prey plasmids.
•  Figure 3.4.8: Restriction Analysis Of Plasmids pPC231-A, pPC231-B And 
PPC231-C.
A.) Restriction Of pPC231-A.
Lane No. Sample.
1 1Kb Ladder
2 pPC229-A uncut
3 pPC231-A uncut
4 pPC229-A cut EcoRI
5 pPC231 - A cut EcoRI
6  pPC231 - A cut Xbal
7 1Kb Ladder.
B.) Restriction Of pPC231-B.
Lane No. 
1
2
3
4
5
6 
7
Sample.
1Kb Ladder 
pPC229-B uncut 
pPC231-B uncut 
pPC229-B cut EcoRl 
pPC231 -B cut EcoRl 
pPC231-B cut Xbal 
1Kb Ladder.
1 2 3 4 5 6 7
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C.) Restriction Of pPC231-C.
Lane No.
1
2
3
4
5
6 
7
3.5: Sum m ary O f Chapter 3.
The end result of all of the above strategies was the construction of the initial 
Control plasmid pPC228 and the alternative Control plasmid pPC230 with its 
manipulated ptac promoter region. Also three initial Prey plasmids called 
pPC229-A, pPC229-B and pPC229C were constructed. The ptac promoter 
region of each of these was manipulated to form the alternative Prey plasmids 
pPC231-A, pPC231-B and pPC231-C respectively. Detailed restriction maps of 
all of these plasmids can be seen in Figure 3.5.1 below.
Sample.
1 Kb Ladder 
pPC229-C uncut 
pPC231-C uncut 
pPC229-C cut £coRI 
pPC231 -C cut EcoRI 
pPC231-C cut Xbal 
1Kb Ladder.
faint 
-  baud
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•  Figure 3.5.1: Restriction Maps Of The Constructed Control And Prey 
Plasmids For The NofA Based P2H System.
A.) Control Plasmids pPC228 And pPC230
K ey
■ - An^icilliii Rcfûtance Gene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = C-Terminal Domain Of NifA.
■ = ptac Promoter
■ = Strong meBTjXi Ribosomal Terminator
E = EcoIQ.
Xm - Xmal
Xh = Xko\
S = Sail
C a d a l
B » BamiU.
P Psrtl
H = Hindm
Xh " Xbal
K ey
■ = Ampicillin Resistance Ce ne
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = C-Terminal Domain Of NifA
■ = pine Promoter
■ = Strong mtBT|Tj Ribosomal
Terminator
E = Eco RI
Xm = Xmal
Xh = Xhol
S = Sail
c s d a l
B = BamW
P = Psil
H Hindm
Xh = Xbal
W iB T sT
pPC228
(6203bps)
PBR322
ori
miBTiTj
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B.) Prey Plasmids pPC229-A And pPC231-A.
Key 55\5 5053
■ = AmpiciUin Resistane« Cene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = ptac Promoter
■ m Strong imBTjTi Ribosomal Terminator
E = £coRI
Xm = Xma I
XJt = Xhol
S = Sali
C = G al
B = BflmHI
P = f t t l
H = Hindm
Xb = Xbal
Key
■ = Ampicillin Resistance Cene
□ = N-Terminal Domain Of NifA
□ m Central Domain Of NifA
■ a ptac Promoter
■ Strong miBTvTi Ribosomal Terminator
E = fcoRI
Xm = Amai
Xh = Xhol
S = Salì
C = G al
B = BamlQ.
P = Pstl
H = Hindm
Xb - Xbal
pBR322
ori
WìBT.T,
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C.) Prey Plasmids pPC229-B And pPC231-B.
Key
■ = Ampicillin Resistance Gene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = ptac Promoter
■ = Strong rmBTjTi Ribosomal
Terminator
£ = FcoRI
Xm = Xmal
XH = Xhol
S = Sali
C = Q al
B ~ jfamHI
P = ftrt
H = Hindm
Xb = Xbal
Key
■ = Ampicillin Resistance Gene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = ptac Promoter
■ = Strong rmBTjTj Ribosomal
Terminator
E = fcoR I
Xm = Xmal
Xk = Xhol
S = Sali
c = aal
B = EaittlR
P = f t f l
H - HindUl
Xb = Xbal
rmBT-.T;
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D.) Prey Plasmids pPC229-C And pPC231-C.
Key
■ = Ampicillin Resistance Gene
□ = N-Terminal Domain Of NifA
□ = Central Domain Of NifA
■ = ptac Promoter
■ = Strong mtBIjTi Ribosomal 
Terminator
E = £coRI
Xm = Xmal
Xh = Xkol
S = Sali
C = G al
B * BarnHl
P = Pstl
H Hindm
Xb = Xbal
3317 i060
■ = Ampicillin Resistance Gene
□ = N-Terminal Domain OfNiü
□ = Central Domain Of NifA
■ = ptac Promoter
■ s Strong rrnBTiTj Ribosomal Terminator
E = EcoHI
Xm = Xmal
Xh = Xkol
S = Sali
c = O al
B = BamHl
P = Pstl
H = Hindm
Xb Xbal
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Chapter 4
Construction O f The Reporter Plasmids pPC185 
And pPC186 For The Prokaryotic Two-Hybrid
System.
124
4.1: Introduction.
This chapter describes the construction of the reporter genes for the proposed P2H 
system. These were to be constructed using the S. meliloti 2011 nifH promoter, a 
promoter naturally regulated by the S. meliloti 2011 NifA protein.
Two reporter genes were to be constructed, a nifH'.lacZa reporter gene and a 
nifH:gent' (gentamycin resistance) reporter gene. The n//7/.7acZareporter gene was to 
be constructed first as it would allow the levels of lacZa expression from the nifH 
promoter to be monitored both on the basis of color intensities of colonies on Xgal 
plates and quantitatively by the Miller assay. The NifA N-terminal-central domains 
were known to activate transcription from nif promoters like the nifH promoter despite 
lacking the C-terminal DNA binding domain, although at a lower level than the entire 
NifA protein. In addition to this E. coli NtrC was known to be capable of inducing low 
level expression from the nifH promoter. The S. meliloti 2011 NifA protein was also 
known to be both temperature sensitive and oxygen sensitive. Considering all of these 
properties of the NifA protein the nifH: lacZa reporter gene would be very useful for;
•  monitoring background levels of expression from the nifH promoter.
•  testing NtrC mutant E. coli strains developed for use with the proposed P2H 
system
•  studying the levels of transcriptional activation induced by the entire NifA 
protein and the NifA NC domain expressed from the Control and Prey 
plasmids discussed in chapter 3.
•  optimization of the growth conditions to be used in the P2H system.
Having optimized the P2H system using the nifH:lacZa reporter gene the nifH:genf 
reporter could be used perform library screens, permitting direct selection for clones 
expressing interacting hybrid proteins on the basis of gentamycin resistance.
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4.2: Selection Of A Suitable Plasmid For Maintaining Reporter Genes
- The Form ation O f Plasm id pPC224.
The constructed reporter genes were to be maintained on a multi-copy plasmid rather 
than being integrated into the genome of an E. coli strain. It was expected that the 
resulting increased copy number of the reporter genes would increase the sensitivity of 
the final P2H system and that it would add to the versatility of the system as specific 
reporter strains would not be required with the nifH:gentr reporter gene. It would thus 
be possible to perform the assay in a wide range of genetic backgrounds. A suitable 
plasmid on which the reporter genes could be maintained therefore had to be selected. 
In addition to the reporter genes, the selected plasmid would also maintain a Bait 
construct for expressing hybrid proteins containing the NifA C-terminal DNA binding 
domain. This fact also had to be taken into consideration when selecting a suitable 
plasmid.
Any plasmid selected for maintaining the reporter genes and the Bait construct had to 
be compatible with the pKK223-3 plasmid upon which the Control and Prey plasmids 
discussed in chapter 3 were based and so plasmid pACYC184 was chosen. The 
pACYC184 plasmid had a pl5A origin of replication known to be compatible with the 
pMBl origin of replication present on plasmid pKK223-3. The plasmid also had a 
tetracycline resistance gene with unique restriction sites into which ni/H.iacZa or 
ni/H:gentr reporter genes, and later the Bait construct, could be cloned (see Figure 
4.2.1). The plasmid also had a chloramphenicol resistance gene that could be used to 
select for the plasmid independently of the pKK223-3 based Control and Prey Vectors 
described in chapter 3.
As mentioned above, in addition to maintaining the reporter genes the pACYC184 
plasmid would also maintain a Bait construct for expressing hybrid proteins containing 
the NifA C-terminal DNA binding domain. The planned Bait construct, which is 
discussed in chapter 5, would contain a BamHl site for cloning genes of interest and 
making fusions with the NifA C-terminal domain sequence. In order for the BamHl 
site within the Bait construct to be a unique restriction site and to thus allow it to be 
used for cloning purposes the existing BamHl site in the tetracycline resistance gene of 
the pACYC184 plasmid had to be destroyed.
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Figure 4.2.1: Map Of The Cloning Vector nACYC184.
BsrD I  4 2 3 3  
Psp1 4 0 6 t 4 1  
BsmB 1 4 0 2 7
Dm I 3 9 8 8  I 
Msc
Sty I Nco I
E c o R  I  1
BspE
T i m  BsciA 1 ,3 1 0
BsinB I 3 2 4
BsCY I 3 4 4 0  
BspE I 3 4 3 7  
Bsg I 3 4 2 3
Ps/iA  I 3 3 0 0  
Beg 1 3 2 9 &  
Bsm  I 3 2 2 2  
Him II 3 2  ! 1
Ahd I  3 2 0 3  
Eco5 7  I 3 1 5 0  
Hsu A I 3141
P/j u M I 2 9 7 -1  
Msc I 2 9 3 8  
I 'puM I 2 9 3 2  
B so B  I /Ava I  2 9 1 9  
Sty I 2 8 6 3
II 5 1 5  
Nhe 1 5 8 3  
/ \c c  I 5 9 4  
B s t l l 0 7  I  5 9 4  
Xmn I  6 3 5  
Bsg I 6 6 5  
SgrA I 6 6 8  
/J.srfJ I 7 5 5
S a c  II  8 3 2
BssS I 9 5 9
Bgl t 2 6 5 7  
BspM I  2 5 5 7
JVru I 2 4 6 6  
Eag  I  2 4 3 3  
lìril I 2 4 2 3  
/ '.s p i '4 0 6  I 2 3 9 4
l>shA I 2 2 0 6  
Big I 2 2 0 2
" t o l W S  E c o N  I 2 1 1 6  
Sal I  2 1 4 5
S / c l  1 6 3 2  
E c o R  V  1 6 7 9  
^  Nlw 1 1 7 2 3
l  I  BsCY I 1 8 6 9  
SgrA I 19 0 3  
Ban II 1 9 7 9 . 1 9 6 5  
B splii  1 9 8 3  
Sph I  Nap I 2 0 5 6
Nsp I 1 1 5 7
Bstìi I 1 3 1 8  
A s e  I  1 4 0 5  
Ssp  I 1 4 1 »  
Xba 1 1 4 2 4  
E a r l  1 4 4 6  
E e o 5 7  1 1 4 6 3
C ! a  I / B s p D  I 
H i n d  m  I 5 2 3
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In order to destroy the BamHl site of the pACYC184 plasmid the plasmid was 
digested with Bamlil. The digested plasmid DNA was then separated on a 0.7% 
agarose gel to verify complete digestion and the band corresponding to the linearised 
plasmid was purified by the gene clean procedure. The 5’ cohesive Bamlil ends were 
filled by performing a Klenow reaction, the DNA was cleaned and then blunt end 
ligated. The ligation was used to transform DH5a and the transformation was plated 
out on LB media to which chloramphenicol had been added to select for the presence 
of the plasmid. Elimination of the Bamlil site would disrupt the tetracycline resistance 
gene on pACYC184 leading to a tetracycline sensitive phenotype so transformants 
were replica plated onto LB chloramphenicol and LB tetracycline plates. In this way 
chloramphenicol resistant, tetracycline sensitive clones were identified, Plasmid DNA 
was isolated from each of the identified clones and digested with Bamlil to verify 
elimination of the Bamlil site. In this way the desired plasmid, pPC184, was obtained. 
Figure 4.2.2 below shows the results of the verifying BamHl digestion on plasmid 
pPC184.
Once constructed the nifH. lacZa reporter gene would be cloned onto the pPC184 
plasmid rather than directly into the pACYC184 plasmid to form a reporter plasmid 
called pPC185. The nifH .genf reporter would also be cloned into pPC184 to form a 
second reporter plasmid called pPC186. Later the Bait construct would be cloned into 
both the pPC185 and pPC186 reporter plasmids to form the final Bait plasmids (see 
chapter 5).
•  Figure 4.2.2: Restriction Analysis Of Plasmid pPC184.
1 2  3  4  5  6
Lane No. Sample.
1 pPC 184 Uncut
2 pACYC 184 Uncut
3 pPC 184 cut BamHl
4 p AC Y C 184 cut BamHl
5 pPCl 84 cut Hindlll
6  1 Kb Ladder
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Figure 4.3.1 below shows a schematic representation of the strategy employed for the 
construction of the nifH:lacZa reporter gene. This strategy is described in detail in 
section 4.3 below. The strategy employed for the construction of the nifH:genf is 
discussed in section 4.4 and a schematic representation of the strategy employed can 
be seen in Figure 4.4.2.
•  Figure 4.3.1: Strategy For The Construction Of The nifU dacZa Reporter 
Gene.
Cloned Into TA
f t i l  F.coRI pCR® n  Vector
PCR
IPI 1ATGIE1
Genomic DNA n ifH  Promoter
From S. meliloti 
2011
PCR
Cloned into pTJC19 
in frame with 
downstream la c Z a  gene ftil
Cut with 
f t i l  and EcoEl
.EcoRI 
I ATC 1
n ifH  Promoter
H ind  III
|h | n itn  l A T O l
Hind HI
n ifH  Promoter : la c Z a  Fusion 
(HZ)
Cloned into TA 
pCRRn Vectoi p P C 2
Cut with
HindJH.
cml
Cloned into unique 
H in d m  Site Of pPC184
<
H
n itH  | A T G | J
n ifH  Promoter : lo.cZA Fusion 
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12 9
4.3: Construction  O f The n i f H : l a c Z a  R eporter G ene - O verview  O f 
Strategy .
In order to construct the nifH:lacZa reporter gene the S. meliloti 2011 nifH promoter 
was amplified from total S. meliloti 2011 genomic DNA as an Pstl-EcoiRl fragment by 
PCR (see Figure 4.3.1) using the primers nifH-FI and nifH-R shown in Figure 4.3.2 
below. The primed regions of the S. meliloti 2011 nifH sequence for which these 
primers were designed are shown in Figure 4.3.3.
•  Figure 4.3.2: Primers Used For The Amplification Of The nifH Promoter. 
From S. meliloti 2011 Total Genomic DNA.
nifH-F I : AAAA - fCTG CAG) - CGC CCA TAC GAC ACT GTC CGT
Pstl Site
nifH-R: CCG - iGAA T C P  - AA -CAT CTT GCT TCC TTT GTT GTT
EcoRl site
NB: U nderlined Bases In Red A re Included For M aintenance O f The Reading Fram e Between 
The nifH  Start Codon And The lacZ a  Gene Subsequently Fused Downstream.
Figure 4.3.3: Primed Regions O f The S. meliloti 2011 nifH  Sequence. 
niJH-fl NifA Binding Site
cgcccatac;jac;actgtccgtagc:cc;t[tgt (cggcttagcg) aca]cgagttgttcgctcaaccatct
ggtcaatttccagatctaactatctgaaagaaagccgagtagttttatttcagacggctggcacgactt
11 gc ac gat c age c c t  gggc gc gc at gc t gt t gc gc at t  c at gt gt c c gaac aac c gaaat age 11 a ^a 
nijH-R
caacaa agga agcaagatg
KBS nifH
Start Codon
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The nifH  promoter was amplified with its own start codon and the resulting PCR was 
cloned first into the TA vector and then sub-cloned as an Pstl-EcoBJ fragment into the 
multiple cloning site of pUC19 to form plasmid pPC19. The nifH-R was designed to 
incorporate two additional bases into the nifH  PCR product between the added EcoRl 
site and the nifH  start codon. These bases were incorporated so that when the nifH 
promoter PCR product was cloned as a Pstl-EcoRI, the start codon of the nifH  
promoter PCR product would be in the correct reading frame with the downstream 
lacZa sequence of pUC19 as shown in Figure 4.3.4.
•  Figure 4.3.4: Cloning Of The nifH  Promoter PCR  Product Into The MCS 
Of pUC19.
E c o  RI
ATG | n ifH  promoter
pUC19 Multiple Cloning Site nifH  promoter PCR product
ac taccgcatta  aairctt gcatgc ct ucattcqcccatacqacactcrtcccFtaqcc
Hind El 
site
aaacaaeaa aggaagcaag atg ttg aat tca ctg gcc gtc gtt tta caa
nifH nifH fcoR I
RBS Start site
codon
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Having made a the fusion between the nifH  promoter and the lacZa gene the entire 
nifH:lacZa (HZ) reporter gene was to be amplified form pPC19 as a HindRl fragment 
using primers HZ-F and HZ-R and the resulting PCR product cloned into the TA 
vector. The sequences of the HZ-F and HZ-R primers used for the amplification of the 
ni/H.iacZa reporter are shown in Figure 4.3.5 below and the primed regions of the 
pPC19 plasmid sequence are shown in Figure 4.3.6.
•  Figure 4.3.5: Primers Used For Amplification Of The m fH :lacZa Reporter 
Gene From pPC19.
HZ-F: CC - (AAGCTT) - GCA TGC CTG CAG
H indlll site
HZ-R: (AAG CTT) - CGG CAT CAG AGC AGA TTG TAC
HindlH  site
Figure 4.3.6: Primed Regions Of The pPC19 Sequence Used For The 
Amplification Of The nifH.'laZa Reporter Gene.
pUCIS MCS HZ-F Prim er ItifM  promo ter sequence  >-
actaccgc a tts  aatfottge atcrcc t(icat>cgcccatacgacact-
H i n d  H I P s t l
--------------------------gcattcatgtgtccgaacaaccgaaatagcttaaacaacaa
lacZ  sequence___
acrtraacfc aagatut  t qaattcac t ggc c gt c g ttt t  acaacgtcgt gac t gggaaaac cctg
K B S  E c o R icodon
gcgttacccaacttaatcgccttgcagcacatccccctttcgccagctggcgtaatagcga
agaggcccgcaccgatcgcccttcccaac agttgcgcage c tgaatggc gaat ggc gc c t  g
atgcggtattttctccttacgcatctgtgcggtatttcacaccgcatatggtgcactctca 
H Z -R  P r i m e r
gtacaatccgctctgatgccg catagttaagccagccccgacacccgccaacacccgctg
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The nifH.lacZa reporter gene was then cut from the TA vector and cloned into the 
unique Hindlll site in the tetracycline resistance gene of plasmid pPC184 to form the 
reporter plasmid pPC185. The results of the above mentioned cloning steps employed 
for the construction of the nifH:lacZa reporter gene and the reporter plasmid pPC185 
are given below.
4.3.1: Am plification O f The Prom oter.
The nifH promoter was amplified from S. meliloti 2011 total genomic DNA as a Pstl- 
EcoRl fragment using the nifH-Fl and nifH-R primers described earlier. The PCR was 
separated on a 1% agarose gel. A photo of the gel obtained and the conditions used for 
the PCR are shown in Figure 4.9 below. As can be seen from Figure 4.3.7 a single 
243bp PCR product corresponding to the desired nifH promoter was obtained. The 
next step in the construction of the nifH.lacZa reporter was to clone this PCR product 
into the TA pCR2.1 vector.
•  Figure 4.3.7: PCR Amplification Of The S. meliloti 2011 nifH  Promoter.
Lane No. Sample.
1 nifH PCR Product
2 1 Kb Ladder
PCR Conditions.
Annealing temperature 60 °C
Annealing time 30 sec
Extension time 1 min
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4.3.2: C loning O f The n ifH  Prom oter PC R  Product Into The TA  
V ector To Form  Plasm id p P C l-A .
The nifH  promoter PCR product was ligated with the TA pCR2.1 vector according to 
the TA protocol. The resulting ligation was used to transform INVaF1 cells and the 
transformation was plated on LB ampicillin/Xgal plates. White colonies were isolated 
and screened by performing ÆcoRI digests on plasmid DNA isolated from each clone. 
In this way the desired plasmid, pPCl-A, was obtained. Figure 4.3.8 shows the results 
of the verifying restriction analysis on the pPCl -A plasmid.
•  Figure 4.3.8: Restriction Analysis Of Plasmid pPCl-A.
Lane No. Sample.
1 pPCl-Auncut
2 pPC 1 - A cut Pstl-EcoRl
3 nifH  PCR Product
4 1Kb Ladder
4.3.3: Sub-cloning O f The n ifH  PCR Product From p P C l-A  Into 
pUC19 To Form  Plasm id pPC19.
Plasmid pPCl-A was digested with Pstl-EcoRl and the digested DNA was separated 
on a 1% agarose gel. The 243bp band corresponding to the nifH  promoter fragment 
was purified from the gel using the gene clean procedure. pUC19 was also digested 
with Pstl-EcoRl, the digested DNA was cleaned and then ligated with the purified 
nifH  promoter fragment. The ligation was used to transform DH5a cells and the 
transformation was plated out on LB ampicillin Xgal plates. All of the colonies 
obtained on the plates were dark blue in color. A number of the blue colonies were 
picked and screened by performing J ’.s'/I-.EcoRI double digests on plasmid DNA
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isolated from each clone. In this way the desired plasmid, pPC19, was obtained. 
Figure 4.3.9 shows the verifying restriction analysis on the isolated pPC19 plasmid.
•  Figure 4.3.9: Restriction Analysis Of Plasmid pPC19.
Lane No.
2
4
3
5
1
Sample
pPC19 uncut 
pPC19 cut Pst\-EcoR\ 
pUC19 cut Pst\-EcoRl 
nifH PCR product 
1Kb Ladder
As mentioned above, all of the transformants obtained were blue in color. Cloning into 
the MCS of pUC19 usually results in white clonies due to disruption of the reading 
frame of the lac a  peptide sequence with respect to the upstream plac promoter. 
However, in this case the nifH promoter was being cloned into the MCS in frame with 
the downstream lacZa sequence. E. coli NtrC was known to activate transcription of 
NifA promoters like the nifH promoter and thus this was thought to be the cause of the 
blue color development. It was thought that the lacZa gene was being expressed from 
the cloned nifH promoter (rather from the upstream plac promoter on pUC19) due to 
activation of the nifH promoter by E. coli NtrC. Although the degree of activation of 
the nifH promoter by NtrC was known to be low, the extremely high copy number of 
pUC19 compensated for the low level of activation thus resulting in dark blue 
colonies.
4.3.4: A m plification O f The n ifH d a cZ a  Fusion From  pPC19.
Having isolated plasmid pPC19, the nifH: lacZa was amplified as a HindlU fragment 
using the HZ-F and HZ-R primers described earlier. The PCR was separated on a 1% 
agarose gel. A photo of the gel and the conditions used for the PCR are shown in
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Figure 4.3.10 below. As can be seen from Figure 4.3.10 a single band corresponding 
to the desired nifH:lacZa sequence was obtained. This PCR product was then cloned
-Mb
into the TA pCR2.1 vector.
•  Figure 4.3.10: PCR Amplification Of The nifH :lacZa Reporter Gene From 
pPC19.
Lane No. Sample
1 nifH: lacZa PCR product
2 nifH  promoter PCR product
3 1Kb Ladder
PCR Conditions
Annealing temperature 57 °C
Annealing time 30 sec
Extension time 1 min
4.3.5: C loning O f The nifH :lacZ a  R eporter Gene Into The TA  
V ector To Form  Plasm id pPC2.
The nifH:lacZa reporter gene PCR product was ligated with the TA pCR2.1 vector 
according to the TA protocol. The ligation was used to transform INVaF' cells and the 
transformation was plated out on LB ampicillin Xgal plates. Again all of the 
transformants obtained were dark blue in color. As before, it was thought that this was 
due to NtrC activation of the nifH:lacZa fusion present on the high copy number TA 
pCR2.1 vector. Some of the blue colonies were picked and screened by performing 
Hindlll digests on plasmid DNA isolated from each of the clones. In this way the 
desired plasmid, pPC2, was obtained. Figure 4.3.11 shows the results of the verifying 
restriction analysis on plasmid pPC2.
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• Figure 4.3.11: Restriction Analysis Of The pPC2 Plasmid.
Lane No. Sample
I» « * »  N u H ^ f r
1  X  »  «
1 pPC2 uncut
2 pPC2 cut Hindlll
3 nifH.jacZa PCR product 1
4 1Kb Ladder
-----------
4.3.6: Sub-cloning O f The n i f H : l a c Z a  R eporter Gene P C R  Product 
F rom  pPC2 Into pPC 184 To Form  The R eporter P lasm id pPC185.
Plasmid pPC2 was digested with Hindlll and the digested DNA was separated on a 
1% agarose gel. The band corresponding to the nifH:lacZa reporter gene fragment was 
purified from the gel by the gene clean procedure. pPC184 was also digested with 
Hindlll and the linearised plasmid DNA was then treated with Calf Intestinal 
Phosphatase (CIP) to remove the 5' phosphates. The dephosphorylated pPC184 DNA 
was then ligated with the purified nifH:lacZa reporter gene fragment. The ligation was 
used to transform DH5a and the transformation was plated out on LB 
chloramphenicol Xgal media. The reason for the incorporation of the Xgal into the 
media was to make use of E. coli NtrC activation of the nifH:lacZa reporter gene for 
identification of the desired plasmids containing the nifH.lacZa reporter gene. Two 
types of colonies were obtained, one type were very light blue in color while the other 
were a darker blue color. Colonies of each type were screened by performing Hindlll 
digests on plasmid DNA isolated from each clone. Having identified several clones 
containing the desired nifH:lacZa Hindlll fragment the orientation of the Hindlll 
fragment was determined for each clone by performing Sall-Pstl double digests. Two 
plasmids were to be isolated, pPC185-A and pPC185-B, differing only in the
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orientation of the nifH:lacZa reporter gene. Restriction maps of these plasmids can be 
seen in Figure 4.3.13. As can be seen from the restriction maps in Figure 4.3.13 a Sail- 
Pstl double digest of pPC185-A was expected to yield two bands, one of 638bps and 
one of 4104bps. A Sall-Pstl double digest of pPC185-B was also expected to yield 
two bands, one of 1107bps and one of 3635bps. Thus by performing Sall-Pstl double 
digests the two plasmids, pPC185-A and pPC185-B, were obtained. The results of the 
verifying restriction analysis on both of these plasmids can be seen in Figure 4.3.12.
Figure 4.3.12: Restriction Analysis Of Plasmid pPC185-A And pPC185-B.
Lane No. Sample.
1 1Kb Ladder
2 pPC185-A uncut
3 pPC185-B uncut
4 pPCl 85-A cut Hindlll
5 pPCl85-B cut Hindlll
6 pPC 185-A Sall-Pstl
1 pPC 185-B cut Sall-Pstl
8 1Kb Ladder
2 3 4  5  6  7 S
•<
Plasmid pPC185-A was found to generate the very light blue colored colonies while 
pPCl 85-B was found to produce the slightly darker blue colonies. As explained earlier 
the light blue color caused by the pPCl 85-A plasmid was thought to be due to weakv
activation of the nifH: lacZa reporter gene by E. coli NtrC. The color development was 
not as intense as that observed when the nifH  promoter was cloned into pUC19 or 
when the nifH:lacZa reporter gene was cloned into the TA vector to form pPC2 
because the pACYC184 based pPCl 85-A plasmid was a much lower copy number 
than pUC19 or TA vector. The slightly darker blue color development of colonies with 
plasmid pPCl 85-B was thought to be due to additional expression of the nifH:lacZa 
reporter gene caused by mRNA transcripts initiated from the upstream tetracycline 
resistance gene promoter present on plasmid pPCl84 (pACYCl 84).
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Figure 4.3.13: Restriction M aps O f The L a c Z a  Reporter Plasmids
PPC185-A And pPC185-B.
l
Key
■ = Tetracyclin resistance gene
■ = Chloramphenicol resistance gene
= ^[i/iiPromoter
£ = £coKI
H = Hindni
P = Pstl
Ei = Eagl
S = Sail
l
m  = Tetracyclin resistance gene
■  = Chloramphenicol resistance gene
nifH Promoter
E = E coKI
H = Kmdm
P = Pstl
Ea = Eag I
S = Sail
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As can be seen from Figure 4.3.13, on the pPC185-B plasmid the tetracycline 
resistance gene and the nifH:lacZa reporter gene are both transcribed in the same 
direction and thus from the same strand. The ni/H: lacZa was cloned into the Hindlll 
site which lies within the promoter for the tetracycline resistance gene on plasmid 
pPC184. Cloning into this site does not always result in the inactivation o f the 
promoter and so transcripts initiated from this promoter would read through the 
niJH:lacZa reporter gene generating mRNA transcripts containing the coding 
sequence for LacZa. This additional expression o f the ni/H.jacZa reporter would not 
occur on the pPC185-A plasmid because the tetracycline resistance gene would be 
transcribed in the opposite direction to the ni/H: lacZa reporter gene and thus from the 
opposite strand. Transcripts initiated from the tetracycline resistance gene would read 
through the nifH.iacZa reporter gene but the mRNA generated would be the non-sense 
strand o f the nifH:lacZa reporter gene and thus would not be translated to give 
functional LacZa.
To verify that the sequence o f the nifII:lacZa reporter was correct the nijHAacZa. 
reporter present on plasmid pPC185-A was sequenced and the sequence obtained is 
shown in Figure 4.3.14 below.
• Figure 4.3.14: Sequence Of The nifH.iacZa Reporter On pPC185-A.
p P C 1 8 4
^ -------------- 1 I----------------- t t i f l l  p r o m o te r  se q u e n c e
a c t a c c g c a t t a  a a t t c t t c f c a t a c c t f f c a q c c f c c c a t a c a a c a c t a t c c a t a c r c c  c t  f t  <it
H in d l l l  P s t l
s i t e  s i te
( c g g c t t a g c g )  a o a ^ c g a g t t g t t c g c t c a a c c a t c t g g t c a a t t t c c a g a t c t a a o t a t  
N ifA
B in d in g  s i te
c  t g a a a g a a a g c  c  g a g t  a g t  t t t  a t  t t c  a g a c g g c  t  g g c  a c  g a c  t t t t  g c  a c  g a t .  c  a g e  c  c  
t g g g c g c g c a t g c t g t t g c g c a t t c a t g t g t c c g a a c a a c c g a a a t a g c t t a a a c a a c a a a
I-------------->  lacZ a . se q u e n c e
( f f f a a a c  a a o a t d t  t t t a a l t c a c  t  g g e e  g t  c  g t  t t t  a c  a a c  g t c g t  g a c  t  g g g a a a a c  c c t g  
K B S  s t a r t  E c o R I
co d o n  s i te
g c g t t a c c c a a c t t a a t c g c c t t g c a g c a c a t c c c c c t t t c g c c a g c t g g c g t a a t a g c g a  
a g a g g c c c g c a c c g a t c g c c c t t c c c a a c a g t t g c g c a g c c t g a a t g g c g a a t g g c g c c t g  
a t g c g g t a t t t t c t c c t t a c g c a t c t g t g c g g t a t t t c a c a c c g c a t a t g g t g c a c t c t c a
I-------------- >  p P C 1 8 4  se q u e n c e
g c a c a a t e t g c t c t q a c a c c g a a B C t t a t c g a t g a t a a c c t q t e a a a c a t g a g a a t t a c a a
H in d  III stop
s i t e  codon
c t t a t a t c g t a t g g g g c t g a c t t c a g g
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4.4: Construction Of The nifH:eentr Reporter Gene - Overview Of
Strategy.
Figure 4.4.2 shows a schematic representation o f the strategy employed for the 
construction o f the nifH:genf reporter gene and the strategy is discussed in detail 
below.
In order to construct the nifH:genf reporter gene the gentamycin resistance gene was 
amplified without its own start codon and as an EcoRl-Hindlll fragment from the 
plasmid pJQ200ks using the primers gent-F and gent-R shown in Figure 4.4.1. The 
primed regions o f the gentamycin resistance gene are shown in Figure 4.4.3. The 
resulting PCR product was first cloned into the TA pCR2.1 vector and then sub-cloned 
into pPC225 (described in Chapter 3) to form plasmid pPC226. The pPC225 plasmid 
was used in this case simply because it possessed suitable restriction sites in the 
correct order to allow a fusion to be made between the S. meliloti 2011 nifH  promoter 
and the gentamycin resistance gene.
• Figure 4.4.1: Primers Used For The Amplification Of The Gentamycin 
Resistance Gene From pJQ200ks.
gent- F: (GAA T T O  - A - TTA CGC AGC AGC A AC GAT GTT
EcoSl site
gent-R: (AAG CTT) - TTA GGT GGC GGT ACT TGG GT
Hindm  site
N B :  Underlined Base In Red Was Included For Maintenance Of The Reading Frame Between 
The Gentamycin Resistance Gene And The Start Codon Of The nifH Promoter With Which It 
Would Later Be Fused
The nifH  promoter was amplified from pPC19 as an Sall-EcoRl fragment using the 
primer nifH-F2 shown in Figure 4.4.4 and the nifH-R primer used in its initial 
amplification from S. meliloti 2011 genomic DNA. The primed regions o f the nifH  
promoter sequence present on plasmid pPC19 for which these primers were designed
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• Figure 4.4.2: Strategy For The Construction Of The nifH:sentr Reporter 
Gene And The pPC186 Reporter Plasmid.
PCR
_L
Hind El
L E I
Gentamycin Resistance 
Gene
Cloned Into TA
p C R s n  Vector
V
Sal I V
HE
PCR
Eco'Kl
lATGlEl
nifH Promoter
V
Cloned Into TA 
p C R * n  Vector
C u t  W i t H  E c o K l
and Hin dm
se n tr
H
C u t  W i t h  S a l \  a n d  £ c ö R I  
a n d  L i g a t e  W i t h  n i f H  
Promoter
G u t  W i t h  S a i l  
E c o  R I
I X T G i
n i f H  P r o m o t e r
M/
Continued overleaf
Promoter
d o m 'd  In t o  p P C 2 2 5  
n t a *  W a tt  A l s o  C u t  
W i t h  E c o R l  A n d  H i n  a m
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P C R
HindUi.
H
v
nifH A T C ~ |¥ gentr
Hind IDiH
nifH  P ro m o te r : C c n ta n q x in  R e s is ta n c e  
G en e F u s io n  (H G )
C lo n e d  Into TA 
p C R *  XI V ector
pPC8
C u t w ith
Hmdm
H
i !
H
I
nifH ATG E gentr
nifH Prom oter : G entam ycin  R esistan ce  
G ene F u sio n  (H G )
Cloned Into The Unique 
Hindm  Site O f  pPC184
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are shown in Figure 4.4.5. Once amplified the resulting nifH promoter PCR product 
was cloned into the TA vector.
Figure 4.4.3: Primed Regions Of The Gentamvcin Resistance Gene From 
pJQ200ks.
gent -F Primer
a t g  t tacgcag  cagcaacgat g ttacgcagc  agggcagtcg ccctaaaaca  aag ttagg tg
Start
codon
gc tcaag ta t gggcatcatt cgcacatg ta ggctcggccc tgaccaagtc
gggctgctct t g a t c t t t t c ggtcg tgag t teggagaegt agccacctac
agccggactc c g a ttac c tc gggaacttgc te eg ta g ta a gaca ttca tc
ccttcgacca agaageggtt g ttggcgctc tc gcggc tta cg ttc tgccc
agccgcgtag tg a g a tc ta t a t c ta t g a tc tcgcag tc tc cggcgagcac
gcattgccac cgcgctcatc a a tc tc c tc a agcatgaggc caacgcgctt
tg a tc ta c g t gcaagcagat tacggtgacg atcccgcagt g g c tc tc ta t
geataeggga agaagtgatg
gent-R Printer
c a c t t t g a t a  tcgacccaag  taccgccacc
aaatccatgc
tcccaacatc
gcgcttgctg
aggtttgagc
cggaggcagg
g g tg c t ta tg
acaaagttgg
t a a
Stop
codon
• Figure 4.4.4: Primers Used For The Amplification Of The nifH  Promoter 
From pPC19.
nifH-F2: (GTC GAC) - GCA TGC CTG CAG CGC CCA
Sail site
nifH-R: CCG - (GAA TCC) - AA - CAT CTT GCT TCC TTT GTT GTT
iicoR I site
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•  Figure 4.4.5: Primed Regions O f The nifH Promoter On pPC19.
PU C19 M CS
a c t a c c g c a t t a  a a g c t t  
Hind, m
nifH -Fl nifH prom oter sequence
g e a t g e  c t g c a g  c g c c c e C a c g a c a c t
■g c a L t c a c g c g i c c g a a c a a c c g a a a c a g c L c a a a c a a c a a
nifH-R la c Z  Ct sequence
acftfaaac aagatgt c gaattc a c t g g c c g t - c g t t t t a c a a c g t c g t  g a c t g g g a a a a c c c t g
K B S sta r t
codon
EcoKL
The amplified nifH  promoter Sall-EcoRl fragment was cut from the TA vector and 
sub-cloned into pPC226 to make an in frame fusion with the gentamycin resistance 
gene . The resulting plasmid with the nifH:genf reporter gene was called pPC227. 
Having made a fusion between the nifH  promoter and the gentamycin resistance gene 
the entire nifH:gentr reporter gene was amplified from pPC227 as a HindWl fragment 
using a forward primer called nifH:genf-F shown in Figure 4.4.6 and the gent-R 
reverse primer used earlier for the amplification o f the gentamycin gene from 
pJQ200ks. Figure 4.4.7 shows the primed regions o f the nifH:genf sequence.
• Figure 4.4.6: Primers Used For The Amplification Of The nifH:eenf 
Reporter Gene From pPC227.
ni/H:gentr-F: (AAGCTT}- GCA TGC CTG CAG CGC CCA 
Hindlll site
gent-R: (AAG CTT) - TTA GGT GGC GGT ACT TGG GT
Hindlll site
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•  Figure 4.4.7: Primed Regions O f The nifH:eenf Sequence On pPC227.
Fprimer n i^  promoter sequence
gcatgc ctgcag cgcccstacgacactgtcgac 
Sail Psti
- - gc at c c au gi; gt c c gaac aac c gaaacage n: a aac aac aa
gentamycin resistance gene
atrqaacrcaaq atti ttc( aat tea t ta  ege age age aac gat gtt a c g -------
KBS start £ co K Icodon
gettt-R  Primer
  agaagtgatg cactttgata  tcgacccaag taccgccacc taa aagctt
StoP Hmim
codon site
The resulting nifH:gentr PCR product was first cloned into the TA pCR2.1 vector and 
then sub-cloned into the unique Hindlll site o f plasmid pPC184 to form the 
reporter.plasmid pPC186. The results o f the above mentioned cloning steps employed 
for the construction o f the nifH:gentr reporter gene and the pPC186 reporter plasmid 
are given below.
4.4.1; Amplification Of The Gentamycin Resistance Gene From 
pJQ200ks.
The gentamycin resistance gene (g en f) was amplified from pJQ200ks as an EcoRI- 
Hindlll fragment using the gent-F and gent-R primers described earlier. The PCR 
product was separated on a 1% agarose gel. A photo o f the gel obtained and the
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conditions used for the PCR are shown in Figure 4.4.8 below. As can be seen from 
Figure 4.4.8, a band of 544bps corresponding to the desired gentamycin resistance 
gene was obtained.
Figure 4.4.8: PCR Amplification Of The Gentamycin Resistance Gene 
(senf)  From pJQ200ks.
Lane No.
1
2
Sample.
gen f PCR product 
1Kb Ladder
PCR Conditions
Annealing temperature 57 °C
Annealing time 30 sec
Extension time 1 min
4.4.2: Cloning Of The genf PCR Product Into The TA Vector To 
Form Plasmid pPC7.
The g en f  PCR product was ligated with the TA pCR2.1 vector according to the TA 
protocol. The ligation was used to transform INVaF' cells and the transformation was 
plated onto LB ampicillin Xgal plates. White colonies were picked and screened by 
performing £coRI digests on plasmid DNA isolated from each clone. In this way the 
desired plasmid pPC7 was obtained. Figure 4.4.9 shows the results o f the verifying 
restriction analysis on plasmid pPC7.
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•  Figure 4.4.9: Restriction Analysis O f Plasmid pPC7.
Lane No. Sample
1 1Kb Ladder
2 pPC7 uncut
3 pPC7 cut EcoR\-Hind\l\
4 gen f  PCR product
5 1Kb Ladder
4.4.3: Sub-cloning Of The genf PCR Product From pPC7 Into 
pPC225 To Form Plasmid pPC226.
Plasmid pPC7 was digested with EcoRl-Hindlll and the digested DNA was separated 
on a 1% agarose gel. The 544bp band corresponding to the g en f  fragment was purified 
from the gel using the gene clean procedure. Plasmid pPC225 was also digested with 
EcoRl-Hindlll and the digested DNA was separated on a 0.7% agarose gel. The 4.5Kb 
band corresponding to the pPC223 portion of the pPC225 plasmid was purified from 
the gel using the gene clean procedure and ligated with the purified gen f EcoK\- 
Hindlll fragment. The transformation was used to transform DH5a cells and the 
transformation was plated out on LB ampicillin. Colonies were screened by 
performing EcoRl-Hindlll double digests on plasmid DNA isolated from each clone. 
In this way the desired plasmid pPC226 was obtained. Figure 4.4.10 shows the results 
o f the verifying restriction analysis on plasmid pPC226.
4.4.4: Amplification Of The n ifH  Promoter From Plasmid pPC19.
The nifH  promoter was amplified from plasmid pPC19 as a Sall-EcoRl fragment using 
the W/7/-F2 and nifH-R primers described earlier. The PCR was separated on a 1%
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agarose gel. A photo of the gel obtained and the PCR conditions used are shown in 
Figure 4.4.11. As can be seen from Figure 4.4.11 a single band of 251bps 
corresponding to the desired nifH  promoter was obtained.
• Figure 4.4.1Q: Restriction Analysis Of Plasmid pPC226.
me No. Sample
1 1Kb Ladder
2 pPC226 uncut
3 pPC225 uncut
4 pPC7 uncut
5 pPC226 cut Hindlll
6 pPC225 cut Hindlll
7 pPC7 cut Hindlll
8 PC226 cut £coRI
9 pPC225 cut EcoRA
10 pPC7 cut £coRI
11 pPC226 cut EcoRl-Hindlll
12 pPC225 cut EcoRI-Hindlll
13 pPC7 cut EcoKl-Hmdill
14 1 Kb Ladder
Figure 4.4.11: PCR Amplification Of The nifH  Promoter From pPC19.
Lane No. Sample
1 nifH  promoter PCR product
2 1Kb Ladder
PCR Conditions
Annealing temperature 60 °C
Annealing time 30 sec
Extension time 1 min
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4.4.5: Cloning Of The nifH Promoter Sall-EcoRI PCR Product Into
The TA_vector To Form Plasmid pPCl-B.
The nifH  promoter PCR product amplified from plasmid pPC19 was ligated with the 
TA pCR2.1 vector and the ligation was used to transform IN V aF  cells. The 
transformation was plated on LB ampicillin Xgal and white colonies where picked off 
for screening. Clones were screened by performing EcoRI digests on plasmid DNA 
isolated from each clone. In this way the desired plasmid pPCl-B was obtained and 
Figure 4.4.12 shows the results o f the verifying restriction analysis on this plasmid.
Figure 4.4.12: Restriction Analysis Of Plasmid pPCl-B.
Lane No. Sample
1 1Kb Ladder
2 pPCl-B uncut
3 pPC 1 -B cut Sail
4 pPCl-B cut £coRI
5 pPCl-B Sall-EcoRI
6  nifH  promoter PCR product
7 1 Kb Ladder
4.4.6: Sub-cloning Of The n ifH  Promoter PCR Product From pPCl-B  
Into pPC226 To Form Plasmid pPC227.
Plasmid pPCl-B was digested with Sall-EcoRI and the digested plasmid DNA was 
separated on a 1% agarose gel. The 251 bp Sall-EcoRI fragment corresponding to the 
nifH  promoter was purified from the gel by the gene clean procedure. Plasmid pPC226 
was also digested with Sall-EcoRI to excise a 532bp fragment and the digested DNA 
was separated on a 0.7% agarose gel. The 4.5kb band corresponding to the remainder 
of the plasmid was purified from the gel by the gene clean procedure and ligated with 
the purified nifH  promoter Sall-EcoRI fragment. The ligation was used to transform
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DH5a cells. Transformants obtained were first screened by performing Pstl digests on 
plasmid DNA isolated from each clone. The reason for this was that the pPC226 
plasmid did not possess any Pstl sites (the plasmid is basically pPC223 with the genf 
gene on an EcoRl-Hindlll fragment). The Sall-EcoRl nifH  promoter fragment 
amplified by PCR contained a Pstl site (see Figure 4.4.5). Thus, only the desired 
plasmid, pPC227, containing the nifH  promoter fragment would be linearised by Pstl 
digestion. In this way the plasmid pPC227 was obtained and Figure 4.4.13 below 
shows the results o f the verifying restriction analysis on plasmid pPC227.
U
• Figure 4.4.13: Restriction Analysis Of Plasmid pPC227.
Lane No. Sample
1 1 Kb Ladder
2 pPC226 uncut
3 pPC227 uncut
4 pPC226 cut Pstl
5 pPC227 cut Pstl
6 pPC226 cut Sail
I  pPC227 cut Sail
8 pPC226 cut £coRI
9 pPC227 cut EcoRX
10 pPC226 cut Sall-EcoRl
II pPC227 cut Sal\-Eco\l\
12 pPCl-B cut Sa/I-£coRI
13 1Kb Ladder
1 2 3 4 5 6 7 8 9 10 11 12 13
ui
4.4.7: Amplification Of The nifH :genf Reporter Gene From Plasmid 
pPC227.
Having made the fusion between the nifH  promoter and the gen f  gene the entire 
nifH .genf reporter gene was amplified from plasmid pPC227 as a Hindlll fragment 
using the nifH .genf-F and gent-R primers described earlier. The PCR product was 
separated on a 1% agarose gel. A photo o f the gel obtained and the conditions used for 
the PCR are shown in Figure 4.4.14. As can be seen from Figure 4.4.14 a single band 
corresponding to the desired nifH .genf reporter gene was obtained.
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•  Figure 4.4.14: PCR Amplification O f The nifH.'genf Reporter Gene From
PPC227.
Lane No. Sample
1 1Kb Ladder
2 niJH:genir PCR product
3 gen f  PCR product
4 1Kb Ladder
PCR Conditions
Annealing temperature 58 °C
Annealing time 30 sec
Extension time 1 min
1 2 3 4 5
4.4.8: Cloning Of The n ifH :senf PCR Product Into The TA Vector 
To Form Plasmid pPC8.
The nifH:gentr reporter gene PCR product amplified from plasmid pPC227 was ligated 
with the TA pCR2.1 vector according to the TA protocol. The ligation was used to 
transform INVaF' cells and the transformation was plated on LB ampicillin Xgal 
plates. White colonies were screened by performing HindlU digests on plasmid DNA 
isolated from each clone. In this way the desired clone pPC8 was obtained and Figure
4.4.15 below shows the results of the verifying restriction analysis on this plasmid.
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•  Figure 4.4.15: Restriction Analysis O f Plasmid pPC8.
Lane No. Sample
1Kb Ladder
1 2  3  4  5
4
2
5
3
1
pPC8 uncut 
pPC8 cut Hindlll 
nifH:genf PCR product 
1 Kb Ladder
4.4.9: Sub-Cloning Of The nifH :genf Reporter Gene From pPC8 
Onto Plasmid pPC184 To Form The Reporter Plasmid pPC186.
Plasmid pPC8  was digested with Hindlll and the digested DNA was separated on a 
0.7% agarose gel. The 780bp fragment corresponding to the nifH:gentr reporter gene 
was purified from the gel using the gene clean procedure. pPC184 was also digested 
with Hindlll and the linearised plasmid DNA was dephosphorylated with CIP to 
prevent recircularisation of the plasmid. The Hindlll restricted dephosphorylated 
pPC184 DNA was ligated with the purified nifH .genf Hindlll fragment and the 
transformation was plated out on LB chloramphenicol. Transformants were initially 
screened by performing Hindlll digests on plasmid DNA isolated from each clone. 
Having identified several clones with the desired pPC186 plasmid, plasmid DNA from 
each o f the clones was subjected to Sall-Pstl double digestion to determine the 
orientation of the nifH'.genf reporter gene in each case. Two plasmids were to be 
isolated, pPC186-A and pPC186-B, differing only in the orientation of the nifH.genf 
reporter gene. Restriction maps of the two desired plasmids can be seen in Figure 
4.4.16. From the restriction maps it can be seen that a Sall-Pstl digestion of pPC186-A 
would be expected to yield two bands, one of 638bps and one of 4391bps. Sall-Pstl 
digestion of pPC186-B would be expected to also yield two bands, one of 1394bps and 
one of 3635bps. Thus by performing Sall-Pstl double digests the two desired plasmids 
pPC186-A and pPC186-B were obtained. Figure 4.4.17 shows the results of restriction 
analysis on the two plasmids.
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•  Figure 4.4.16: Restriction Maps O f The nifH:eenf Reporter Plasmids
PPC186-A And pPC186-B.
i
Key
■ _ Tetracyclin resistance gene
■ _ Chloramphenicol resistance gene
- nifH Promoter
E « Econ
H = HindUl
P «  Ail
Ei = Eag I
S = Sail
1
Key
U _ Tetracyclin resistance gene
m _ Chloramphenicol resistance gene
= ilifH Promoter
E = £m RI
H = HindHl
P = Ail
Ei = EagI
S = Sail
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Analysis O f The nifH:eenf Reporter PlasmitiFigure 4.4.17: Restriction
PPC186-A And pPC186-B. 
Lane No. Sample
1 1Kb Ladder
2 pPC186-A uncut
3 pPC186-B uncut
4 pPC 186-A cut Hindlll
5 pPCl 8 6 -B cut Hindlll
6  nifH:genf PCR product
4.5: Summary Of Chapter 4.
The end product o f all o f the cloning strategies discussed in this chapter was the 
construction of four reporter plasmids. Two nifH.lacZa plasmids, pPC185-A and 
pPC185-B (see Figure 4.3.13), differing only in the orientation of the nifH.lacZa 
reporter gene were constructed. Two nifH:genf plasmids, pPC186-A and pPC186-B 
(see Figure 4.4.16), again differing only in the orientation of the nifH.genf reporter 
gene, were also constructed. Each of these reporter plasmids would later have a Bait 
construct cloned into them in order to form the final Bait plasmids for the proposed 
P2H system. The construction of the Bait construct and the final Bait plasmids is 
discussed in Chapter 5,
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Chapter 5
Construction O f The Bait Plasmids pPC187 And 
pPC!88 For The Prokaryotic Two-Hybrid System.
5.1: Introduction.
This chapler describes the construction of the Bait plasmids for the P2H system. Two 
Bait plasmids were to be constructed, pPC187 and pPC188. These plasmids would 
maintain the reporter genes for the P2H system and a Bait construct for the 
expression of hybrid proteins containing the C-terminal DNA binding domain (DBD) 
o f S. meliloti 2011 NifA.
A Bait construct was to be cloned into the previously described pPC185 reporter 
plasmid maintaining the nifH:lacZa reporter gene (see chapter 4) in order to form the 
final Bait plasmid pPC187. Similarly the pPC186 reporter plasmid maintaining the 
nifH:genf reporter gene was to have a Bait construct cloned into it to form the second 
Bait plasmid pPC188. The strategy employed for the construction of the Bait 
construct and the results o f the steps involved in the construction of the Bait plasmids 
is discussed below. Schematic representations of the strategies for the construction of 
the pPC187 and pPC188 Bait plasmids can be seen in Figure 5.2.1 and 5.2.2 
respectively.
5.2: Construction Of The Bait Construct And The Final Bait 
Plasmids pPC187 And pPC188 - Overview Of Strategy.
In order to make the Bait construct for the expression of hybrid proteins containing 
the C-terminal DNA binding domain (DBD) of S. meliloti 2011 NifA, the sequence 
for the C-terminal DBD of the NifA protein was amplified from S. meliloti 2011 
genomic DNA as a BamHl-Hindlll fragment using the C-term-F and C-term-R 
primers shown in Figure 5.2.3 below. The C-term-F forward primer was designed for 
an inter-domain region of the NifA protein separating the central and C-terminal 
DBD domains. The DNA sequence for this region possessed a natural BamKl site and 
so the C-term-F primer did not have to be designed to incorporate a BamHl site. The 
C-term-R primer was designed to incorporate a Hindlll site into the NifA DBD PCR 
product. The regions of the S. meliloti 2011 nifA sequence for which these primers 
were designed are shown in Figure 5.2.4.
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Figure 5.2.1: Strategy For The Construction O f The Bait Construct And
Final Bait Plasmid pPC187 With The nifH:lacZa Reporter Gene.
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Figure 5.2.2: Strategy For The Construction Of The Bait Construct And The 
Final Bait Plasmid pPC188 With nifH:genf Reporter System.
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• Figure 5.2.3: Primers Used For The Amplification Of the C-Terminal DBD 
Of NifA From S. meliloti 2011 Genomic DNA.
C-term-F: (GGA TCC) - GCA GGA GTG GCA TCC
BamWY site
C-term-R: (AAG CT H - GAC GGA GAA AAG AGG CGA CGC
HindlU  site
Figure 5.2.4: Primed Regions Of The S. meliloti 2011 nifA Sequence Used 
For The Amplification Of The C-Terminal DBD Of NifA.
C -term -F Prim er 
n atu ra l fisn iH I iite
1621 ttgctcggag cgccagccaatgacgttccg ccgaaagagc cc ggatcc gc aggagtggca 
1681 tccjaatctga tcgagcgcga ccggttgatc agtgcgctgg aggaggccgg ttggaatcag 
1741 gcaaaggcag ctcgcatcct cgaaaaaacg ccccggcagg tcgggtatgc tctacgtcgg
1801 catggtgtgg acgtgagaaagctctaagctgccggtgagataaaggcgt c g eg a | g cgt eg
C -term -R  P rim er
1861 cctcttttct CCgtC
Once amplified the NifA DBD domain sequence was first cloned into the TA vector 
and then sub-cloned as a BamRl-HindUl fragment into the MCS o f plasmid pPC223 
to form a plasmid called pPC224. Cloning the C-terminal domain fragment in this 
fashion essentially formed the Bait construct on plasmid pPC224. As depicted in 
Figure 5.2.5 below the Bait construct consisted of the strongptac  promoter followed 
C terminally by a MCS with unique Xmal and BamHl sites that could be used for 
cloning genes o f interest. C-terminally to the MCS was the sequence for the NifA 
DBD and then the rraBT 1T2 transcriptional termination sequence.
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•  Figure 5.2.5: Schematic O f The Proposed Bait Construct On Plasmid
pPC224
EcoRI BamHl HindHI
site Site site
n
agga  aa ca  g a a t t  cccgg  |  DNAbindingD om a^J
Cloning genes o f interest into the unique restriction sites o f the MCS o f this construct 
would fuse them N-terminally to the NifA DBD. The NifA DBD sequence would 
thus be located in a position mirroring its natural location within the ni/A gene 
sequence. Transcription o f the resulting hybrid genes would be initiated from the 
strong upstream ptac promoter and could be regulated using IPTG. Genes o f interest 
would have to be cloned with their own ATG start codons to facilitate translation 
from the Bait construct RBS. They would also have to be cloned in the correct 
reading frame with the downstream NifA DBD sequence, and without their own stop 
codons to facilitate read-through translation into the NifA DBD sequence. Depending 
on the distance o f the ATG start codon o f the final cloned gene o f interest from the 
Bait construct RBS, genes o f interest might also have to be cloned with their own 
RBS in order to facilitate efficient translation o f the hybrid proteins. It was not felt
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that these stipulations would be a major hindrance to investigators using the final 
P2H system since the DNA sequence o f the protein to be used as a Bait would most 
likely be known. The gene could therefore be amplified from a suitable source by 
PCR to meet the above mentioned requirements for cloning into the Bait construct 
and for efficient expression of hybrid proteins from the Bait construct.
Having made the proposed Bait construct the next step in the construction of the final 
Bait plasmids was to amplify the Bait construct from plasmid pPC224 as an Eagl- 
Sall fragment using the Bait-F and Bait-R primers shown in Figure 5.2.6 below. The 
primed regions of the pPC224 sequence for which these primers were designed are 
shown in Figure 5.2.7 below.
• Figure 5.2.6: Primers Used For The Amplification Of The Bait Construct 
From Plasmid pPC224.
Bait-F: (CGG CCG) - ATC CGG AGC TTA TCG ACT
Eagl site
Bait-R: ACG - (GTC GAC) - GCG GAT ACA TAT TTG AAT GTA
Sail site
Once amplified the Bait construct was first cloned into the TA vector. It was then 
sub-cloned into the tetracycline resistance gene of the pPC185-A and pPC185-B 
nifH:lacZa reporter plasmids described in chapter 4 as an Eagl-Sall fragment to form 
the final Bait plasmids pPC187-A and pPC187-B respectively. Similarly the Bait 
construct was sub-cloned into the pPC186-A and pPC186-B nifH .genf reporter 
plasmids to form the final Bait plasmids pPC188-A and pPC188-B respectively. The 
orientation in which the Bait construct was cloned into each of the reporter plasmids 
placed the m ?BTiT 2 transcriptional terminator sequence between the Bait construct 
and the reporter genes already on the reporter plasmids. This would prevent any read- 
through transcription into the reporter genes from the Bait construct and vise versa.
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Figure 5.2.7: Primed Regions Of Plasmid pPC224 Used For The 
Amplification Of The Bait Construct.
2 6 0
I Bait- F Printer
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45 |  - + n i f A  DBD
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L
KBS Xm al EamHl
gga gtg gca tcc aat ctg ate gag ege - - - - - - - - - - - - - -  —  - -
- -  —  - - - - - - - - - - - - -  gae gtg aga aag ctc taa get geeggtgaga
stop
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4 5 4 4
I
taaaggcgtc gegagegteg c c tc t t t t c t  ccgtc aagctt gc tt t t  tggcggatga - -  -
fliidjn
taaactgcct ggcatcaaat taagcagaag gccatcctga cggatggcct t t t tg c g t t t
„  . „  „  . 4 0 8 1
Bait- R Prune r
ctacaaactc t t t t g t t t a t  t t t t c ta a a t  acattcaaat atgtatccgc tcatgagaca
5.2.1: Amplification Of The NifA C-Terminal DNA Binding Domain 
Sequence From S. meliloti 2011.
The NifA C-terminal DBD sequence was amplified from S. meliloti 2011 genomic 
DNA as a BamHl-Hindlll fragment using the C-term-F and C-term-R primers 
described earlier. The PCR was separated on a 1% agarose gel. A photo o f the gel 
obtained and the conditions used for the PCR can be seen in Figure 5.2.8 below. As 
can be seen from Figure 5.2.8 a single band o f 219bp corresponding to the desired 
NifA DBD sequence was obtained.
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•  Figure 5.2.8: P C R  Amplification O f The NifA DBD sequence From S.
meliloti 2011 Genomic DNA.
Lane No.
1
2
Sample
NifA DBD PCR product 
1Kb Ladder
PCR Conditions
Annealing temperature 
Annealing time 
Extension time
64 °C 
30 sec 
1 min
5.2.2: Cloning Of The NifA DBD PCR Product In The TA Vector To 
Form Plasmid pPC3.
The NifA DBD PCR product was ligated with the TA pCR2.1 vector according to the 
TA protocol. The resulting ligation was used to transform INVaF' cells and the 
transformation was plated out on LB ampicillin Xgal plates. White colonies were 
selected and screened by performing BamUl-Hindlll double digests on plasmid DNA 
isolated from each clone. In this way the desired plasmid, pPC3, was obtained and 
Figure 5.2.9 below shows the results o f the verifying restriction analysis on this 
plasmid.
• Figure 5.2.9: Restriction Analysis Of Plasmid pPC3.
Lane No. Sample. Lmruta MawWr I X  3 *
1 pPC3 uncut r—t■itmm
2 pPC3 cut BamHl-Hindlll --- -
3 NifA DBD PCR product
4 1Kb Ladder
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5.2.3: Sub-cloning Of The NifA DBD PCR Product From pPC3 Into
pPC223 To Form Plasmid pPC224.
Plasmid pPC3 was digested with BamHl-Hindlll and the digested DNA was 
separated on a 1% agarose gel. The 219bp band corresponding to the NifA DBD 
BamHl-Hindlll fragment was purified from the gel using the gene clean procedure. 
Plasmid pPC223 was also digested with BamHl-Hindlll and the restricted DNA was 
run on a 0.7% agarose gel. The 4.5Kb band corresponding to the linearised pPC223 
plasmid was purified from the gel using the gene clean procedure and ligated with the 
purified NifA DBD BamHl-Hindlll fragment. The ligation was used to transfrom 
DH 5a and the transformation was plated on LB ampicillin plates. Colonies obtained 
were screened by performing BamHl-Hindlll double digests on plasmid DNA 
isolated from each of the clones. In this way the desired plasmid, pPC224, was 
obtained. Figure 5.2.10 below shows the results o f the verifying restriction analysis 
on this plasmid.
• Figure 5.2.10: Restriction Analysis Of Plasmid pPC224.
Lane No. Sample.
1 pPC224 uncut
2 pPC224 cut BamHl-Hindlll
3 pPC223 cut BamHl-Hindlll
4 N ifA  D BD PCR product
5 1Kb Ladder
5.2.4: Amplifiction Of The Bait Construct From Plasmid pPC224.
The Bait construct was amplified from plasmid pPC224 as an Eagl-Sall fragment 
using the Bait-F and Bait-R primers described earlier. The PCR was separated on a 
0.7% agarose gel. A photo of the gel obtained and the conditions used for the PCR 
are shown in Figure 5.2.11 below. As can be seen from Figure 5.2.11 below a single 
971bp band corresponding to the desired Bait construct was obtained.
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•  Figure 5.2.11: P C R  Amplification O f The Bait Construct From Plasmid
pPC224.
Lane No.
1
2
Sample
Bait PCR product 
1Kb Ladder
PCR Conditions
Annealing temperature 
Annealing time 
Extension time
48 °C 
30 sec 
2  mins
5.2.5: Cloning Of The Bait Construct PCR Product Into The TA 
Vector To Form Plasmid pPC4-B.
The Bait construct PCR product was ligated with the TA pCR2.1 vector according to 
the TA protocol and the ligation was then used to transform INVaF' cells. The 
transformation was plated out LB ampicillin Xgal plates. White colonies were picked 
and screened by performing Eagl-Sall double digests on plasmid DNA isolated from 
each clone. In this way the desired plasmid pPC4-B was obtained. Figure 5.2.12 
below shows the results of the verifying restriction analysis on this plasmid.
Figure 5.2.12: Restriction Analysis On Plasmid pPC4-B.
Lane No. Sample
1 1Kb Ladder
2 pPC4-B uncut
3 pPC4-B cut Sail
4 pPC4-B cut Eagl-Sall
5 1Kb Ladder
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The final step in the construction of the final Bait plasmids involved the sub-cloning 
o f the Bait construct from pPC4-B onto each of the reporter plasmids.
5.2.6: Sub-cloning Of The Bait Construct From Plasmid pPC4-B 
Into The pPC185 Plasmids To Form The Final nifH :lacZa  pPC187 
Bait Plasmids.
The final step in the construction of the Bait plasmids was to sub-clone the Bait 
construct from pPC4-B as an Eagl-Sall fragment into the tetracycline resistance gene 
of each of the nifH.lacZa  reporter plasmids pPC185-A and pPC185-B to form the 
Bait plasmids pPC187-A and pPC187-B respectively.
Plasmid pPC4-B was digested with Eagl-Sall and the digested DNA separated on a 
0.7% agarose gel. The 971 bp band corresponding to the Bait construct Eagl-Sall 
fragment was purified from the gel using the gene clean procedure. Plasmid pPC185- 
A was also digested with Eagl-Sall and the digested DNA separated on a 0.7% 
agarose gel. The 4454bp band corresponding to the linearised plasmid was purified 
from the gel by the gene clean procedure and ligated with the purified Eagl-Sall Bait 
construct fragment. The ligation was used to transform DH5a and the transformation 
was plated on LB chloramphenicol plates. Colonies were picked and screened 
initially by performing BamHl digests. Only plasmid DNA containing the Bait 
construct with its unique BamHl restriction site would be cleaved and thus by 
screening in this way the desired Bait plasmid pPC187-A was obtained. The above 
procedure was repeated for the pPC185-B reporter plasmid and resulted in the 
isolation of the final Bait plasmid pPC187-B. Detailed restriction maps of these two 
Bait plasmids can be seen in Figure 5.2.13 and the results of the verifying restriction 
analysis on plasmids pPC187-A and pPC187-B can be seen in Figures 5.2.14 and
5.2.15 respectively.
In order to verify the orientation of the nifH:lacZa reporter genes on these plasmids 
relative to the Bait construct Sall-Pstl digests were performed and the results of these 
digests can be seen in Figure 5.2.16 below.
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•  Figure 5.2.13: Restriction Maps O f The nifH:lacZci Bait Plasmids pPC187-A
And PPC187-B.
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•  Figure 5.2.14: Restriction Analysis O f Bait Plasmid pPC187-A.
Lane No. Sample
1 1Kb Ladder
2 pPC185-A uncut
3 pPC187-A uncut
4 pPCl 85-A cut Sail
5 pPC187-A cut Sail
6 pPC185-A cut BamHl
7 pPC187-A cut BamHl
8 pPC185-A cut Xmal
9 pPC187-A cut Xmal
1 0 pPC185-A cut£coRI
11 pPC187-A cut £coRI
1 2 pPC185-A cut Hindlll
13 pPC187-A cut Hindlll
14 1Kb Ladder
Figure 5.2.15: Restriction Analysis Of Bait Plasmid pPC187-B.
Lane No. Sample
1 1Kb Ladder
2 pPC185-B uncut
3 pPC187-B uncut
4 pPC185-B cut Sail
5 pPC187-B cut Sail
6 pPC185-B cut BamHl
7 pPCl 87-B cut BamHl
8 pPC185-B cut Xmal
9 pPC187-B cut Xmal
1 0 pP C l85-B cut £coRI
11 pPC187-B cut EcoKl
1 2 pPC185-B cut Hindlll
13 pPC187-B cut Hindlll
14 1Kb Ladder
1 2 3 4 5 6 7 8 9 10 11 12 13 14
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Figure 5.2.16: Verification O f The Orientation O f The nifH.'lacZa Reporter
Gene On Plasmids pPC187-A And pPC187-B.
Lane No. Sample
1 pPC185-A uncut
2 pPC187-A uncut
3 pPCl 85-A cut Hindlll
4 pPC185-B cut Hindlll
5 pPC187-A cut Hindlll
6 pPC187-B cut Hindlll
7 pPC185-A cut Sall-Pstl
8 pPC185-B cut Sall-Pstl
9 pPC187-A cut Sall-Pstl
1 0 pPC187-B cut Sall-Pstl
11 pPC187-A cut BamHl-Pstl
1 2 pPC187-B cut BamHl-Pstl
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5.2.7: Sub-cloning Of The Bait Construct From Plasmid pPC4-B 
Into The pPC186 Plasmids To Form The Final nifH :eenf pPC188 
Bait Plasmids.
The Bait construct was sub-cloned from plasmid pPC4-B onto each of the nifH .genf 
reporter plasmids pPC186-A and pPC186-B in exactly the same way as that described 
above for the pPC185 nifH:lacZa reporter plasmids. This generated the other desired 
Bait plasmids pPC188-A and pPC188-B. Detailed restriction maps of each of these 
Bait plasmids can be seen in Figure 5.2.17. The results o f verifying restriction 
analysis on plasmids pPC188-A and pPC188-B can be seen in Figures 5.2.18 and 
5.2.19 respectively.
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•  Figure 5.2.17: Restriction M aps Of The uifH :senf Bait Plasmids pPC188-A
And PPC188-B.
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Figure 5.2.18: Restriction Analysis O f Bait Plasmid pPC188-A.
Lane No. Sample
1 1Kb Ladder
2 pPC186-A uncut
3 pPC188-A uncut
4 pPC 186-A cut Sail
5 pPC 188-A cut Sail
6 pPC186-A cut BamHl
7 pPCl 8 8 -A cut BamHl
8 pPC 186-A cut Xmal
9 pPC 188-A cut Xmal
1 0 pPC186-A cut EcoRl
11 pPC188-A cut icoR I
1 2 pPC186-A cut Hindlll
13 pPCl 8 8 -A cut Hindlll
14 1Kb Ladder
1 2 3 4 5 6 7 8 9 10 11 121314
• Figure 5.2.19: Restriction Analysis Of Bait Plasmid nPC188-B.
Lane No. Sample
1 1 Kb Ladder
2 pPC186-B uncut
3 pPC188-B uncut
4 pPC186-B cut Sail
5 pPC188-B cut Sail
6 pPC 186-B cut BamHl
7 pPC188-B out BamHl
8 pPCl 8 6 -B cut Xmal
9 pPC188-B cut Xmal
10 pPCl 8 6 -B cut EcoRl
11 pPC188-B cut EcoRl
1 2 pPCl 8 6 -B cut Hindlll
13 pPC188-B cut Hindlll
14 1Kb Ladder
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5.3: Summary Of Chapter 5.
The end" product o f the cloning strategies described in this chapter was the 
construction of four final Bait Plasmids for the proposed P2H system. The pPC187-A 
and pPCl 87-B Bait plasmids (see Figure 5,2.13) contain the nifH.lacZa  reporter gene 
while the pPC188-A and pPC188-B Bait plasmids (see Figure 5.2.17) contained the 
nifH .genf reporter gene. The usefulness o f each of these plasmids would be assessed 
in E. coli strains developed for the proposed P2H system described in Chapter 6 .
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Development O f Suitable E. coli Strains For The 
Prokaryotic Two-Hybrid System And Optimization
O f The P2H Assay.
Chapter 6
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6.1: Introduction.
In addition to the construction of the plasmid vectors for the NifA based P2H system 
it was also necessary to develop a suitable host strain of E. coli in which the 
plasmids would be used. The reason for this was that NtrC, another well studied 
member of the Enhancer Binding Protein (EBP) family, had been observed to 
activate the same promoters as NifA. Although this activation was very weak it 
would be necessary to eliminate it as it could contribute to false positives in the 
proposed P2H system. For this reason two strains of E. coli in which the gene for the 
NtrC protein (glnG) was deleted were obtained and developed for use with the 
proposed NifA based P2H system plasmids.
Like NifA, NtrC is part of the EBP family of proteins. It is a transcriptional activator 
responsible for regulating the expression o f genes involved in nitrogen assimilation. 
It has three functional domains: an N-terminal domain which is involved in the 
regulation of the protein's activity by NtrB, a central transcriptional activation 
domain and a C-terminal DNA binding domain responsible for binding of the 
protein to UAS's found upstream of promoters regulated by the NtrC. Homologous 
NtrC proteins have been identified in a large number of bacterial strains. In E.coli 
the gene for NtrC, glnG , is part of the complex glnALG operon and expression of 
this operon has been extensively studied. The glnL gene product is NtrB which 
regulates the activity o f NtrC through phosphorylation. NtrC is initially expressed as 
an inactive protein and requires phosphorylation of its N-terminal domain by NtrB 
in order to be activated. The glnA gene of the glnALG operon codes for glutamine 
synthase.
As already mentioned above two glnG mutant E. coli strains were obtained and 
developed for use with the proposed NifA based prokaryotic system. One of these 
strains, YMC11, has the entire gin operon deleted (Agln2000). Because of the glnA 
deletion, growth of this E.coli strain is severely retarded unless media is 
supplemented with 0.2% L-glutamine. This is because glutamine synthase plays a 
key role in amino acid biosynthesis in the cell.
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A common element in all amino acids is the a-amino group. All a-amino groups are 
derived from ammonia by way of the amino groups of L-glutamate. The simplest 
route to glutamate and therefore to all amino group formation is the direct reductive 
amination o f a-ketoglutarate with ammonia, a reaction that is catalysed by glutamate 
dehydrogenase (see Figure 6.1.1). This means of making glutamate is only exhibited 
by bacteria when grown in a medium containing an ammonium salt as the sole 
nitrogen source. The prevelent reaction by which glutamate is formed is the 
amination of a-ketoglutarate by glutamate synthase, a reductive reaction in which 
the source of the amino group is not ammonia itself but an ’’activated” form, the 
amide group of L-glutamine. This reaction generates two molecules o f glutamate, 
one of which must be amidated again to form L-glutamine in order to sustain the 
continued synthesis o f amino groups. Glutamine synthase is responsible for the 
amidation o f glutamate to form L-glutamine (see Figure 6.1.1) and is therefore the 
key enzyme in the conversion of NH4+ to organic nitrogen. Although this mode of 
amino group formation requires a high energy phosphate there is considerable 
advantage since amide group formation can proceed at a much lower concentration 
o f NH4+ than can amination by glutamate dehydrogenase. The K m for NFL)+ of the E. 
coli glutamate dehydrogenase is 1.1 mM, whereas that of E. coli glutamine synthase 
is about 0.2mM. NH4+ is not often present in high concentrations in the soil due to 
microbial oxidation of NH 4"1" and regulatory mechanisms that control both NO3' 
reduction and nitrogen fixation. The formation o f amino groups in plants and 
microorganisms usually therefore occurs in a low NH4 1 environment and is achieved 
by amination o f a-ketoglutarate through the activities of glutamate synthase and 
glutamine synthase.
From the above description of the role of glutamine synthase in L-glutamate 
formation and thus in the biosynthesis of all amino acids, it is clear that deletion of 
the gene for this enzyme, glnA, would seriously retard the growth of a bacterial cell. 
This was evident from the extremely slow growth rate exhibited by the YM Cll 
strain of E. coli on LB agar plates unless media was supplemented with L-glutamine. 
Supplementing media with L-glutamine effectively bypasses the need for the
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reaction catalyzed by glutamine synthase in the formation o f L-glutamate and thus 
overcomes the growth retardation.
• Figure 6.1.1: The Conversion Of Ammonia Into The a-Amino Group Of 
Glutamate And Into The Amide Group Of Glutamine
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In addition to the YMC11 strain described above, another strain of E. coli called 
ET6016 was obtained. This strain had an undefined deletion of the glnL and/or glnG 
gene. Although the deletion was undefined, a deletion of either the glnL or glnG 
genes would ensure that active NtrC was absent. Because the glnA gene was still 
present growth of this strain did not require the addition of L-glutamine to media. 
Both o f the above strains were selected for development as host strains for the NifA 
based P2H system by virtue of their deletions in the glnG gene. Unfortunately, these 
strains also had the entire lac operon deleted (AU169) and therefore did not posses 
the correct lac genetic background for a-complementation of p-galactosidase. This 
genetic background was required for the P2H system's nifHAacZa reporter system 
(described in chapter 4) to work. Most strains designed for a-complementation of |3- 
galactosidase, like DH5 a, initially have the entire lac operon deleted and the correct 
complementing genetic background, /acZAM15, is re-introduced. In the case of 
DH5a this complementing background was re-introduced using the transducing 
phage 4>80 while in the case of JM103 the correct complementing background was 
re-introduced on an F ’-factor by conjugation. Once the complementing genetic 
background is re-introduced into strains the strains are stabilized by the introduction 
o f mutations in the recA gene. The RecA protein plays a role in homologous 
recombination and in the SOS DNA repair system. It is also required for induction 
o f lambdoid prophage, like (¡>80, by ultraviolet light. In cases were the 
complementing background was introduced on an F ’-factor, mutations are often 
introduced in the traD gene o f the F' factor. This mutation significantly reduces the 
frequency of conjugation of the F' factor.
Due to the lack of availability of a suitable transducing phage bearing the required 
lac complementing genetic background it was decided that the required lac genetic 
background would be introduced into the two glnG mutant E.coli strains, YMC11 
and ET6016, on an F' factor by conjugation.
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6.2:Introduetion Of The lacZa Complementing Genetic Background
Into The E. coli Strains YMC11 And ET6016.
The required lacZa complementing genetic background was to be introduced into the 
two selected glnG mutant E. coli strains YMC11 and ET6016 on an F' Factor by 
conjugation with the E. coli strain XLl-Blue. This strain of E. coli possesses an F' 
Factor with the required lacZa complementing genetic background, lacZ&M 15. It 
also possesses the la c f  allele that expresses 10  times as much la d  repressor as the 
wild type allele. This was also desirable since both the Prey and the Bait plasmids 
constructed for the NifA based P2H system expressed hybrid proteins from a ptac 
promoter. The LacI repressor represses expression from this promoter and this 
repression can be relieved through the use of IPTG. The presence of the la c f  allele 
would ensure that LacI levels in the cell would be sufficiently high to repress 
expression from all copies o f the ptac promoter present on the Prey and Bait 
plasmids and would thus allow expression of hybrid proteins to be regulated using 
IPTG. In addition to this the F' Factor did not possess a traD mutation and thus 
efficient conjugal transfer of the F' Factor into the two glnG mutant E. coli strains 
would be expected to occur. The F' Factor also possessed a TnlO transposon bearing 
a tetracycline resistance gene which would provide a useful means of selecting for 
transconjugants when performing conjugations (see Figure 6.2.1).
Rifampicin resistant mutant strains of each of the glnG E. coli mutant strains, 
YMC11 and ET6016, were generated in order to facilitate selection of 
transconjugants in conjugations performed with XLl-Blue (see Figure 6.2.1). These 
rifampicin resistant mutants were generated by plating 2 0 0 f.il o f overnight cultures of 
each of the strains on LB agar to which rifampicin had been added (LBrif) to a 
concentration of 100|_ig/ml. Plates were incubated at 37 °C for 24 hours. 
Approximately 15 to 20 colonies were obtained on each plate. Colonies were picked 
from each plate and purified by streaking on fresh LBrif agar. The rifampicin 
resistant YM C11 and ET6016 strains obtained were called YM C11 r if  and ET6016n/ 
respectively. These rifampicin resistant mutants were used in conjugations with X L l- 
Blue.
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Figure 6.2.1: Schematic Representation Of YMCl \r if  or ET6016/7/’Conjugation 
With XLl-Blue.
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6.2.1: Conjugation Of YM Cllrz/W ith XLl-Blue.
Figure 6.1.1 shows a schematic representation of the manner in which the 
conjugation between YM C11 r if  and XLl-Blue was performed. Culture of YMC11 rif 
and XLl-Blue were grown to an ODeoonm of approximately 0.4 corresponding to mid 
log phase. Three tubes, A, B and C were then set up. Tube A contained 2mls of the 
YM C11 r i f  culture, 2mls of the XLl-Blue culture and 3.2mls of fresh LB media. This 
was the conjugation mixture. Tube B contained 2mls of the YMC11 r if  culture and 
1.6mls of fresh LB media while Tube C contained 2mls of the XLl-Blue culture and 
1.6mls o f fresh LB media. Tubes B and C were to serve as control tubes. The tubes 
were incubated at 37 °C for 2 hours without shaking to allow mating to occur and 
were then vortexed to interupt mating. Cells were harvested by centrifugation at 
3000rpm for 5 mins, washed twice with 5mls of 0.85% sterile saline solution and 
each o f the final pellets was then resuspended in 2mls of 0.85% sterile saline 
solution.
Serial dilutions of the Tube A conjugation were prepared to a dilution factor o f 10'6. 
A 2 0 0 (0,1 sample from each dilution was plated in duplicate onto LB agar to which 
rifampicin and tetracycline had been added (LBrif/tet). Only YM C11 r if  cells that had 
received an F' Factor with its tetracycline resistance gene from XLl-Blue, 
YM Cllrz/F' transconjugants, could grow on this media. The number of 
transconjugants on each of the plates was counted and these counts were used to 
calculate the total number of transconjugants in the original mating mixture. The 
counts obtained and the calculated transconjugant total count can be seen in Table 
6 .2.1 below.
A 200(.d sample from each dilution was also plated out in duplicate on LBrif media. 
Only recipient YMC11 r i f  cells and YMC1 IrifF' transconjugants could grow on this 
media. The number o f colonies on each of the plates was counted and these counts 
were used to calculate a recipient count for the mating mixture. The counts obtained 
and the calculated total recipient count can be seen in Table 6.2.2 below.
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Table 6.2.1:YMC11»'/F' Trausconiugant Counts Obtained On LBrif/tet Media.
Dilution Factor Colony Counts Average Count
200|jl Neat TNTC TNTC TNTC
200fil 10 1 TNTC TNTC TNTC
200^110 401 370 386
200fil 10 35 43 39
200^110 4 1 2 2
200jil 10 3 - - -
200^110 6 - - -
Total Number O fY M C lln /F '
Transeonjugants In 200|j.l Neat Sample =  3.88 x 104
Total Number O f Transeonjugants
In Total 2mls O f The Mating Mixture =  (3.88 x 104) x 10
= 3.88 x 105 ~  3.88 x 10s
Table 6.2.2: YMC11 r if  Recipient Counts Obtained On LBrif Media.
Dilution Factor Colony Counts Average Count
200|il Neat TNTC TNTC TNTC
200|il 10 1 TNTC TNTC TNTC
200^110 2 TNTC TNTC TNTC
200fil 10 3 TNTC TNTC TNTC
200(0.110 4 TNTC TNTC TNTC
200^110 5 492 522 507
200^110 b 47 59 53
Total Number O f YM C 11 r i f
Recipients In 200(^1 Neat Sample =  5.18 X  107
Total Number O f Recipients In
Total 2mls O f The Mating Mixture =  (5.18 X  107) X  10 -  5.18 X  108
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Using the calculated recipient count and transconjugant count the transfer efficiency 
(Tf) was calculated as:
T f =  number o f transconjugants
number of recipients
Tf = 3.88 x 105
5.18 x 108
T f =  7.5 x 10 4
Serial dilutions of the Tube C mixture containing only X L 1-Blue were prepared to a 
dilution factor of 10'3. A 200p,l neat sample of the X L 1-Blue cells and a 200(j.l 
sample of each of the prepared dilutions of the XL 1-Blue cells was plated on LBrif 
media and LBrif/tet media. These plates were to serve as negative controls. As 
expected, a small number of colonies, 6  on the LBrif and 8  on the LBrif/tet media, 
were obtained when the neat sample of XLl-Blue cells from the Tube C mixture was 
plated. These colonies were XLl-Blue rifampicin resistant mutants generated in the 
same way the YMC11 r if  strain had been generated earlier. No colonies were
obtained when the other dilutions were plated on the LBrif or LBrif/tet media. It
-2could therefore be deduced that all of the colonies obtained when 2 0 0 |ui o f the 1 0 ‘", 
10'3 and 10’4 dilutions of the Tube A conjugation mixture were plated on the 
LBrif/tet media were transconjugant YMC1 lri/F' cells and not spontaneously 
generated XLl-Blue rifampicin resistant mutants. A 200pl sample of the Tube B 
mixture containing only YMC11 r i f  cells was also plated on LBrif/tet media as a 
negative control and no growth was obtained.
One o f the YMCllrZ/F1 transconjugant colonies obtained when the 10'4 dilution of 
the Tube A conjugation mixture was plated on LBrif/tet media was picked off and 
purified by streaking on fresh LBrif/tet media. In order to verify that the desired
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lacZa  complementing genetic background had been introduced, competent 
YMC1 \ riJV' cells were prepared and transformed with pUC19. The transformation 
was plated out on LBrif/tet Xgal media. Blue colonies were obtained thus verifying 
that the correct lacZa  complementing genetic background had been successfully 
introduced.
6.2.2: Conjugation Of ET6016W/~With XLl-Blue.
The conjugation between ET6016rif and XLl-Blue was carried out in exactly the 
same way as that described for the conjugation between YM C1 Ir if and XLl-Blue. 
Cultures of ET6016rif and XLl-Blue were grown to an ODóoonm of approximately 
0.4 corresponding to mid log phase. Three tubes, A, B and C were then set up. Tube 
A contained 2mls of the ET6016r// culture, 2mls of the XLl-Blue culture and 3.2mls 
of fresh LB media. This was the conjugation mixture, l ube B contained 2mls of the 
ET6016r i f  culture and 1.6mls of fresh LB media while Tube C contained 2mls of the 
XLl-Blue culture and 1.6mls of fresh LB media. As before Tubes B and C were 
control tubes. The tubes were incubated at 37 °C for 2 hours without shaking to allow 
mating to occur and then vortexed to interupt mating. Cells were harvested by 
centrifugation at 3000rpm for 5 mins, washed twice with 5mls of 0.85% sterile saline 
solution and each of the final pellets was then resuspended in 2mls of 0.85% sterile 
saline solution.
Serial dilutions of the Tube A conjugation were prepared to a dilution factor of 10~6. 
A 200p.l sample from each dilution was plated in duplicate onto LBrif/tet media. 
Only ET6016r if  cells that had received an F' Factor with its tetracycline resistance 
gene from XLl-Blue, ET6016rzyF' transconjugants, could grow on this media. The 
number o f transconjugants on each o f the plates was counted and these counts were 
used to calculate the total number of transconjugants in the original mating mixture. 
The counts obtained and the calculated transconjugant total count can be seen in 
Table 6.2.3 below.
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Table 6.2.3: ET6016r;‘/F' Transconiugant Counts Obtained On LBrif/tet Media.
Dilution Factor Colony Counts Average Count
200^1 Neat TNTC TNTC TNTC
200^110 1 TNTC TNTC TNTC
200^110 '2 TNTC TNTC TNTC
200[il 10 J TNTC TNTC TNTC
200^110 4 352 381 367
200fil 10 3 36 32 34
200^110 -6 3 2 3
Total Number O f 6016n/F'
Transconjugants In 2 0 0 (4.1 Neat Sample =  3.36 x 106
Total Number O f Transconjugants
In Total 2mls O f The Mating Mixture =  (3.36 x 106) x 10
= 3.36 x 107
Table 6.2.4: ET601 ónTRecipient Counts Obtained On LBrif Media.
Dilution Factor Colony Counts Average Count
200|il Neat TNTC TNTC TNTC
200^110 1 TNTC TNTC TNTC
200(il 10 'z TNTC TNTC TNTC
200^110 3 TNTC TNTC TNTC
200(il 10 4 TNTC TNTC TNTC
200|xl 10 3 TNTC TNTC TNTC
200[il 10 6 446 471 459
Total Number O f ET6016n/
Recipients In 200p.l Neat Sample =  4.59 x 108
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Total Number Of Recipients In
Total 2mls O f The Mating Mixture =  (4.59 x 108) x 10
= 4.59 x 109
A 2 0 0 (4,1 sample from each dilution was also plated out in duplicate on LBrif media. 
Only recipient ET6016W/" cells and ET6016n/F' transconjugants could grow on this 
media. The number o f colonies on each of the plates was counted and these counts 
were used to calculate a recipient count for the Tube A mating mixture. The counts 
obtained and the calculated total recipient count can be seen in Table 6.2.4 below. 
Using the calculated total recipient count and transconjugant count the transfer 
efficiency (Tf) was calculated as:
T f =  number of transconjugants 
number o f recipients
T f =  3.36 x 107 
4.59 x 109
T f =  7.3 x 103
Serial dilutions of the Tube C mixture containing only XL 1-Blue were prepared to a 
dilution factor o f 10’3. A 200p,l neat sample of the XL 1-Blue cells and a 200(il 
sample o f each o f the prepared dilutions of the XLl-Blue cells was plated on LBrif 
media and LBrif/tet media. As for the YM Cllrz/conjugation, these plates were to 
serve as negative controls. Again a small number o f XLl-Blue rifampicin resistant 
mutant colonies, 6  on the LBrif and 7 on the LBrif/tet media, were obtained when the 
neat sample of XLl-Blue cells from the Tube C mixture was plated. No colonies 
were obtained when the other dilutions were plated on the LBrif or LBrif/tet media.
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It could therefore be deduced that all o f the colonies obtained when 200|a,l o f the 10'5 
and 10'6 dilutions of the Tube A conjugation mixture were plated on the LBrif/tet 
media were transconjugant ET6016/7yF' cells and not spontaneously generated XL1- 
Blue rifampicin resistant mutants. A 200|il sample of the Tube B mixture containing 
only ET6016rz/cells was also plated on LBrif/tet media as a negative control and no 
growth was obtained.
One of the ET6016r//F' transconjugant colonies obtained when the 10"5 dilution of 
the Tube A conjugation mixture was plated on LBrif/tet media was picked off and 
purified by streaking on fresh LBrif/tet media. As before the presence of the desired 
lacZa  complementing genetic background was confirmed by preparing competent 
ET6016 /7 /F' cells and transforming them with pUC19. The transformation was plated 
out on LBrif/tet Xgal media. Blue colonies were obtained thus verifying that the 
correct lacZa  complementing genetic background had been successfully introduced.
6.3: Optimization Of The P2H System.
Having constructed two E. coli host strains, ET6016r//F' and YM C11 rift', in which 
the constructed plasmids for the NifA based P2H system could be used, the next step 
was to assess the usefulness o f all of the constructed plasmids in each of the host 
strains and to optimize the growth conditions under which the P2H assay would be 
carried out in each of the two strains.
As previously mentioned the NC domain of the NifA protein was known to be 
capable of activating transcription from the niftl promoter despite lacking the ex­
terminai DBD of the protein. The level of expression from the niJH promoter induced 
by the NifA NC domain was known to be lower than that observed for the whole 
NifA protein. It was hoped that by using the Control plasmid pPC228 (expressing the 
whole NifA protein) as a positive control and the Prey plasmid pPC229-A 
(expressing the NC domain of NifA) as negative control with each of the nifH.lacZa 
Bait plasmids, pPC187-A and pPC187-B, that the growth conditions could be
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manipulated to optimize the contrast between the colony colour intensities given by 
the positive pPC228 and pPC229-A negative controls on Xgal plates. Growth 
conditions were to be optimized in the same way for the alternative Control and Prey 
Plasmids, pPC230 (expressing the whole NifA protein from manipulated ptac 
promoter) and pPC231-A (expressing the NifA NC domain), with each of the Bait 
plasmids pPC187-A and pPC187-B and their usefulness compared with that of the 
pPC228/pPC229-A combination of Control/Prey plasmids. In this way the most 
useful Control/Prey plasmid combination and the most useful Bait plasmid would be 
determined along with the growth conditions under which they gave the best results. 
Several factors had to be taken into consideration when optimizing growth 
conditions. First o f all, it was known that the NifA protein is oxygen sensitive. 
Oxygen was known to inhibit the ability of the NifA protein to bind to its cognate 
DNA sequence and also its ability to activate transcription. However, it was known 
that even in the presence of oxygen some NifA induced expression from the nifH 
promoter could still occur. It was hoped that the oxygen sensitivity o f the NifA 
protein could be used to advantage by helping to reduce the low level o f nifH.iacZa 
expression induced by the NifA NC domain (expressed from the Prey plasmids 
pPC229-A and pPC231-A) to an undetectable level while still permitting the 
detection of more strongly induced nifH:lacZa expression by the whole NifA protein 
(expressed from the Control plasmids pPC228 and pPC230) or by positive protein- 
protein interactions in the context of an actual P2H assay. In this way clear positive 
and negative results could be distinguished.
Another factor that had to be considered was the fact that the NifA protein is 
temperature sensitive, working optimally at a temperature of 28 °C. Also the optimal 
IPTG level to be used for inducing the expression of the whole NifA protein from the 
Control plasmids and the NifA NC domain from the Prey plasmids would have to be 
determined. It was expected that lower levels of induction would produce the best 
contrast between positive pPC228/pPC230 controls and their corresponding pPC229- 
A/pPC231-A negative controls. The theory behind this was that the NifA NC domain 
activated transcription from the nifH  promoter from solution as it did not possess a 
C-terminal DBD. The level to which NifA NC domain induced expression from the
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nifH promoter was therefore expected to be dependent on its concentration in the cell 
and thus the lower its concentration in the cell the lower the level o f induced 
expression from the nifH  promoter. On the other hand, the level o f expression 
induced from the nifH  promoter by the whole NifA protein was not expected to be as 
dependent on its concentration in the cell due to its ability to bind at the nifH 
promoter. This binding activity would be expected to increase the local concentration 
of the whole NifA protein in the vicinity of the nifH  promoter.
The results o f the optimization process for both strains are given below and a 
discussion of the results can be found in Chapter 8 .
6.3.1: Optimization Of The P2H System In The E. coli Host Strain 
ET6016/77F'.
Initial attempts to optimize the P2H system in the E. coli host strain ET60!6n/F' 
focused on determining which combination of Control and Prey plasmids 
(pPC228/pPC229-A or pPC230/pPC231-A) gave the best positive control (whole 
NifA protein) to negative control (NifA NC domain protein) contrast with each of the 
two nifH.iacZa Bait plasmids (pPCl 87-A and pPC187-B) on Xgal plates. In order to 
do this the constructed Control, Prey and nifHAacZa Bait plasmids were transformed 
into ET6016n/F' in the combinations shown in Figure 6.3.1 and plated on 
appropriate selective media (see Figure 6.3.1) .
Each combination of plasmids was plated on three different levels of IPTG; 0.5mM, 
l.OmM and 1.5mM. The purpose of this was to determine which level o f IPTG 
would give the best results for each combination of plasmids. The resulting set of 
plates was incubated at 30 °C for 72 hours. Some colour development of colonies 
was visible after 48 hours but a further 24 hours incubation was required for strong 
color development. A duplicate set o f plates was prepared and incubated first at 
37 °C for 24 hours and then switched to 30 °C for another 24 hours after which
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strong colour development o f colonies was obtained. The reason for the 37 °C 
incubation is discussed in Chapter 8 .
Figure 6.3.1: Combinations Of Control. Prey And Bait Plasmids
Transformed Into ET6016n/F'
Plasmid Combinations
pPC185-A pC185-B
pPCl 87-A pPC187-B
pPC187-A / PPC228 
pPC187-A / pPC229-A 
PPC187-A / pPC230 
pPC187-A/pPC231-A
pPC187-B / PPC228 
pPC187-B / pPC229-A 
pPC187-B / pPC230 
pPC187-B / pPC231-A
Plated On
LB tetracycline / chloramphenicol 
Xgal (50/tg/itil)
IPTG
LB tetracycline / chloramphenicol 
ampie illin 
X g a l (5 0 p g /m l)
IPTG
The colour intensity o f colonies on all o f the plates was compared and the colony 
colour intensity on each plate was graded on a visual basis. In the final P2H system 
positive protein-protein interactions would be identified by visual inspection of 
plates and so it was decided that the system should be initially optimized on a visual 
basis. The results obtained are given in Table 6.3.1 and Table 6.3.2 below
Table 6.3.1:Results For ET6016riTF' Plates Incubated At 30 °C For 72 hours.
Plasmids 0.5 m M 1.0 m M 1.5 m M
pPC 185A + + -
pPC 187A + + -
p P C l 8 7A-pPC228 ++++ ++++ ++++
p P C l 8 7A  -pPC22 9 +++ +++ ++
p P C l 8 7A  -pPC23 0 ++++ ++++ ++++
p P C l 8 7A  -pPC231 ++++ ++++ +++
p P C 1 8 5B +++ +++ ++
p P C l 87B +++ +++ ++
p P C l 8 7B-pPC228 ++++ ++++ ++++
p P C l 87B-pPC229 ++++ ++++ ++++
p P C l 8 7B-pPC23 0 ++++ ++++ ++++
p P C l 8 7B-pPC231 ++++ ++++ ++++
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Tabic 6.3.2: Results For ET6016ri'/F' Plates Incubated At 37 °C For 24
hours And Then 30 °C For 24 hours.
Plasmids 0.5 m M 1.0 m M 1.5 m M
pPC 185A + + -
pPC 187A + + -
p P C l 8 7A-pPC228 ++++ ++++ ++++
p P C l 8 7A  -pPC22 9 +++ +++ ++
p P C l 8 7A-pPC23 0 ++++ +++ ++++
p P C l 8 7A  -pPC231 ++++ +++ +++
p P C 1 8 5B +++ +++ ++
p P C l 87B +++ +++ ++
p P C l 8 7B-pPC22 8 ++++ ++++ ++++
p P C l 8 7B-pPC22 9 ++++ ++++ ++++
p P C l 8 7B-pPC23 0 ++++ ++++ ++++
p P C l 8 7B-pPC231 ++++ ++++ ++++
The results obtained for the plates incubated at 37 °C for 24 hours followed by a 
30 °C incubation for another 24 hours mirrored those obtained for the plates 
incubated at 30 °C for 72 hours.
As can be seen from Table 6.3.1 and Table 6.3.2 the Bait plasmid pPC187-B was of 
very little use with any o f the constructed Control or Prey plasmids under any of the 
IPTG concentrations or incubation conditions used. This Bait plasmid exhibited high 
levels o f lacZa expression from its ni/H.lacZa reporter gene in the absence o f any 
expressed NifA or NifA NC domain proteins. Because o f the high level of 
background expression from the pPC187-B Bait plasmid the colour intensity o f the 
pPC228 positive control (expressing the whole NifA protein) could not be clearly 
distinguished from its corresponding pPC229-A negative control (expressing the 
NifA NC domain). Similarly the pPC230 positive control could not be clearly 
distinguished from its corresponding pPC231-A negative control. The pPC187-B 
Bait plasmid was thus eliminated from further optimization experiments.
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The pPC187-A Bait plasmid, which has the nifH.lacZa reporter in the opposite 
orientation, also exhibited some background expression from its nifH.lacZa reporter 
gene in the absence of any expressed whole NifA or NifA NC domain protein but the 
level o f this background lacZa expression was much lower than that observed for the 
pPC187-B Bait plasmid. Because the level of background expression from the 
pPC187-A plasmid was low the colony colour intensity given by each of the positive 
controls (pPC228 and pPC230) could be more clearly distinguished from that given 
by their corresponding negative controls (pPC229-A and pPC231-A respectively). 
The possible reasons for the background expression from the two pPC187 
nifH.lacZa  Bait plasmids and the reason for the difference in the level o f background 
expression exhibited by each o f the plasmids are discussed in chapter 8.
Another interesting and unexpected trend was also observed for both of the pPC187 
Bait plasmids although it was more obvious for the pPC187-A plasmid because of 
the lower levels o f background nifH. lacZa  expression it exhibited. It was observed 
that increasing the IPTG concentration decreased the level of background expression 
from the nifH:lacZa reporter gene from these plasmids and the possible reasons for 
this are also discussed in chapter 8.
Of the two Control plasmid/Prey plasmid combinations, pPC228/pPC229-A and 
pPC230/pPC231-A, the pPC228/pPC229-A combination with the pPC187-A Bait 
plasmid was found to give the best positive control to negative control contrast. 
Strong activation of the nifH.lacZa reporter on the pPC187-A plasmid by the whole 
NifA protein expressed from the pPC228 Control plasmid was observed for all levels 
o f IPTG and incubation temperatures. Activation of the nifH:lacZa reporter by the 
NifA NC domain expressed from pPC229-A Prey plasmid was also evident but was 
lower than that observed for the pPC228 plasmid. The strength of nifH.lacZa 
activation induced by the NifA NC domain protein seemed to decrease as the level of 
IPTG increased and the contrast between the positive pPC228 and negative pPC229- 
A controls was thus enhanced by increasing the IPTG level in the media. It was 
thought that the level of activation caused by the NifA NC domain expressed from 
the pPC229-A plasmid was actually very low. The improved contrast between the 
positive pPC228 and negative pPC229-A controls caused by increasing the IPTG
193
concentration was attributed to the decreased background nifH.lacZa expression 
from the pPC187-A Bait plasmid caused by increasing the IPTG concentration rather 
than to an actual decrease in the level o f activation of the nifH.lacZa reporter by the 
NifA NC domain.
Strong activation of the nifH.lacZa reporter gene on pPC187-A by NifA expressed 
from the pPC230 Control plasmid was also observed and was comparable to that 
observed for the pPC228 Control plasmid. However, the level of nifH.lacZa 
expression induced by the NifA NC domain protein expressed from the pPC231-A 
Prey plasmid was stronger than that observed when it was expressed from the 
pPC229-A Prey plasmid. As a result o f this the contrast between the pPC230 positive 
control and the pPC231-A negative control was not as distinct as that observed for 
the pPC228/pPC229-A combination of plasmids. Increasing the IPTG concentration 
did enhance the contrast between the pPC230 positive control and the pPC231-A 
negative control but the contrast obtained for the pPC228/pPC229-A combination of 
plasmids was still more distinct. The pPC230/pPC231-A combination of 
Control/Prey plasmids was therefore eliminated from further optimization 
experiments.
Overall the best results were obtained when the pPC228 Control plasmid and the 
pPC229-A Prey plasmid were used with the pPC187-A Bait plasmid and when a high 
concentration of IPTG (1.5mM) was used to induce expression of the NifA and NifA 
NC domains. Results obtained when a 30 °C incubation for 72 hours was used were 
slightly better than those obtained when plates were first incubated at 37 °C for 24 
hours followed by incubation at 30 °C for another 24 hours. The pPC228, pPC229-A 
and pPC187-A plasmids were selected for a second round of optimization 
experiments to try and further enhance the contrast between the positive pPC228 and 
negative pPC229-A controls.
In the second round of optimization experiments the level o f IPTG used to induce 
expression of the NifA and NifA NC domain proteins from the pPC228 and pPC229- 
A plasmids was extended to 2mM to see if this would further enhance the contrast 
between the positive pPC228 and negative pPC229-A controls. Plasmids where
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transformed into ET6016n/F’ in the combinations shown in Figure 6.3.2 and plated 
on appropriate selective media.
Each combination of plasmids was plated on 4 different levels o f IPTG; 0.5mM, 
l.OmM, 1.5mM and 2mM. The resulting set of plates was incubated at 30 °C for 72 
hours. These plates were designated the (A) set o f plates.
• Figure 6.3.2: Combinations Of Control. Prey And Bait Plasmids 
Transformed Into ET6016r//F'.
Plasmid Combinations Plated On
LB  tetracycline ! chloramphenicol 
Xgal (50^g/m l)
IPTG
LB  tetracycline / chlnramphenicol/ampicillin 
X gal(50pg/m l)
IPTG
A duplicate set of plates was also prepared, sealed with parafilm and incubated at 
30 °C for 72 hours. This set of plates was designated the (B) set o f plates. The 
purpose o f wrapping these plates in parafilm was to try and provide micro-aerobic 
conditions under which NifA worked optimally. Initially bacteria growing on the 
plates would have sufficient oxygen to grow and thus would grow more quickly to 
form visible colonies than if they were placed in an anaerobic jar. As the bacteria 
grew the oxygen within the plates would gradually be depleted and micro-aerobic 
conditions would ensue. It was hoped that under these conditions the expressed NifA 
protein from the pPC228 Control plasmid would activate the nifH.lacZa reporter 
gene more efficiently and generate more rapid and more intense colour development. 
It was also hoped that this would enhance the contrast between the colour intensity of 
the positive pPC228 control and the negative pPC229-A.
The colour intensity o f colonies on both the (A) and (B) sets of plates was compared 
and plates were graded on a visual basis as before. The results obtained are given in
pPC185-A ^
pPC187-A 
pPC187-A / PPC228 
pPC187-A / pPC229-A
\
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Table 6.3.3 below. The experiment was repeated again with the exception that plates 
were incubated first at 37 °C for 24 hours and then at 30 °C for another 24 hours. The 
colour intensity o f colonies on all o f these plates was compared and plates were 
graded on a visual basis. The results obtained are given in Table 6.3.4 below.
Table 6.3.3: Results For Second Round Of Optimization Experiments In 
ET6016r//F' - Plates Incubated At 30 °C For 72 hours.
Plasmids 1.5m M IPTG 2.0niM IPTG
HBOLLI— A B A B
pPC228-pPC187A +++ ++++ +++ ++++ +++ ++++ +++ ++++
| pPC229A-pPC187A ++ ++++ ++ ++++ + ++++ + ++++
1 pPC185A ++ +++ ++ +++ + ++ - ++
pPC187A ++ +++ ++ +++ + ++ - ++
A =  unwrapped plates B = plates wrapped in parafilm
Table 6.3.4: Results For Second Round Of Optimization Experiments In 
ET6016r//F' - Plates Incubated At 37 °C For 24 hours And 30 °C For 24 hours.
Plasmids 0.5niM IPTG 1.0mIVI IPTG l.SmM IPTG 2.0niM IPTG
A B A B A B A B
pPC228-pPC187A +++ ++++ +++ ++++ +++ ++++ +++ ++++
pPC229A-pPC187A ++ +++ ++ +++ + ++ + +
pPC185A ++ ++ + ++ + + - +
pPC187A ++ ++ + ++ + + - +
A =  unwrapped plates B =  plates wrapped in parafi ini
The results obtained for plates that were not wrapped in parafilm (the A set of plates) 
mirrored those obtained in the initial optimization experiments. Increasing IPTG 
concentration caused a reduction in the amount o f background expression from the 
nifH:lacZa reporter gene on the pPC187-A Bait plasmid. At the highest 
concentration o f IPTG (2mM) background expression from the nifli'.lacZa reporter 
gene was not detected on Xgal plates (see Figure 6.3.3). The greatest positive 
pPC228 control to negative pPC229-A control contrast was also obtained when 2mM
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IPTG was used (see Figure 6.3.4). Activation o f the nifH'.lacZa. reporter by the 
pPC229-A expressed NifA NC domain protein was barely detectable on Xgal plates 
when 2mM IPTG was used to induce its expression (see Figure 6.3.5). As in the 
initial optimization experiments the results obtained for plates incubated at 30 °C for 
72 hours mirrored those obtained for the set o f plates that were incubated first at 
37 °C for 24 hours and then switched to 30 °C for another 24 hours. However the 
results obtained for the plates that were incubated at 30 °C for 72 hours were slightly 
better.
Figure 6.3.3: Plates Showing IPTG Effect On Background Expression 
From pPC185-A.
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D = pPC185-A/ 2.0mM IPTG
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Figure 6.3.5: Plates Showing IPTG Effect On pPC229-A Induced 
Reporter Expression
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D = pPC229-A / 2.0mM IPTG
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Miller assays were performed in order to quantify the levels o f nifH:lacZ<x 
expression observed for each o f the combinations o f plasmids on Xgal plates 
containing different concentrations o f IPTG. ET6016n/F’ transformants containing 
each combination o f plasmids were inoculated into 30ml universals containing 20mls 
o f selective LB broth to which IPTG had been added to a final concentration of 
0.5mM, l.OmM, 1.5mM and 2.0mM IPTG. The lids o f the tubes were closed tightly 
and the tubes were incubated at 30 °C with low shaking for 48 hours. The tubes were 
then assayed in duplicate for p-galactosidase activity. The results obtained are shown 
in Table 6.3.5 below and mirror the results that were obtained on Xgal plates. Similar 
levels o f p-galactosidase activity were obtained when assays were performed after 48 
hours incubation
Table 6.3.5: P-Galctosidase Activity For Each Combination Of Plasmids
In ET6016r//F’ Under Different Concentrations Of IPTG.
Plasmids ß-Galactosidase Activity (Miller Units)
0.5mM IPTG l.OmM IPTG I.SmM IPTG 2.0mM IPTG
I pPC185A 4.99 4.87 4.75 4.50
pPC187A 4.20 4.38 4.90 4.05
pPC228-pPC187A 6.99 7.27 11.29 12.62
pPC229A-pPC 187 A 5.81 5.73 5.60 5.52
Wrapping plates in parafilm had the unexpected effect o f increasing background 
expression from the nifH:lacZa reporter on the pPC187-A Bait plasmid, especially 
for the plates that were incubated at 30 °C for 72 hours (see Table 6.3.3 and Table 
6.3.4). This made it difficult to distinguish the color intensity of colonies obtained for 
the pPC228 positive control from those obtained for the pPC229-A negative control. 
Although increasing the IPTG concentration had the effect o f decreasing this 
background expression from the niJH:lacZa reporter and enhancing the contrast 
between the positive pPC228 and negative pPC229-A controls, the best results were 
still obtained for the unwrapped set o f plates. Again the results obtained for the
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wrapped set o f plates incubated at 30 °C for 72 hours were slightly better than those 
obtained for those that were incubated first at 37 °C for 24 hours and then switched 
to 30 °C for another 24 hours.
From all o f the above optimization experiments it was determined that the best 
combination of Control/Prey plasmids was the pPC228/pPC229-A combination and 
that these gave the best results when used with the pPC187-A Bait plasmid. The 
optimal growth conditions for these plasmids in the E. coli strain ET6016rzyF’ was 
incubation on media containing 2mM IPTG at 30 °C for 72 hours without wrapping 
the plates in parafilm (see plate D in Figure 6.3.3).
6.3.2: Optimization Of The P2H System In The E. coli Host Strain 
YMCllrfYF'.
Having determined that the pPC228/pPC229-A combination of Control/Prey 
plasmids gave the best results with the pPC187-A Bait plasmid in the ET6016rzyF’ 
strain of E. coli it was decided to test these plasmids in the YMCllrzyF’ strain of E. 
coli to see if the contrast between the positive pPC228 control the negative pPC229 
control would be enhanced. This strain has a gross deletion of the glnALG operon an 
grows very slowly in the absence of glutamine.
Plasmids where transformed into YMCllrzyF’ in the same combinations as those 
shown in Figure 6.3.2 and plated on appropriate selective media (see Figure 6.3.2). 
Each combination of plasmids was plated on 4 different levels o f IPTG; 0.5mM, 
l.OmM, 1.5mM and 2mM. These plates were designated the (A) set of plates and 
where incubated at 30 °C. A duplicate set of plates was prepared, sealed with 
parafilm and also incubated at 30 °C. This set o f plates was designated the (B) set of 
plates. Colour development of colonies was very slow and, contrary to what was 
observed in the ET6016nyF’ strain of E. coli, only developed on the plates that were 
wrapped in parafilm (the B set of plates). Although some colour development was 
evident on these plates after 72 hours they required another 24 hours incubation for 
distinct colour development to occur. The colour intensity of colonies on these plates
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was graded on a visual basis as before and the results obtained are given in Table 
6.3.6 below. The experiment was repeated again with the exception that plates were 
initially incubated first at 37 °C for 24 hours. These plates then required incubated at 
30 °C for another 48 hours before strong color development was obtained and again 
color development was only obtained for the plates wrapped in parafilm (the B set of 
plates). The color intensity of colonies on these plates was graded on a visual basis 
and the results obtained are given in Table 6.3.7 below.
Table 6.3.6: Results Optimization Experiments In YMCllrfyF* - Plates 
Incubated At 30 °C For 96 hours.
Plasmids 0.5 mM IPTG l.OmM IPTG 1.5mM IPTG 2.0mM IPTG
A B A B A B A B
pPC228-pPC187A - +++ - +++ - +++ - +++
pPC229A-pPC187A - ++ - ++ - + - +
pPC185A - ++ - ++ - + - -
pPC187A - ++ - ++ - + - -
A  =  unwrapped p lates B  =  p lates w rapped in parafilm
Table 6.3.7: Results For Optimization Experiments In YM Clln'/F1 - 
Plates Incubated At 37 °C For 24 hours And 30 °C For 48 hours.
Plasmids 0.5mM IPTG l.OmM IPTG 1.5mM IPTG 2.0mM IPTG
A B A B A B A !i
pPC228-pPC187A - +++ - +++ - +++ - +++
pPC229A-pPC187A - ++ - ++ - + - +
pPC185A - ++ - ++ - + - +
pPC187A - ++ - ++ - + - +
A  =  unw rapped plates B  =  plates w rapped in parafilm
While no colour development was observed for unwrapped plates the results 
obtained for the wrapped plates mirrored those obtained for the ET6016nyF’ 
unwrapped plates. The reason for no color development on the unwrapped 
YMC1 lnyF’ plates was attributed to the slow growth rate o f the YMC1 lrz^F’ strain. 
It was felt that because o f its slow growth rate this strain only expressed very low
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levels of the NifA protein from plasmid pPC228. This fact coupled with the oxygen 
sensitivity of NifA protein resulted in a failure to detect NifA induced nifH:lacZa 
expression on Xgal plates. Wrapping plates in parafilm had the same effect of 
enhancing nifH:lacZa background expression from the pPC187-A Bait plasmid as it 
did in ET6016r//F’ but in the Y M C lln/F ’ strain this increase in nifH.lacZa 
background expression was required in order to boost NifA induced nifH.lacZa 
expression to a level that could be detected on Xgal plates. Increasing IPTG 
concentration caused a decrease in the level of background expression from the 
nifH.lacZa reporter gene on pPC187-A and enhanced the contrast between the 
positive pPC228 and negative pPC229-A controls. Slightly better results were 
obtained when 2mM IPTG was used and when plates were incubated at 30 °C for 96 
hours rather than at 37 °C for 24 hours followed by 48 hours at 30 °C.
Miller assays were performed in order to quantify the levels of nifH.lacZa 
expression observed for each of the combinations of plasmids on Xgal plates 
containing different concentrations of IPTG. YMCllrz/F’ transformants containing 
each combination of plasmids were inoculated into 30ml universals containing 20mls 
of selective LB broth to which IPTG had been added to a final concentration of
0.5mM, l.OmM, 1.5mM and 2.0mM IPTG. The lids of the tubes were closed tightly 
and the tubes were incubated at 30° C with low shaking for 24hours. The tubes were 
then assayed in duplicate for p-galactosidase activity. No p-galactosidase activity 
could be detected even when cultures were incubated for 48hours or 72hours without 
shaking.
From the above optimization experiments it was determined that the best contrast 
between the positive pPC228 and negative pPC229-A controls was obtained when 
media containing 2mM IPTG was used and when plates were sealed with parafilm 
and incubated at 30 °C for 96 hours.
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The work described in this chapter resulted in the identification of the most useful set of 
Control, Prey and Bait plasmids out of all o f the plasmids that were constructed. It also 
resulted in the determination of the optimal growth conditions under which these 
plasmids should be used when performing P2H assays. The optimal set of plasmids 
comprised the pPC228 Control plasmid, the pPC229-A Prey plasmid and the pPC187-A 
Bait plasmid. The optimal growth conditions where determined to be 30 °C for 72 hours 
on media containing 2inM IPTG and under aerobic conditions for the strain ET6016n/F'. 
The same conditions were optimal for the YMC11/7/F' strain with the exception that 
plates had to be sealed with parafilm in order to provide microaerobic conditions.
6.4: Summary Of Chapter 6.
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Testing O f The NifA Based Prokaryotic Two-Hybrid
System,
Chapter 7
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7.1: Introduction.
Having identified the most useful set of constructed Control, Prey and Bait plasmids 
(pPC228, pPC229-A and pPC187-A respectively) and having optimized the growth 
conditions under which the P2H assay would be carried out, the ability of the constructed 
NifA based P2H system to detect protein-protein interactions in vivo was tested. In order to 
do this the genes for two proteins known to interact were to be cloned into the pPC229-A 
Prey and pPC187-A Bait plasmids to see if the interaction between the proteins could be 
detected in the NifA based P2H system. The proteins selected for this purpose were the 
Intimin and Tir proteins of Enteropathogenic E. coli (EPEC) which had been shown to 
interact in the yeast two-hybrid (Y2H) system by Hartland et al (1999). The structural and 
biological characteristics of these two proteins are described below and in the paper by 
Hartland et al (1999).
7.1.1: The Tir And Intimin Proteins Of EPEC.
EPEC and Enterohaemorrhagic E. coli (EHEC) constitute a significant risk to human 
health worldwide. EPEC and EHEC adhere to host cells and induce characteristic attaching 
and effacing (A/E) lesions on epithelial cells. A/E lesions are characterised by localised 
destruction (effacement) of brush border microvilli and reorganisation of the host cell 
cytoskeleton beneath the intimately attached bacteria. This event is mediated, in part, by 
binding of the bacterial outer membrane protein, intimin, to a second EPEC protein called 
Tir (Translocated Intimin Receptor) which is translocated to the host cell where it becomes 
integrated into the host cell plasma membrane. The genes coding for the intimin protein 
(eae gene) and the Tir protein (tir) are located in a pathagenicity island known as the locus 
of enterocyte effacement or the 'LEE' region
The product of the eae gene in EPEC is intimin a  and its cell binding activity is localised 
to the C-terminal 280 amino acids (Int280a). Int280a comprises three separate domains,
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two immunoglobulin-like domains and a C-type lectin-like module. Int280a can bind to 
host cells even in the absence of Tir and this binding requires a correctly folded C-type 
lectin-like domain. Correct folding of the C-type lectin-like module of Int280a relies on a 
disulphide bridge between Cys-858 and Cys-937. Int280C/Aa and Int280C/Sa are two 
biologically inactive forms of Int280cc in which Cys-937 has been substituted by Serine or 
Alanine. Neither of the mutant forms of Int280a binds to host cells in the absence of Tir. 
This data provides strong evidence that intimin interacts not only with Tir but also with a 
host cell intimin receptor.
Tir consists of at least three functional regions, an extracellular domain(s) that interact with 
intimin, a transmembrane domain(s) and a cytoplasmic domain(s) that can focus 
polymerised actin and other cytoskeletal proteins beneath intimately attached bacteria, 
leading to the formation of characteristic pedestal-like structures. Kenny et al (1997) 
highlighted the presence of two putative transmembrane domains along the Tir 
polypeptide. This implies that Tir is inserted into the host cell membrane in a 'hairpin loop' 
topology in which the loop may be facing either side of the host cell membrane. Hartland 
et al (1999) utilised the yeast two-hybrid (Y2H) system to localise the intimin-binding 
region of Tir to the central 107-amino-acid region, designated Tir-M, located between the 
two putative transmembrane domains.
7.1.2: Analysis Of Tir-Int280a Binding Using The Y2H System.
In order to analyse the interaction between Tir and Int280a Hartland et al (1999) amplified 
tir and the DNA sequences for the Int280a, Int280C/Aa and Int280C/Sa proteins by PCR 
and cloned the resulting PCR products into the Y2H system plasmids pGBT9 and 
pGAD424. The tir gene was cloned into pGBT9 as an EcoRl-Bamlll fragment to form the 
plasmid pICCIO that expresses Tir as C terminal fusion with the Gal4-DBD. The DNA 
sequences for the Int280a (int280a), Int280C/Aa (int280C/Aa) and Int280C/Sa 
0int280C/Sa) proteins were cloned as EcoRl-BamRl fragments into the pGAD424 plasmid 
to form plasmids pPC19, pPC20 and pPC21 respectively. These plasmids express the
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Int280a, Int280C/Aa and Int280C/Sa proteins as C-terminal fusions with the Gal4 AD.m
Each of these plasmids was co-transformed with plasmid pICCIO into the reporter yeast 
strain PJ69-4A (trp, leu, ura3, his3, gal4, gal80, Gall-HIS3, Gal2-ADE, Gal7-lacZ). 
Int280a, Int280C/Aa and Int280C/Sa were all found to interact with Tir indicating that the 
C-type lectin like domain was not required for the binding of Tir to Int280a.
In order to localise the intimin-binding domain of Tir, three fragments of tir corresponding 
to the amino-terminal region (Tir-N), the carboxy-terminal region (Tir-C) and the middle 
region located between the two putative transmembrane domains (Tir-M) were amplified 
by PCR and cloned into the pGBT9 plasmid to form plasmids pICC13, pICC14 and 
pICC15 respectively. Each of these plasmids expresses its intimin protein as a C-terminal 
fusion with the Gal4 AD. Each of the plasmids was co-transformed with pICC19 
(expressing Int280a as a fusion with the Gal4 DBD) into the yeast reporter strain PJ69-4A 
and interaction was only detected between Tir-M (pICC15) and Int280a (pICC19). This 
localised the intimin-binding domain to the Tir-M region of tir.
Because the interaction between the two EPEC proteins Tir and Int280a proteins had been 
detected in the Y2H system is was decided that these two prokaryotic proteins would be 
used to test the newly constructed NifA based P2H system. Plasmids pICCIO, pICC19 and 
pICC20 were obtained as a gift from Gad Frankel at the Imperial College Of Science, 
Technology And Medicine In London. These plasmids were used as sources from which 
the DNA sequences for Tir (tir), Int280a (int280a) and Int280C/Aoc (int280C/Aa) were 
amplified by PCR. The resulting PCR products were cloned into the newly constructed 
Prey and Bait plasmids for the NifA based P2H system. The tir gene was cloned into the 
pPC187-A Bait plasmid while the int280a and int280C/A a  sequences were cloned into the 
pPC229-A Prey plasmid. Figure 7.2.1 and Figure 7.3.1 show schematic representations of 
the strategies employed for the cloning of tir and int280a respectively. These cloning 
strategies are described in detail in the following sections of this chapter.
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Figure 7.2.1: Cloning Of tir Into The Bait Plasmid pPC187-A To Generate A N- 
Terminal Fusion With The Downstream NifA DNA Binding Domain Sequence.
PCR
EaitiHl £
■hrTKgiTT lA'i'cj
tir BamHl
tir gene u  amplified, using prim ers that introduce 
an  upstream  BamHI site and incorporate 
d ie upstream, ribosome binding site (RBS) from 
the pPC223 p lasm id and introduce a  start codon
Clone Into TA 
Vector
V
pPC13
Excise tir PCR product
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7.2: Clonmg Of tir Into The r>PC187-A Bait Plasmid To Form Plasmid 
pPC190 - Overview Of Strategy.
The tir gene was to be amplified from plasmid pICCIO by PCR and then cloned into the 
pPC187-A Bait plasmid N-terminally to the NifA DBD sequence. The iscoRI site within 
the Bait construct of the nifH:lacZa Bait plasmid pPC187-A could not be used for cloning 
tir as there are several EcoKl restriction sites within the pPC187-A Bait plasmid (see 
Figure 5.2.13). Only the unique Xmal and Bamlil restriction sites within the Bait construct 
on pPC187-A can be used for cloning genes N-terminally to the NifA-DBD. Although 
there are no Xmal or Bamlil sites within the tir gene it could not be directionally cloned 
into the pPC187-A Bait plasmid as an Xmal-BamHl fragment. The reason for this was that 
the Xmal and Bamlil restriction sites within the Bait construct of pPC187-A partially 
overlap so that cutting of the plasmid by either one of the two enzymes prevents the other 
from cutting (this problem was encountered when cloning the NifA NC domain sequence 
into pPC223 - see section 3.2.1). It was therefore planned that the tir gene would be 
amplified from plasmid pICCIO as a Bamlil fragment which would then be cloned into 
pPC187-A to form a plasmid called pPC190. This plasmid would express a tir-NifA DBD 
hybrid protein from its ptac promoter.
Cloning of the above tir gene PCR product into the Bait plasmid pPC187-A as a BamYll 
fragment would present a problem in that it would place the start codon of the tir PCR 
product too far from the pPC187-A plasmid borne RBS to facilitate efficient translation. 
The tir gene therefore had to be cloned with its own RBS. In order to add a RBS onto the 
tir gene prior to its cloning into the pPC187-A Bait plasmid the tir gene was first cut from 
plasmid pICCIO as an EcoKl-BamRl fragment and cloned into pPC223 to form plasmid 
pPC232 (see Figure 7.2.1). The tir gene was then amplified from pPC232 as a Bamlil 
fragment using the primers tir-F and tir-R. The sequence of these primers is shown in 
Figure 7.2.2 below and the primed regions of the pPC232 sequence for which these 
primers were designed are shown in Figure 7.2.3.
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• Figure 7.2.2: Primers Used For The Amplification Of The tir Gene From
PPC232.
tir-F: ÍGGA I C O  - CAC AGG AAA GAA TTC ATG CCT
BamHI
tir-R: (GGA TCC) - AAC GAA ACG TAC TGG
Banifíl
•  Figure 7.2.3: Primed Regions Of The tir Gene On Plasmid pPC232.
pPC223 plasmid DNA tir
Ííf-F primer
t t t c a c a c  aqqa aa ca g a a ttc  attj cc tattggta  accttggtaa taatg taaat
KBS £«>RI start
codon "
ggcaatcatt taattccccc tgcgccgcea ctaccttcac aaacagacgg cgcggcacgg
ggaggaactg g tcatctaat tagctctaca  ggagcattag gatctcgttc  -------------
tgcgcttctg  gcaaacagcg gcggattgcg tttagg ta tg  ggaggattaa cgagtggtgg
tir-R primer
cgagagcgca g taagttctg  taaatgccgc accaacgccggga ccagtac g tt tc g tt  taa
stop
codon
pPC223 plasmid DNA
ggatcc  gtcgac  c tgcag  cc a a g c tt  
--------- 1______ II______ I I______ I
BamHI Sail Pstl Hind m
NB: Bases in red were eliminated by the primer sequences
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As can be seen from Figure 7.2.3 the tir-F primer was designed to incorporate the RBS of 
«■»
pPC223 into the tir PCR product. This primer also incorporated a BamHl site onto the end 
of the tir PCR product. The tir-R primer was designed to eliminate the tir stop codon so 
that when the tir PCR product was cloned into the pPC187-A Bait plasmid translation 
could proceed through the tir sequence into the downstream NifA DBD sequence to 
generate a Tir-NifA DBD hybrid protein.
Once amplified the tir PCR product with its added RBS was cloned into the TA pCR2.1 
vector. It was then sub-cloned into pPC187-A as a BamHl fragment N-terminally and in 
the correct reading frame with the downstream NifA DBD sequence to form plasmid 
pPC190 (see Figure 7.2.1). The tir PCR product was also cloned into the pPC188-A 
nifH:genf Bait plasmid in the same manner to form the plasmid pPCI91 (see Figure 7.2.1). 
Both the pPC190 and pPC191 plasmids express a Tir-NifA DBD hybrid protein.
7.2.1: Sub-cloning Of tir From pICCIO Into pPC223 To Form Plasmid 
pPC232.
The plasmid pICCIO was digested with EcoRl-BamHl and the digested plasmid DNA was 
separated on a 0.7% agarose gel. The 1661 kb band corresponding to the excised tir gene 
was purified from the gel using the gene clean procedure. Plasmid pPC223 was also 
digested with EcoRl-BamHl and the restricted plasmid DNA was run on a 0.7% agarose 
gel. The 4.5kb band corresponding to the linearised plasmid DNA was purified from the 
gel using the gene clean procedure. The linearised pPC223 plasmid DNA was ligated with 
the purified tir EcoRl-BamHl fragment. The ligated DNA was used to transform DH5a 
and the transformation was plated on LBamp media. Clones were screened by performing 
EcoRl-BamHl double digests on plasmid DNA prepared from each clone. Screening in this 
manner resulted in the identification of the desired plasmid called pPC232. Figure 7.2.4 
shows the results of the verifying restriction analysis of pPC232.
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Figure 7.2.4: Restriction Analysis Of Plasmid pPC232.
1  2  3  4  5  6
Lane No. Sample
1 1Kb Ladder
2 pPC232 uncut
3 pPC232 cut EcoRI-BamHI
4 pPC223 cut EcoRI-BamHI
5 pICC 10 cut EcoRI-BamHI
6 1Kb Ladder
7.2.2: PCR Amplification Of tir From pPC232.
The tir gene was amplified from the plasmid pPC232 as a BamHl fragment using the tir-F 
and ft'r-R primers described earlier. The PCR product was separated on a 0.7% agarose gel. 
A photo of the gel obtained and the conditions used for the PCR are shown in Figure 7.2.5 
below. As can be seen from Figure 7.2.5 a single 1676bp band corresponding to the desired 
tir gene PCR product was obtained.
•  Figure 7.2.5: PCR Amplification Of tir From pPC232.
Lane No. Sample
1 1Kb Ladder
2 tir PCR Product
PCR Conditions
Annealing temperature 60 °C
Annealing time 30 sec
Extension time 2 mins
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7.2.3: Cloning Of The tir PCR Product Into The TA Vector To Form 
Plasmid pPC13.
The tir PCR product was ligated with the TA pCR2.1 vector according to the TA protocol. 
The ligated DNA was used to transform INVaF' cells and the transformation was plated on 
LB ampicillin/Xgal plates. White colonies were isolated and screened by performing 
BamHl digests on plasmid DNA isolated from each clone. Screening in this way resulted 
in the identification of the desired plasmid called pPC13. Figure 7.2.6 below shows the 
results of the verifying restriction analysis of plasmid pPC13.
•  Figure 7.2.6: Restriction Analysis Of Plasmid pPC13. 
Lane No. Sample
1 1Kb Ladder
2 pPC13 uncut
3 pPC13 BamHl
4 tir PCR Product
5 1Kb Ladder
7.2.4: Sub-cloning Of The tir PCR Product From pPC13 Into The 
pPC187-A Bait Plasmid To Form Plasmid pPC190.
Plasmid pPC13 was digested with BamHl and the restricted plasmid DNA was separated 
on a 0.7% agarose gel. The 1676bp band corresponding to the excised tir BamHl fragment 
was purified from the gel by the gene clean procedure. The nifH.lacZa Bait plasmid 
pPC187-A was also digested with BamHl and the digested plasmid DNA was separated on 
a 0.7% agarose gel to verify complete digestion. The 5.4kb band corresponding to the 
linearised plasmid DNA was purified from the gel by the gene clean procedure and ligated
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with the purified tir BamHl fragment. The ligated DNA was used to transform DH5a and 
the transformation was plated on LBamp media. Clones obtained were screened by 
performing BamHl digests on plasmid DNA isolated from each clone. Several clones 
containing a pPC187-A plasmid with an inserted tir BamHl fragment were identified. 
Plasmid DNA from each of these clones was then digested with iscoRI to determine the 
orientation of the inserted tir BamHl fragment as the tir PCR product has an EcoK\ site at 
it N-terminal (see Figure 7.2.1). EcoK\ digestion of the pPC187-A Bait plasmid generates 
3 fragments of 1560bp, 1775bp, and 2160bp. £coRI digestion of the desired pPC190 
plasmid was expected to yield three fragments of 1775bp, 2160bp and 3236bp 
while a pPC187-A plasmid with the tir gene cloned in the opposite orientation was 
expected to yield four fragments of 1560bp, 1676bp, 1775bp and 2160bp. Screening by 
performing EcoRl resulted in the identification of a clone containing a pPC187-A plasmid 
with a tir BamHl fragment inserted in the desired orientation and the resulting plasmid was 
called pPC190. The results of the verifying restriction analysis of the pPC190 plasmid can 
be seen in Figure 7.2.7 below.
Figure 7.2.7:Restriction Analysis Of Plasmid pPC190.
Lane No. Sample
1 1Kb Ladder
2 pPC 18 7-A uncut
3 pPC190 uncut
4 pPCl 87-A cut BamHl
5 pPC 190 cut BamHl
6 pPC 187-A cut £coRI
7 pPC 190 cut £coRI
8 1Kb Ladder
1 2 3 4 5 6 7 8
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7.2.5: Sub-cloning Of The tir PCR Product From pPC13 Into The
pPC188-A Bait Plasmid To Form Plasmid pPC191.
The tir PCR product was sub-cloned from pPC13 into the nifH:genf Bait plasmid pPC188 
to form plasmid pPC191 in the same way it was sub-cloned into the pPC187-A Bait 
plasmid. Plasmid pPC13 was digested with BamHl and the restricted plasmid DNA was 
separated on a 0.7% agarose gel. The 1676bp band corresponding to the excised tir BamHl 
fragment was purified from the gel by the gene clean procedure. The nifH:genf Bait 
plasmid pPC188-A was digested with BamHl and the digested plasmid DNA was 
separated on a 0.7% agarose gel to verify complete digestion. The 5.6kb band 
corresponding to the linearised pPC188-A plasmid DNA was purified from the gel by the 
gene clean procedure and ligated with the purified tir BamHl fragment. The ligated DNA 
was used to transform DH5a and the transformation was plated on LBamp media. Clones 
obtained were screened by performing BamHl digests on plasmid DNA isolated from each 
clone. Several clones containing a pPC187-A plasmid with an inserted tir BamHl fragment 
were identified. Plasmid DNA from each of these clones was then digested with £coRI to 
determine the orientation of the inserted tir BamHl fragment. EcoRl digestion of the 
pPC188-A Bait plasmid generates 3 fragments of 1560bp, 2062bp, and 2074bp.
•  Figure 7.2.8: Restriction Analysis Of Plasmid pPC191.
Lane No. Sample
1 1 Kb Ladder
2 pPC188-A uncut
3 pPC 191 uncut
4 pPC188-A cut BamHl
5 pPC191 cut BamHl
6 pPC 188-A cut £caR.I
7 pPC 190 cut EcoRl
8 1Kb Ladder
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£coRI digestion of the desired pPC191 plasmid was expected to yield three fragments of 
2062bp, 2074bp and 3236bp while a pPC188-A plasmid with the tir gene cloned in the 
opposite orientation was expected to yield four fragments of 1560bp, 1676bp, 2062bp, and 
2074bp. Screening by performing EcoRl digests thus resulted in the identification of a 
clone containing a pPC188-A plasmid with a tir BamHl fragment inserted in the desired 
orientation and the resulting plasmid was called pPC191. The results of the verifying 
restriction analysis of the pPC191 plasmid can be seen in Figure 7.2.8.
7.3: Cloning Of int280a And int280C/Aa Into The pPC229-A Prey 
Plasmid - Overview Of Strategy.
Figure 7.3.1 shows a schematic representation of the strategy employed for the cloning of 
int280a into the pPC229-A Prey plasmid. The int280a sequence was amplified by PCR 
from plasmid pICC19 as a BamHl-Hindlll fragment using the primers 280a-F and 280a-R 
and cloned. The sequences of these primers are given in Figure 7.3.2 and the primed 
regions of the pICC19 are shown in Figure 7.3.3. Once amplified the int280a PCR product 
was cloned into the TA pCR2.1 vector and then sub-cloned into the pPC229-A Prey 
plasmid as a BamHl-Hindlll fragment C-terminally and in the correct reading frame with 
the upstream NifA-AD sequence. The resulting plasmid was called pPC233 and expresses 
a NifA AD-Int280a hybrid protein from its ptac promoter.
The int280C/Aa sequence differs from the int280a sequence by only one codon. This 
codon exchange results in the substitution of the Cys-937 residue of Int280a with an 
Alanine residue. The sequences of plasmids pICC19 and pICC20 are thus identical with 
the exception of this single codon exchange. The int280C/Aa sequence was amplified from 
pICC20 using the 280a-V forward primer and the reverse primer 280C/Aa-R. The 
sequence of the 280C/Aa-R primer is shown in Figure 7.3.2. The 280C/Aa-R primer 
encompasses the single codon exchange in the int280C/Aa sequence and this codon is 
indicated in red in Figure 7.3.2. As with int280a, int280C/Aa was amplified as a BamHl- 
Hindlll fragment.
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•  Figure 7.3.1: Cloning Of int280a Into The Prey Plasmid pPC229-A To Generate 
A C-Terminal Fusion With The Upstream NifA AD Sequence.
int280a
GaMDBD 
p
A D H1
P C K  u s i n g  p r i m e r s  t h a t  
i n c o i p o r a t e  a n  u p s t r e a m  
Earn H I  s i t e  a n d  a  d o w n s t r e a m  
HmdUl s i t e
do
Hindm
_L
H
cut with 
6’amHI and HindM
pPC229-A
S a mH Ii_
int2S0a
N i f A  A D int280a
ampr
N i f A  A D
mtBTfä
Y
Hindm________ I
a m p  r
Cloned Into The TApCR2.1 
Vector
c u t  w i t h  
BamHl a n d  Hindm
mtBTfö
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• Figure 7.3.2: Primers Used For The Amplification Of int280a From Plasmid
PICC19.
280a -F: (GGA T C P  - ATT ACT GAG ATT AAG GCT
BamHl
280a-R: (AAG CTT) - TTA TTT TAC ACA AGT GGC
280C/Aa-R (AAG CTT) - TTA TTT TAC AGC AGT GGC
fI indin
•  Figure 7.3.3: Primed Regions Of The int280a Sequence On Plasmid plCC19.
pGAD424
plasmid <-------1------------- > inilWct
2 8 9 a -F primer
 jactac tgagattaag  gcqgataaaa caacggcagt agcaaatggt caggatgcta
ttacatacac  tg t taaag tg  atgaaggggg ataagcctgt a tc taa tcag  gaagtgacct
ttacgacgac cttaggtaag  t ta a g ta a t t  ccactgaaaa aacggatacg aatggctatg
ccaaagtaac a ttaacatcg  acaactccag gaaaatcact egttagtgee cgtgttagcg
atgtcgccgt tgatgtcaaa gcacctgaag t t g a a t t t t t  taeaacgctt  acaattgatg
aeggtaatat  tg a a a ttg t t  ggaaccggag ttaaagggaa gttacccact g tatggttgc
aata tgg tca  a g tta a tc tg  aaagccagcg gaggtaaegg aaaatataca tggcgctcag
caaatccagc aa ttg e tteg  g tggatgctt  c t tc tg g tc a  ggtcacctta  aaagagaagg
gaactacaac t a t t t c c g t t  a tc tcaagtg  ataatcaaac tgcaac tta t  actattgcaa
cacctaatag  t c tg a t tg t t  cc taa ta tga  geaagegtgt gacctataat gatgctgtga
atacatg taa  g aa ttttgga  ggaaagttgc c g tc t tc tc a  gaatgaactg gaaaatgtct
ttaaagca tg  gggggctgca aa taaa ta tg  a a ta t ta ta a  g tctagtcag  a c ta ta a t t t
catgggtaca acaaacagct caagatgcga agagtggtgt tgcaagtaca tacgatttag
280&-R primer
ttaaacaaaa  ccctctgaat  aa ta ttaagg  ctagtgaatc  ta a tg e tta t  gccacttgt  g 
|------ ^ pCAD424 plasmid
taaaa taa gga t c c ■
codon EanM  
site
NB: sequence ofpICC20 is identical to thatofpICC19 shown above with 
the exception of the three bases in red which are exchanged for jet
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The int280C/Aa PCR product was first cloned into the TA pCR2.1 vector and then sub­
cloned as a BamHl-HindlU fragment into the pPC229-A Prey plasmid C-terminally and in 
the correct reading frame with the upstream NifA NC domain sequence. The resulting 
plasmid was called pPC234 and expresses a NifA AD-Int280C/Aa hybrid protein from its 
ptac promoter.
7.3.1: PCR Amplification Of int280a And int280C/Aa From Plasmids 
pICC19 And plCC20 Respectively.
The int280a sequence was amplified from the plasmid pICC19 as a BamHl-Hindlll 
fragment using the 280a-F and 280a-R primers described earlier. The PCR product was 
separated on a 0.7% agarose gel. A photo of the gel obtained and the conditions used for 
the PCR are shown in Figure 7.3.4 below. As can be seen from Figure 7.3.4 a single 855bp 
band corresponding to the desired int280a PCR product was obtained.
Figure 7.3.4: PCR Amplification Of int280a From pICC19.
Lane No. Sample
1 1Kb Ladder
2 int280a PCR Product
PCR Conditions
Annealing temperature 43 °C
Annealing time 30 sec
Extension time 1 min
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The int280C/Aa sequence was amplified from the plasmid pICC20 as a BamHl-Hindlll 
fragment using the 280a-F and 280C/A a-R primers described earlier. The PCR product 
was separated on a 0.7% agarose gel. A photo of the gel obtained and the conditions used 
for the PCR are shown in Figure 7.3.5 below. As can be seen from Figure 7.3.5 a single 
855bp band corresponding to the desired int280C/A a  PCR product was obtained.
Figure 7.3.5: PCR Amplification Of int280C/AaFrom pICC20.
Lane No. Sample
1 1Kb Ladder
2 int280C/A a  PCR Product
PCR Conditions
Annealing temperature 
Annealing time 
Extension time
43 °C 
30 sec 
1 min
7.3.2: Cloning Of The int280a and int280C/Aa PCR Products Into The 
TA Vector To Form Plasmids pPCll And pPC12 Respectively.
The int280a PCR product was ligated with the TA pCR2.1 vector according to the TA 
protocol. The ligated DNA was used to transform INVaF' cells and the transformation was 
plated on LB ampicillin/Xgal plates. White colonies were isolated and screened by 
performing EcoRl digests (EcoRl sites flank the PCR product insertion point on the TA 
pCR2.1 vector) DNA isolated from each transformant. Clones identified as possessing an 
pCR2.1 vector with an inserted int280a were then screened further by performing BamHl- 
Hindlll double digests on plasmid DNA prepared from each clone. Screening in this way
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resulted in the identification of the desired plasmid called pPCll. Figure 7.3.6 below 
shows the results of the verifying restriction analysis of plasmid pPCl 1.
The int280C/Aa PCR product was cloned into the TA pCR2.1 vector in exactly the same 
way and the desired plasmid, called pPC12, was identified by first performing EcoRl and 
then BamHI-Hindlll double digests on plasmid DNA isolated from individual 
transformants. Figure 7.3.7 below shows the results of the verifying restriction analysis of 
plasmid pPC12.
Figure 7.3.6: Restriction Analysis Of Plasmid pPCll.
Lane No. Sample
1 1Kb Ladder
2 pPC 11 uncut
3 pPCl 1 cut ¿scoRI
4 pPCl 1 cut BamHI-Hindlll
5 int280a PCR Product
6 1Kb Ladder
•  Figure 7.3.7: Restriction Analysis Of Plasmid pPC12.
Lane No. 1 2 3 4 5 6 le
1 1Kb Ladder
2 pPCl 2 uncut
3 pPCl2 cut EcoR\
4 pPCl2 cut BamHI-Hindlll
5 int280C/A a  PCR Product
6 1Kb Ladder
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7.3.3: Sub-cloning Of The int280a PCR Product From Plasmid pPCll
Into The pPC229-A Prey Plasmid To Form Plasmid pPC233.
The int280a PCR product was sub-cloned from pPCl 1 into the pPC229-A Prey Plasmid to 
form plasmid pPC233. Plasmid pPCl 1 was digested with BamHl-Hindlll and the restricted 
plasmid DNA was separated on a 0.7% agarose gel. The 855bp band corresponding to the 
excised int280a BamHl-Hindlll fragment was purified from the gel by the gene clean 
procedure. The pPC229-A Prey plasmid was also digested with BamHl-Hindlll and the 
digested plasmid DNA was separated on a 0.7% agarose gel to verify complete digestion. 
The 6kb band corresponding to the linearised plasmid DNA was purified from the gel by 
the gene clean procedure and ligated with the purified int280a BamHl-HindlU fragment. 
The ligated DNA was used to transform DH5a and the transformation was plated on 
LBamp media. Clones obtained were screened by performing BamHl-Hindlll double 
digests on plasmid DNA isolated from each clone. Screening in this manner resulted in the 
identification of the desired plasmid pPC233 and Figure 7.3.8 shows the results of the 
verifying restriction analysis of plasmid pPC233.
•  Figure 7.3.8; Restriction Analysis Of Plasmid nPC233.
Lane No. Sample
1 1Kb Ladder
2 pPCl 1 uncut
3 pPC229-A uncut
4 pPC233 uncut
5 pPC 11 cut BamHl-Hindlll
6 pPC229-A cut BamHl-Hindlll
7 pPC233 cut BamHl-Hindlll
8 1 Kb Ladder
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7.3.4: Sub-cloning Of The int280C/Aa PCR Product From Plasmid
pPC12 Into The pPC229-A Prey Plasmid To Form Plasmid pPC234.
The int280C/Aa PCR product was sub-cloned from pPC12 into the pPC229-A Prey 
Plasmid to form plasmid pPC234. Plasmid pPC12 was digested with BamHl-Hindlll and 
the restricted plasmid DNA was separated on a 0.7% agarose gel. The 855bp band 
corresponding to the excised int280C/Aa BamHl-Hindlll fragment was purified from the 
gel by the gene clean procedure. The pPC229-A Prey plasmid was also digested with 
BamHl-Hindlll and the digested plasmid DNA was separated on a 0.7% agarose gel to 
verify complete digestion. The 6kb band corresponding to the linearised plasmid DNA was 
purified from the gel by the gene clean procedure and ligated with the purified int280C/Aa 
BamHl-Hindlll fragment. The ligated DNA was used to transform DH5a and the 
transformation was plated on LBamp media. Clones obtained were screened by performing 
BamHl-Hindlll double digests on plasmid DNA isolated from each clone. Screening in this 
manner resulted in the identification of the desired plasmid pPC234 and Figure 7.3.9 
shows the results of the verifying restriction analysis of plasmid pPC234.
•  Figure 7.3.9: Restriction Analysis Of Plasmid oPC234.
Lane No. Sample
1 1Kb Ladder
2 pPC12 uncut
3 pPC229-A uncut
4 pPC234 uncut
5 pPC12 cut BamHl-Hindlll
6 pPC229-A cut BamHl-Hindlll
7 pPC234 cut BamHl-Hindlll
8 1Kb Ladder
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7.4: Performing The P2H Assay For The In vivo Detection Of Tir
Interactions With Int280a And Int280C/Aa.
Having constructed the plasmids pPC190 (expressing a Tir-NifA DBD hybrid protein), 
pPC233 (expressing a NifA AD-Int280a hybrid protein) and pPC234 ( expressing a NifA 
AD-Int280C/Aa hybrid protein) they were used to perform a P2H system assay in order to 
determine if the interactions between Tir with Int280a or Tir with Int280C/Aa could be 
detected in the newly constructed NifA based system. As already described earlier these 
interactions had been detected in the Y2H system by Hartland et al (1999) and it was 
therefore expected that these interactions would be detected in the NifA based P2H system. 
In order to perform the NifA based P2H assay the combinations of plasmids shown in 
Figure 7.4.1 were transformed into the E. coli strain ET6016nyF' and plated on appropriate 
selective media. IPTG was added to the media to a final concentration of 2mM to induce 
expression of hybrid proteins as this level of IPTG had been determined to be the optimal 
concentration during the optimization experiments described in chapter 6.
•  Figure 7.4.1: Combinations Of Plasmids Transformed Into ET6016/-f'/Ft To 
Perform The P2H Assay.
LB chloramphenicol / tetracycline 
Xgal, IPTG
LB chloramphenicol / tetracycline 
ampicillin 
Xgal, IPTG
pP C 185-A  =  nifH:lacZa reporter plasm id pP C 229 =  Prey p lasm id
pPC 187-A  =  n ifH :la cZ a  B ait p lasm id pPC233 expresses N ifA  AD-Int280oc
pP C 228 =  Control p lasm id pP C 234 exp resses N ifA  A D -In t280C /A a
pPC18:5-A pPC187-A pPC190
pPC18.5-A/pPC228 pPC187-A /pPC228 pPC 190 / pPC228
pPC185-A /pPC229-A pPC187-A /pPC229-A pPC190 / pPC229-A
pPC185-A /pPC233 pPC187-A /pPC233 pPC 190/pPC 233
pPC 18J-A /pP C 234 pPC187-A /pPC 234 pPC 190 / pPC234
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Plates were incubated at 30 °C for 72 hours after which the colour intensity of colonies on 
each of the plates was compared and then graded on a visual basis. The results obtained are 
given in Table 7.4.1 below.
•  Table 7.4.1: Colony Colour Intensities Obtained For P2H Assay.
Plasmids Colonv Colour Intensity Expected Results
pPC185-A - -
pPC185-A / pPC22 8 ++++ ++++
pPC185-A /pPC229-A + +
pPC185-A /pPC233 + + (same as pPC229-A)
pPC185-A /pPC234 ++++ + (same as pPC229-A)
pPC187-A - -
pPC187-A /pPC228 ++++ ++++
pPC187-A /pPC229-A + +
pPC187-A /pPC233 + + (same as pPC229-A)
pPC187-A /pPC234 ++++ + (same as pPC229-A)
pPCl 90 - -
pPCl 90 / PPC228 ++++ ++++
pPCl 90 /pPC229-A + +
pPCl 90 /pPC233 + ++++
pPCl 90 /pPC234 ++++ ++++
As can be seen from Table 7.4.1 the results obtained were not as expected. No interaction 
was detected between the NifA AD-Int280a hybrid protein (expressed from pPC233) and 
Tir-NifA DBD hybrid protein (expressed from pPC190). In addition to this the NifA AD-
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Int280C/Aa hybrid protein (expressed from pPC234) generated a strong positive result 
even in the absence of the Tir-NifA DBD hybrid protein. The possible reasons for these 
results are discussed in Chapter 8.
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Chayter 8
Discussion.
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8.1: Discussion.
The purpose of this work was to construct a novel prokaryotic two-hybrid (P2H) system 
for the detection and analysis of protein-protein interactions in vivo. The system would 
function in E. coli and was to be constructed using the DNA binding and transcriptional 
activation domains of the S. meliloti 2011 NifA protein. Such a system would be a 
valuable addition to the ever growing range of methods for the detection of molecular 
interactions in vivo of which the yeast two-hybrid system (Y2H) is currently most 
powerful.
8.1.1: Benefits Of A Prokaryotic Two-Hybrid System.
A P2H system would facilitate the analysis of prokaryotic protein-protein interactions in 
a prokaryotic genetic background. Such a system could also be of use for the analysis of 
eukaryotic proteins in situations where homologous yeast proteins interfere with the 
interactions of the proteins under investigation. In addition to this manipulation of 
bacterial DNA is generally easier than that of yeast and much higher transformation 
efficiencies are attainable in E. coli. This facilitates the rapid and simple screening of 
large complex libraries of protein to identify putative binding partners for a given 
protein of interest. This potential makes prokaryotic systems particularly attractive for 
the purpose for the construction of proteomic linkage maps.
It may be argued that a prokaryotic based system would be of limited use for the 
analysis of eukaryotic proteins on the basis that such proteins may not be stable or be 
capable of folding correctly in a prokaryotic background. Also some eukaryotic proteins 
require post-translational modifications such as phosphorylation or glycosylation in 
order to fold and function correctly and thus would not function in E. coli. However, it 
is important to note that limitations such as these are also encountered in the 
conventional Y2H system where hybrid proteins are targeted to and interact in the 
nucleus and thus are not subject to post-translational modifications such as 
glycosylation and disulfide bond formation that occur in the endoplasmic reticulum. 
Proteins that require phosphorylation or acétylation by non-yeast proteins also fail to 
interact in the conventional Y2H system.
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8.1.2: Overview Of The S. meliloti 2011 NifA Protein - Reasons For Its Selection For 
The Construction Of A Novel P2H System.
The novel P2H system constructed in this work is based on the transcriptional activating 
protein NifA from S. meliloti 2011. NifA activates the expression of several n if and fix 
genes in response to cellular oxygen and/or nitrogen status. It belongs to a large family 
of bacterial Enhancer Binding Proteins (EBP's) that activate transcription from 
promoters requiring the alternate sigma factor a 54 (NtrA or RpoN).
The RNA polymerase containing a 54 (a 54-holoenzyme or Ect54) is capable of binding to 
distinct promoter sequences to form transcriptionally closed complexes but is unable to 
initiate transcription unless an EBP, such as NifA, is present. NifA activates 
transcription by binding to sites characterized by the palindromic motif TGT-Nio- AC A 
that are located 100 to 200bp upstream of n if promoters and contacts E g54 bound to 
such promoters by means of DNA loops or kinks. In many instances the formation of 
the DNA loop is assisted by the DNA bending protein Integration Host Factor (IHF) 
which binds at a site located between the NifA and E g54 NifA activates transcription by 
catalyzing the isomerization of transcriptionally inactive closed complexes between 
E a54 and promoter sequences to transcriptionally active open complexes in a reaction 
that depends upon hydrolysis of a nucleoside triphosphate by NifA. Other EBP's, such 
as NtrC and DctD, activate transcription of their associated promoters by a similar 
mechanism.
NifA, as well as the other EBP's, is a three domain protein. Like many eukaryotic 
transcription factors, many EBP's are modular in nature. This simply means that the 
domains of the proteins are functionally independent of one another and can be 
physically separated from each other while still retaining their functionality. In the case 
of NifA, the central domain of about 220 amino acids is responsible for the activation of 
transcription. This domain is highly conserved among all of the EBP's. The function of 
the N-terminal domain of NifA is unknown whereas the C-terminal domain contains a 
helix-turn-helix motif that is required for binding to the UAS.
The modular nature of the EBP's and the functional separation of DNA binding and 
transcriptional activation activities, makes them potential candidates for the 
development of P2H systems. The S. meliloti 2011 NifA protein was chosen for this 
purpose because it is one of the best studied EBP's and because unlike the other EBP's it
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is synthesized as a completely functional protein. Other EBP's are synthesized in an 
inactive form and require activation through the activity of another protein in response 
to certain environmental stimuli. For example, NtrC requires phosphorylation of its N- 
terminal domain by NtrB before it is capable of activating the expression of ct54 
dependent genes concerned with nitrogen assimilation. This phosphorylation only 
occurs under nitrogen limiting conditions. The requirement for specific environmental 
conditions (such as nitrogen starvation in the case of NtrC) for activation of most of the 
EBP's would complicate the application of any P2H system constructed from them.
The S. meliloti 2011 NifA protein was also chosen because unlike NtrC it is completely 
heterologous to other proteins found in E. coli (i.e. there is no equivalent NifA protein 
in E. coli as E. coli does not carry out nitrogen fixation). There is a homologous NtrC 
protein in E. coli encoded by the glnG gene in the glnALG operon. NifA could therefore 
be utilised in E. coli without substantially interfering with normal E. coli cellular 
processes.
Thus NifA was selected as the most suitable of all of the studied EBP's for the 
construction of a novel P2H system that would function in E. coli. The DNA sequences 
for the transcriptional activating N-terminal-central (NC) domain and the DNA binding 
domain (DBD) of the NifA protein were amplified from S. meliloti 2011 genomic DNA 
and used for the construction of the P2H system Prey and Bait plasmids respectively. 
The sequence for the NifA dependent nifH promoter (the promoter for the nifHDK 
operon in S. meliloti 2011) was also amplified from S. meliloti 2011 genomic DNA by 
PCR and used for the construction of two reporter genes for the P2H system, one 
nifH.lacZa reporter gene and one nifH:genf reporter gene. In addition to the 
construction of the Prey plasmids, Bait plasmids and reporter genes for the P2H system, 
suitable E. coli strains had to be developed in which the P2H assay would be performed. 
The reason for this was that the product of the glnG gene in E. coli, NtrC, had been 
observed to weakly activate the same promoters as NifA. Although this activation was 
weak it would contribute to false positives when performing P2H assays and so strains 
of E. coli in which the glnG gene had been deleted had to be obtained and developed for 
use as host strains for the P2H system.
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8.1.3: Construction O f The Reporter Genes For The NifA Based P2H System.
Two repdTter genes were constructed for the novel NifA based P2H system, one 
nifH:lacZa reporter gene and one nifH.genf reporter gene. As described in chapter 4 
the nifH.lacZa reporter gene was constructed first as it would be of greater use for the 
optimization of the P2H system.
Several interesting observations were made during the construction of the nifH.lacZa 
reporter gene. When the amplified nifH promoter was cloned into the multiple cloning 
site of pUC19 tQ, make an in frame fusion between it and the downstream lacZa 
sequence (see Figure 4.3.4) DH5a colonies containing the desired plasmid pPC19 were 
found to produce a very intense dark blue colour on Xgal plates. There where two 
possible reasons for the colour development. Since DH5a did not have a deletion of the 
glnG gene the reason for the intense blue colour development may have been due to E. 
coli NtrC activation of the nifH. lacZa reporter fusion present on pPC19 (see Figure 
8.1a). Although the level of activation of nifH by NtrC was reported to be low it was 
amplified by the high copy number of pUC19 to a level easily detectable on Xgal plates. 
Another possible reason for the intense colour development was that transcription of the 
lacZa sequence was being initiated from the upstream plac promoter. Transcripts 
initiated at this point would first read through the nifH promoter sequence and then into 
downstream lacZa sequence. A functional LacZa peptide would not be translated from 
the resulting RNA transcript using the ribosome binding site (RBS) and start codon 
present in the plac promoter because of disruption of the reading frame by the 
intervening cloned nifH promoter sequence. However a functional LacZa peptide could 
be translated from RNA transcripts using the RBS and start codon of the cloned nifH 
promoter since it was cloned into the MCS of pUC19 so that its start codon would be in 
frame with the downstream lacZa sequence (see Figure 8.1b).
When the nifH:lacZa reporter gene was amplified by PCR and cloned into the high 
copy number TA pCR2.1 vector all of the colonies obtained when the transformation 
was plated out on selective Xgal were dark blue in colour. This observation supported 
the theory that the intense blue colour development obtained for colonies containing 
plasmid pPC19 was caused by NtrC activation of transcription from the nifH promoter 
of the nifH.lacZa fusion on the plasmid rather than as a result of transcription initiated
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•  Figure 8.1: Two Possible Mechanisms For The Expression Of Functional 
LacZa From pPC19.
A.) Transcription Initiated From  n ifH  Promoter B y  N trC
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from the upstream plac promoter. If the latter had been the case an equal number of 
white and blue colonies would have been obtained upon cloning of the nifH.iacZa PCR 
product into the TA pCR2.1 vector since the niflhlacZa PCR product could insert into 
the pCR2.1 plasmid in either orientation with respect to the plac promoter on the 
pCR2.1 plasmid. In one orientation transcripts initiated at the plac promoter would 
contain the coding sequence of the nifH.iacZa reporter gene and functional LacZa 
peptide would be translated to from the nifH derived RBS and start codon to generate 
intense blue colour development on Xgal plates in the same way as that described for 
pPC19. In the other orientation transcripts initiated at the plac promoter would contain 
the nonsense strand of the nifH:lacZa reporter and thus no functional LacZa would be 
produced and white colonies would be the result. NtrC activation of the nifH:lacZa 
reporter gene would be independent of its orientation and thus all colonies would appear 
blue. While this appeared to be the case it could not be ruled out that both transcription 
initiated from the nifH promoter as a result o f NtrC activation and transcription initiated
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from the plac promoter on pPC19 and pCR2.1 contributed to the expression of 
functional LacZa and the intense blue colour development observed on Xgal plates. 
However the extreme high copy number of the TA pCR2.1 vector made it impossible to 
differentiate between colonies in which both processes contributed to functional LacZa 
expression (when the nifH iacZa  PCR product was cloned in the correct orientation 
with respect to the plac promoter on the pCR2.1 vector) and colonies in which only 
NtrC activated transcription from the nifH:lacZa reporter contributed to function LacZa 
expression (when the nifH iacZa  PCR product was cloned in the opposite orientation). 
This fact became clear when the nifH.lacZa reporter gene was sub-cloned from the high 
copy number TA pCR2.1 vector into the much lower copy number pPC184 
(pACYC184 with the unique BamHl site in the tetracycline resistance gene eliminated) 
plasmid to form the reporter plasmids pPC185-A and pPC185-B (see Figure 4.3.13).
The nifH.iacZa reporter was cut from plasmid pPC2 (pCR2.1 vector with the 
nifH.lacZa PCR product cloned into it) as a Hindlll fragment and ligated with Hindlll 
restricted and dephosphorylated pPC184 plasmid DNA. The ligation was used to 
transform DH5a and the transformation was plated on selective media to which Xgal 
had been added. The reason for the addition of the Xgal was to screen for NtrC 
activation of the nifH. lacZa reporter gene and thus to help detect colonies containing 
plasmids that had the Hindlll cloned nifH.iacZa reporter gene fragment. Interestingly 
two classes of colonies were obtained on plates, some being very light blue in colour 
while others were slightly darker. Because the nifH iacZa  reporter was not directionally 
cloned into pPC184 it could insert into the plasmid in either of two orientations and 
upon identification of the desired reporter plasmids pPC185-A and pPC185-B it was 
discovered that pPC185-A generated the very light blue colonies while plasmid 
pPC185-B generated the slightly darker blue colonies. This finding supported the earlier 
theory that the blue colour development observed for plasmid pPC19 and when the 
nifH.lacZa reporter was cloned into the TA pCR2.1 vector was probably due to a 
combination of transcription initiated from both the plac promoter and as a result of 
NtrC activation from the nifH promoter. It was determined that plasmid pPC185-A 
produced very light blue colonies on Xgal plates as a result of weak NtrC activation of 
the nifH iacZa  reporter. The pPC185-B plasmid produced a slightly darker blue colour 
intensity because in addition to the weak NtrC induced activation of the nifH iacZa
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there was also some transcription initiated from the upstream tetracycline resistance 
gene promoter (see Figure 4.3.13). The Hindlll site into which the nifH.lacZa reporter 
gene was cloned lies within the promoter for the tetracycline resistance gene and 
cloning into this site does not always result in inactivation of the tetracycline promoter. 
As described earlier, functional LacZa was translated from the nifH derived RBS within 
the resulting transcripts initiated from the tetracycline promoter (see Figure 8.1b).
In addition to the nifH.lacZa reporter gene a nifH:genf reporter gene was also 
constructed and cloned as a Hindlll fragment into the Hindlll site of plasmid pPC184 to 
form the reporter plasmids pPCl 86-A and pPCl 86-B. In order to generate the final Bait 
plasmids for the P2H system a Bait construct was constructed using the C-terminal 
DBD of NifA (described in Chapter 5). It consists of a ptac promoter followed by a 
MCS into which the sequence for a protein of interest can be cloned. C-terminally to the 
MCS is the sequence for the DNA binding domain of NifA. Cloning into the MCS 
results in the expression of a hybrid protein bearing the DNA binding domain of NifA. 
This construct was directionally cloned as a Eagl-Sall into each of the reporter plasmids 
pPC185-A, pPC185-B, pPC186-A and pPC186-B to form the final Bait plasmids 
pPC187-A, pPC187-B, pPC188-A and pPCl 88-B respectively (see Figure 5.2.13 for the 
nifH:lacZa Bait plasmids pPC187-A and pPC187-B and see Figure 5.2.17 for the 
nifHgen /B a it plasmids pPC188-A and pPCl 88-B).
8.1.4: Construction Of The Prey Plasmids For The NifA Based P2H System.
Three Prey plasmids, pPC229-A, pPC229-B and pPC229-C, were constructed (see 
Figure 3.5.1) using the sequence for the N-terminal domain-central domain (NC) 
portion of NifA. In these plasmids the NC portion of the NifA protein is expressed from 
a strong ptac promoter. C-terminally to the sequence for the NC portion of NifA is a 
multiple cloning site (MCS) into which a library of DNA fragments can be cloned to 
generate a library of hybrid proteins bearing the activation domain of NifA. The NC 
portion of the NifA protein was used rather than just the central activating domain of the 
NifA protein by itself because the N-terminal domain of the protein had been shown to 
stabilize the protein when expressed in E. coli. The NC domain of NifA was also
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amplified from a second internal start codon rather than from its natural start codon 
because proteins expressed from this start codon had been demonstrated to be more 
stable in E. coli. The three Prey plasmids differ from each other only in the reading 
frame of the multiple cloning site relative to the upstream sequence for the NC portion 
of NifA. The reason for constructing three Prey plasmids was to facilitate the easy 
construction of libraries of hybrid proteins. Another related Control plasmid expressing 
the whole NifA protein from the ptac promoter, pPC228, was also constructed (see 
Figure 3.5.1). This plasmid was constructed to be used as a positive control when 
performing P2H assays.
When expression of the NifA protein from plasmid pPC228 was tested using the 
nifH:lacZa reporter plasmid pPC185-A very poor colour development was observed. 
As described earlier in Chapter 3, it was felt that this was due the ATG start codon on 
the cloned nifA gene sequence being too far from the plasmid borne RBS to facilitate 
efficient translation of NifA from RNA transcripts initiated at the ptac promoter. It was 
therefore decided that the ptac promoter region of plasmid pPC228 would be 
manipulated to reduce the distance between the nifA start codon and the plasmid borne 
RBS in the hope that this would result in improved translation of the NifA protein. The 
manner in which this manipulation was carried out is described in detail in Chapter 5 
and resulted in the formation of the alternative Control plasmid pPC230. When this 
Control plasmid was introduced into E. coli with the nifH.lacZa reporter plasmid 
pPC185-A it was found to produce more intense colour development on Xgal plates. As 
the distance between the start codon and the plasmid borne RBS on each of the 
constructed Prey plasmids pPC229-A, pPC229-B and pPC229-C was the same as it was 
on pPC228 the ptac promoter region of each of these plasmids was also manipulated to 
generate three alternative Prey plasmids, pPC231-A, pPC231-B and pPC231-C 
respectively (see Figure 3.5.1).
8.1.5: Development Of Suitable Host Strains And Optimization Of Growth Conditions 
For The NifA Based P2H System.
In addition to the construction of the plasmids for the P2H system a suitable strain of E. 
coli had to be developed in which the plasmids could be used. This strain had to have
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the glnG gene deleted since the product of this gene, NtrC, had been observed to 
activate the nifH promoter and would thus give rise false positive. Such activation by E. 
coli NtrC was observed during the construction of the nifH.lacZa reporter construct. 
Two glnG mutant strains of E. coli were obtained, YMC11 and ET6016, but 
unfortunately both of these lacked the correct genetic background for lacZa 
complementation which the nifH.lacZa reporter system requires. The correct genetic 
background was introduced into the E. coli strains on an F1 factor by conjugation with 
XL 1-Blue as described in Chapter 6 and two suitable E. coli host strains, YMCllrzyF' 
and ET6016n/F',,were thus obtained for the NifA based P2H system.
Having constructed two E. coli host strains, ET6016rzyF' and YMCllrzyF', in which the 
constructed plasmids for the NifA based P2H system could be used, the next step was to 
assess the usefulness of all of the constructed plasmids in each of the host strains and to 
optimize the growth conditions under which the P2H assay would be carried out in each 
of the two strains. The manner in which these optimization experiments were carried out 
and the results obtained are described in Chapter 6 (see section 6.3). These experiments 
yielded some strange and unexpected results which are discussed below in relation to the 
strain ET6016r//F'. Results obtained for the alternative YMC11 rifF' strain mirrored those 
obtained for the ET6016W/F1 strain.
The first unexpected result was obtained when the nifH: lacZa reporter plasmids 
pPC185-A and pPC185-B and the final nifH.lacZa Bait plasmids pPC187-A and 
pPC187-B were introduced into ET6016rifF' alone. This E. coli strain was known to 
have a deletion of its glnG gene and thus should not express any functional NtrC. It was 
therefore expected that when the reporter plasmids pPC185-A and pPC185-B, were 
introduced into ET6016rz/F' that pPC185-A would not produce any colour development 
on Xgal plates and that pPC185-B would produce a significantly reduced level of colour 
development compared to that observed in DH5a (which has an intact glnG gene) if any 
colour development at all. The final Bait plasmids pPC187-A and pPC187-B were 
expected to yield the same results since they differed from their related reporter 
plasmids only in that they possessed the additional Bait construct. However, similar 
levels of colour development to those observed in DH5a were obtained for plasmids 
pPC185-A and pPC185-B indicating that the observed colour development in DH5a 
was not the result of NtrC induced transcription from the nifH promoter of the 
nifH.lacZa reporter but rather the result of leaky baseline transcription from the nifH
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promoter. Such leaky transcription from a 54 promoters has been reported to be caused 
by transient melting of DNA and is enhanced by conditions that favour DNA melting, 
such as DNA supercoiling, elevated temperatures, and lower ionic strengths (Wang et 
al, 1997). The final Bait plasmids pPC187-A and pPC187-B generated colony colour 
intensities equivalent to their corresponding related reporter plasmids (pPC185-A and 
pPC185-B respectively) as expected. The colour intensity of colonies generated by 
pPC187-B was stronger than that observed for pPC187-A and as described earlier in 
section 8.1.3 (see Figure 8.1b) this was due to initiation of transcription from the 
tetracycline promoter reading through the nifH. lacZa reporter (see Table 6.3.1). Due to 
the high level of background expression exhibited by plasmids pPC185-B and pPC187- 
B these plasmids were quickly eliminated from further optimization experiments.
The NC domain of the NifA protein was known to be capable of activating transcription 
from the nifii promoter despite lacking the C-terminal DBD of the protein. This 
transcriptional activation by the NifA NC domain occurs from solution (rather than from 
non-specific interaction with DNA sequences) and the level of expression from the niJY\ 
promoter induced by the NifA NC domain was known to be lower than that observed for 
the whole NifA protein. It was hoped that by using the Control plasmid pPC228 
(expressing the whole NifA protein) as a positive control and the Prey plasmid pPC229-A 
(expressing the NC domain of NifA) as negative control that growth conditions could be 
manipulated to optimize the contrast between the colony color intensities given by the 
positive pPC228 and negative pPC229-A controls on Xgal plates. Growth conditions 
were to be optimized in the same way for the alternative Control and Prey Plasmids (i.e. 
those that had manipulated ptac promoter regions to reduce the distance between the RBS 
and the start codon of the cloned nifA and NifA NC domain sequences), pPC230 
(expressing the whole NifA protein) and pPC231-A (expressing the NifA NC domain), 
with each of the Bait plasmids pPC187-A and pPC187-B and their usefulness compared 
with that of the pPC228/pPC229-A combination of Control/Prey plasmids. In this way 
the most useful Control/Prey plasmid combination and the most useful Bait plasmid 
would be determined along with the growth conditions under which they gave the best 
results.
Several approaches were taken to try and optimize the contrast between positive 
pPC228/pPC230 and negative pPC229-A/pPC231-A controls. Firstly it was known that 
the S', meliloti 2011 NifA protein was intrinsically sensitive to oxygen. Oxygen inhibits
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the ability of NifA to both bind to its cognate DNA binding site and to initiate 
transcription. This is in contrast to the NilA protein from Klebsiella pneumoniae which 
is not sensitive to oxygen and inactivation of this NifA protein under aerobic conditions 
is entirely dependent on the activity of the K pneumoniae NifL protein. However, the 
inhibition of S. meliloti 2011 NifA induced transcriptional activation under aerobic 
conditions is not complete. The reason why the S. meliloti 2011 NifA was chosen for 
use in the construction of the P2H system rather than the K pneumoniae NifA protein 
was that it was hoped that the oxygen sensitivity of the protein could be used to 
advantage. It was hoped that performing the P2H assay under aerobic conditions would 
minimize the strength of induced nifH.lacZa activation from solution by the NifA NC 
domain.
A second approach involved initial incubation of plates at 37 °C for 24 hours followed 
by incubation at 30 °C for a further 24hours. The theory behind this approach is 
discussed below in relation to the initially constructed Control and Prey plasmids 
pPC228 and pPC229-A. NifA is temperature sensitive working optimally at a 
temperature of 28 °C and is not active at 37 °C. IHF also plays an important role in the 
activation of the nifH promoter by NifA by mediating DNA bending to bring NifA 
bound to its cognate DNA binding sequence upstream of the promoter into contact with 
E a54 bound at the promoter. Levels of IHF within the cell vary according to growth 
phase and there is a 10 fold increase in IHF levels during stationary phase. It had been 
noticed in initial plate tests that colour development of colonies containing plasmid 
pPC228 (expressing the whole NifA protein) and pPC187-A (the nifH.lacZa reporter 
plasmids) on Xgal plates was very slow requiring 72 hours at 30 °C for significant 
colour development to occur. It was also noted that colour development progressed 
from the centre of colonies out towards the edges of the colonies. It was therefore 
thought that initiation of nifH.iacZa transcription by the whole NifA protein occurred 
primarily during stationary phase of growth due to increased levels of IHF upon which 
activation by bound NifA depends. In contrast the NifA NC domain (expressed from 
plasmid pPC229-A) cannot bind DNA and activates transcription of the nifH. lacZa 
reporter on pPC187-A from solution and is therefore not dependent on IHF to activate 
transcription. There would therefore be a continuous accumulation of colour 
development of colonies containing the Prey plasmid pPC229-A (expressing the NifA 
NC domain) and pPC187-A throughout the growth of colonies on plates when plates
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were incubated at 30 °C. On the other hand, significant induction of the nifH:lacZa 
reporter gene on pPC187-A by the whole NifA (expressed from pPC228) would not 
occur until colonies started to enter into stationary phase. It was hoped that 
accumulating colony colour development produced by NifA NC domian (expressed 
from pPC229-A) would be prevented by an initial incubation at 37 °C for 24 hours. 
Incubation at this temperature would promote the fast growth of colonies and thus the 
stationary phase of growth would be achieved more rapidly than it would using 
incubation at 30 °C. At the same time any expressed NifA NC domain would be kept 
inactive and prevented from inducing expression of the nifH:lacZa reporter. Activation 
by of the nifH.iacZa reporter by the whole NifA (expressed from pPC228) would also 
be prevented at this temperature. However, after 24 hours at 37 °C plates would be 
switched to 30 °C for a further 24 hours to permit colony colour development. Since 
colonies on the plates would be entering into stationary phase after the initial incubation 
at 37 °C it was hoped that any newly synthesized NifA would readily activate the 
nifH:lacZa reporter to produce strong colony colour development. Obviously any newly 
synthesized NifA NC domain would also begin to activate expression of the ni/H. lacZa 
reporter but at a much lower level than that of NifA. It was hoped that by suppressing 
activation of nifH:lacZa expression by the NifA NC domain until colonies had entered 
into the stationary phase that the contrast between the colour intensity of colonies on 
positive control plates (containing plasmids pPC228 and pPC187-A) and colonies on 
negative control plates (containing plasmids pPC229-A and pPC187-A) would be 
enhanced. Unfortunately this was not to be the case as can be seen from the results 
presented in Chapter 6. In general, sets of plates incubated at 37 °C for 24 hours 
followed by incubation at 30 °C for another 24 hours mirrored those obtained for sets of 
plates incubated at 30 °C for 72 hours. The only desirable effect obtained by using an 
initial incubation at 37 °C for 24 hours was that results were obtained more quickly.
A third approach used to try and optimize the contrast between positive 
pPC228/pPC230 and their corresponding negative pPC229-A/pPC231-A controls 
involved the manipulation of IPTG levels used for inducing expression of the whole 
NifA and the NifA NC domain. As described in Chapter 6 it was expected that lower 
levels of induction would produce the best contrast between positive pPC228/pPC230 
controls and their corresponding pPC229-A/pPC231-A negative controls. The theory 
behind this was that the NifA NC domain activated transcription from the nifH promoter
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from solution as it did not possess a C-terminal DBD. The level to which NifA NC 
domain induced expression from the nifH promoter was therefore expected to be 
dependent on its concentration in the cell and thus the lower its concentration in the cell 
the lower the level of induced expression from the nifH promoter. On the other hand, 
the level of expression induced from the nifH promoter by the whole NifA protein was 
not expected to be as dependent on its concentration in the cell due to its ability to bind 
at the nifH promoter. This binding activity would be expected to increase the local 
concentration of the whole NifA protein in the vicinity of the nifH promoter. Results 
obtained were completely opposite to what was expected. It was found that increasing 
the concentration of IPTG from 0.5mM to 2mM caused a decrease in the colour 
intensity of colonies containing either pPC185-A or pPC187-A plasmids on their own. 
This was mirrored by a decrease in the colour intensity of colonies containing 
pPC229-A with pPC187-A allowing a clear distinction to be made between them and 
colonies containing plasmids pPC228 with pPC187-A. It is believed that the induced 
higher levels of transcription of the nifA gene and the sequence for the NifA NC domain 
from strong ptac promoters on plasmids pPC228 and pPC229-A respectively sequesters 
of core-RNA polymerase away from a 54. Although one might argue that such 
sequestering of core RNA polymerase into involvement in the transcription of nifA and 
NifA NC domain sequences might have a more general effect on bacterial cells causing 
them to grow more slowly it must be noted that a 54 is present in cells at much lower 
levels than a 70 and that it interacts with core RNA polymerase relatively weakly in
70 »comparison with a  . Any sequestering of core RNA polymerase due to enhanced levels 
of transcription of nifA and NifA NC domain sequences would therefore have a more 
pronounced and noticeable effect on a 54-dependent promoters like the nifH promoter of 
the nifH.lacZa reporter. Although NifA and NifA NC domain concentrations within the 
cell increase with increasing IPTG concentration as a result of higher levels of 
transcription there is a reduced amount of E a54 bound at the nifH promoter available for 
activation. Therefore there is a reduction in the amount of both leaky and induced 
transcription from the nifH promoter of the nifH.lacZa and a corresponding reduction 
in the colour intensity of colonies on Xgal plates. In support of this theory, increasing 
levels of NifA or NifA NC domain within the cell by increasing translational efficiency 
rather than by increasing levels of transcription does result in increased levels of 
induced nifH.lacZa expression. This can be seen by comparing the colour intensity of
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colonies given by pPC230 with those given by pPC228 for any one level of IPTG. The 
colour intensity of colonies given by pPC230 with its manipulated ptac promoter region 
for more efficient translation of NifA is greater than that observed for pPC228 for the 
same level of IPTG.
One final approach to try and optimize the contrast between positive pPC228/pPC187-A 
and negative pPC229-A/pPC187-A controls involved sealing plates with parafilm. Due 
to the slow colony colour development observed when plates were incubated at 30 °C it 
was felt that incubation under anaerobic conditions simply would not be feasible. The 
theory behind wrapping plates in parafilm was that bacteria would initially have 
sufficient oxygen to grow and form visible colonies but that as they grew they would 
gradually utilise all of the available oxygen within the sealed agar plate. Micro-aerobic 
conditions, under which NifA works optimally, would ensue and it was hoped that NifA 
induced colony colour development on Xgal plates would occur more rapidly. 
Unfortunately wrapping plates in parafilm had the undesirable effect of enhancing the 
colour development of colonies containing only the pPC187-A plasmid to a level that 
did not allow a clear distinction to be made between the positive pPC228/pPCl 87-A 
and negative pPC229-A/pPC187-A controls. One possible reason for this increased 
colony colour development was not that there was increased expression of lacZa from 
the nifH.iacZa reporter on pPC187-A but that there was increased expression of the 
complementing P-galactosidase background from the F' factor in ET6016r//Fl. This may 
have been caused as a result of rapid exhaustion of carbon sources due to anaerobic 
respiration followed by the CAP protein activating expression of the P-galactosidase 
complementing background from the F1 factor. The increased concentration of 
complementing background within the cell would result in an increase in colony colour 
development.
The end result of the optimization experiments was the identification of the optimal set 
of constructed plasmids for the P2H system and the growth conditions under which they 
were to be used. The optimal set of plasmids consisted of the pPC228 Control plasmid, 
the pPC229-A Prey plasmid and the pPC187-A Bait plasmid. The optimal conditions 
were determined to involve growth on media containing 2mM IPTG and incubation at 
30 °C for 72 hours under aerobic conditions. Having optimized the P2H system the next 
step was to test the ability of the system to detect protein-protein interactions in vivo.
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8.1.6: Testing O f The N if 'A Based P2H System Using The Model Interaction O f The
Tir and Intimin Proteins.
Having constructed the plasmids for the novel NifA based P2H system, developed 
suitable E. coli strains in which they could be used and optimized the growth conditions 
under which the assay would be performed the final step was to test the systems ability 
to detect protein-protein interactions in vivo. In order to do this a pair of proteins known 
to interact and that had been demonstrated to interact in the Y2H system were chosen. 
These proteins were the Tir and Intmin 280a (Int280a) proteins of enteropathogenic E. 
coli. As described in Chapter7, tir was cloned into the Bait plasmid pPC187-A to form 
plasmid pPC190 that would express it as a fusion with the DBD of NifA. The sequence 
for Int280a and a mutant form of the protein called Int280C/Aa were cloned into the 
Prey plasmid pPC229-A to form plasmids pPC233 and pPC234 respectively that 
express them as fusions with the NifA NC domain. Each of these plasmids was 
introduced into the host E. coli strain ET6016r//F' with plasmid pPC190 to see if an 
interaction between them and the Tir hybrid protein would be detected. Unfortunately 
the expected interaction between wild type Int280a and Tir was not detected.
There are several reasons as to why the expected interaction may not have been 
detected. The first of these is that although tir is expressed in enteropathogenic E. coli it 
is translocated to host epithelial cells where it becomes phosphorylated and then 
integrated into the host cell plasma membrane. The Tir protein may only fold correctly 
in eukaryotic cells or perhaps the phosphorylation of the protein in host cells is required 
for it to adopt a conformation capable of binding to Int280a. Consider that both the Tir 
and the Intimin proteins are expressed inside the same E. coli cell the very fact that Tir 
doesn't bind to Int280a inside E. coli might in itself be important since such binding 
would be detrimental to the cell. Another explanation for the failure to detect an 
interaction between the Tir and Int280a proteins might simply be because of occluson 
of the binding site on one of the proteins by NifA domains. If this is the case changing 
the polarity of the fusions i.e. fusing Int280a to the NifA DBD and Tir to the NifA AD. 
may overcome the problem and permit the detection of an interaction between Tir and 
Intimin. This problem is sometimes encountered in the Y2H system. It is important to 
note that due to the use of PCR for the amplification of tir and int280a sequences the
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failure to detect an interaction between Int280a and Tir may have been due to mutations 
introduced in the sequence for either protein during their amplification.
An interesting result was obtained for the Int280C/Aa-NifA NC domain protein 
expressed from plasmid pPC234. This protein generated a strong positive result, 
stronger than that given by the whole NifA protein, even in the absence of the Tir 
hybrid protein. This indicated that the Int280C/Aa protein interacted non-specifically 
with some protein bound at the nifli promoter, perhaps with Ect54 itself, to induce strong 
activation of the nifH.iacZa reporter gene. While the interaction detected was not the 
desired interaction with the Tir protein it does suggest that a protein-protein interaction 
can bring the NifA NC domain into proximity with the nifH  promoter to activate 
transcription of the nifH:lacZa reporter gene. This shows that in principle the P2H 
system should work.
The fact that a positive interaction detected in the P2H system would generate a level of 
nifH .iacZatranscription exceeding that observed for the NifA protein is not surprising. 
As mentioned earlier the NifA protein is sensitive to oxygen which inhibits both its 
ability to bind to DNA and to activate transcription. Once separated from the remainder 
of the protein the C-terminal DNA binding domain of NifA is not oxygen sensitive and 
can bind to it cognate DNA sequence. Therefore any hybrid protein fused to the DBD of 
NifA would bind at the nifH promoter irrespective of oxygen levels. Activation of 
transcription is then dependent on interaction between the protein fused to the NifA 
DBD and another protein fused to the NifA NC domain and is not dependent on oxygen 
tension.
8.2: Conclusions And Future Prospects.
Although an interaction between the Tir and Int280a proteins was not detected in the 
novel NifA based P2H system there are numerous reasons as to why the interaction may 
not have been detected. However the results obtained for the Int280C/Aa hybrid protein 
do provide some encouragement that the system will work in theory. It may simply be 
the case that the model protein-protein interaction initially chosen to test the novel P2H 
system was not a suitable one although as stated above the fact that no interaction
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between Int280a and Tir was detected might in itself by an important finding. Future 
work will obviously involve testing the system with other model protein-protein 
interactions in order to determine its worth. It will also involve testing and optimization 
of the nifH:gentr which although constructed has not been subject to any testing as yet. 
The primary reason for this was that it was felt that until the P2H system had been 
sufficiently optimized to permit clear distinction between positive and negative controls 
that the nifH:genf would be of little use.
There are several ways in which the P2H system can be improved. First of all the NC 
domain of the K. pneumoniae which is not oxygen sensitive could be used. This would 
help to promote more rapid colour development under aerobic conditions. In addition to 
this the nifH promoter of K. pneumoniae could be used in place of the S. meliloti 2011 
nifH promoter. It is now known that this promoter binds a 54 more weakly than the S. 
meliloti 2011 nifH promoter because it lacks a tract of thymine residues between -15 
and -17. Because of this the concentration of bound Ect54 at the promoter is lower and 
activation of transcription from the promoter from solution is thus lower. The promoter 
exhibits a greater dependency for bound NifA protein and so using this promoter rather 
than the S. meliloti nifH promoter would help to overcome the problems associated with 
activation of reporter genes from solution by the NifA NC domain. Using this promoter 
and the K. pneumoniae NifA NC domain should enhance the performance of the P2H 
system considerably. In addition to these changes additional binding sites for NifA 
might be incorporated upstream of the nifH promoter to improve the sensitivity of the 
system while MCS's could be expanded upon to make the plasmids more useful.
Assuming the basic NifA based P2H system described in this thesis can be shown 
conclusively to be capable of detecting protein-protein interaction in vivo there is 
obviously the potential for the development of a whole range of systems for detecting 
other types of molecular interaction such as prokaryotic one-hybrid (P1H) systems for 
the detection of protein-DNA interactions and prokaryotic reverse two-hybrid (PR2H) 
systems for detecting disruption of protein-protein interactions.
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